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1.1 Abstract 
 
The plasma membrane oxidoreductase (PMO) complex may exert important functions in cellular 
defence mechanism against oxidative stress and in apoptosis. Thus, we aimed to investigate the function 
of the five proteins GAPDH, Hsc70, enolase γ, aldolase C and Ulip, all of them tightly bound members of 
a neuronal PMO multi-protein complex, previously isolated and purified from synaptic vesicles and 
synaptic plasma membranes by our group. Earlier reports have shown an altered subcellular distribution 
of some these members in both apoptosis and in the cellular response to oxidative stress. We have now 
extended these studies using confocal laser scanning microscopy in the hope of uncovering clues to the 
elusive role of these five proteins by immunocytochemistry. Furthermore, CNS-derived cells, the mouse 
neuroblastoma NB41A3, and non-CNS derived cells, R6 fibroblast and an apoptosis-resistant Bcl-2 
expressing transfectant (R6Bcl-2), were transiently and stably transfected with GFP- and BFP-fusion 
constructs containing either GAPDH, Hsc70, enolase γ, aldolase C or Ulip. 
Expression of endogenous GAPDH, the major protein associated with the PMO complex, was 
predominantly nuclear in NB41A3 cells and cytoplasmic in R6 and R6-Bcl-2 cells. Induction of apoptosis 
and oxidative stress by H2O2 or FeCN enhanced the nuclear translocation of endogenous GAPDH in all 
cell types. In apoptotic cells, GAPDH expression was 3 times higher as compared to non-apoptotic cells. 
Consistent with a role of GAPDH in apoptosis, cells transfected by a vector coding for a GAPDH-GFP 
hybrid increased nuclear import of GAPDH-GFP and conferred a higher sensitivity to induction of 
apoptosis caused by exposure to staurosporine or MG132. Per se 10% of cells overexpressing GAPDH-
GFP are apoptotic. Bcl-2 overexpression prevents nuclear translocation of GAPDH and apoptosis in 
untransfected cells, but not in transfected cells overexpressing GAPDH-GFP fusion protein. 
Hsc70 is localised in the cytoplasm of neuroblastomas and fibroblasts. Partial translocation of 
endogenous Hsc70 into the nucleus is induced by oxidative stress, but not by apoptosis. The 
predominantly cytoplasmic localisation of overexpressed Hsc70-GFP in unstressed cells and its 
subsequent translocation into the nucleus after oxidative stress is similar to what is observed with 
endogenous Hsc70. Overexpression of Hsc70 makes cells more resistant to oxidative stress. However, in 
cells exposed to MG132 or staurosporine, no nuclear translocation of Hsc70-GFP is observed and no 
indications of a protective function of Hsc70 against apoptosis are found. 
Aldolase and overexpressed aldolase-GFP, which are present both in a soluble and in a 
cytoskeleton bound form, are expressed predominantly in the cytoplasm of unstressed cells. The 
expression is highest at the perinuclear area and in the somal area at the bases of axons. Induction of 
oxidative stress leads to enhanced nuclear expression of endogenous aldolase in NB41A3 cells. The 
cellular response to apoptosis induced by MG132 or staurosporine is not influenced by overexpression of 
aldolase-GFP, suggesting that aldolase C does not have a crucial function during apoptosis. 
Translocation of endogenous Ulip from the cytoplasm to the nucleus in response to oxidative 
stress is observed in NB41A3 and in R6 cells. In transfected cells overexpressed Ulip-GFP is also 
imported into the nucleus during oxidative stress, but it is still expressed predominantly in the cytoplasm 
and often concentrated in Ulip-GFP-positive speckles. 
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Enolase shows the least oxidative stress-induced changes among the five proteins of the PMO 
complex. The typical cytoplasmic expression of enolase is not significantly altered, except for a slight rise 
in nuclear enolase-GFP in transfected NB41A3 cells. 
Finally we were able to show that many combinations between two of the five PMO proteins in 
double-transfection experiments, enhance differential translocation into the nucleus or into speckles in 
response to oxidative stress. 
From this study we conclude, that the translocation of these PMO associated proteins, especially 
of GAPDH and Hsc70, may be an important event in apoptosis and oxidative stress. Our results also 
indicate that the effect of these proteins, when they are overexpressed, cannot be counteracted by Bcl-2. 
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1.2 Zusammenfassung 
 
Mittels Immunocytochemie untersuchten wir die Rolle der fünf Komponenten des Plasmamembran-
Oxidoreduktase (PMO) Komplexes, GAPDH, Hsc70, Enolase γ, Aldolase C und Ulip, während des 
Oxidativen Stresses und in der Apoptose. Um die Rolle dieser fünf Proteine, welche von unserer 
Forschungsgruppe isoliert worden waren, zu erforschen, machten wir uns die Konfokal Laser Scanning 
Microscopie zu nutze. Darüberhinaus wurden Zellen aus dem Zentral-Nervensystem (ZNS), Maus 
NB41A3 Neuroblastomen, und Nicht-ZNS Zellen, namentlich R6 Fibroblasten und eine Apoptose-
resistente Bcl-2 exprimierende Transfektanten (R6Bcl-2), sowohl transient als auch stabil mit GFP- und 
BFP-Fusions Konstrukten, die entweder GAPDH, Hsc70, Enolase γ, Aldolase C oder Ulip enthalten, 
transfektiert. 
Expression von GAPDH, dem wichtigsten Protein des PMO Komplexes, war vorwiegend im 
Zellkern in NB41A3 und cytoplasmisch in R6 and R6-Bcl-2 Zellen. Induktion von Apoptose und 
Oxidativem Stress erhöhte den Import von zelleigenem GAPDH in den Kern. In apoptotischen Zellen war 
die GAPDH-Expression 3 mal höher als in nicht-apoptotischen. Zellen, in denen GAPDH gekoppelt an 
GFP überexprimiert wurde, waren per se zu 10% apoptotisch und erhöhten den Zellkern-Import von 
GAPDH-GFP und und die Sensibilität auf durch Staurosporine oder MG132 induzierte Apoptose. Bcl-2 
Ueberexpression vermindert den Kern-Import von GAPDH als auch Apoptose in nicht transfektierten, 
nicht aber in GAPDH-GFP transfektierten Zellen.  
Kern-Import von zelleigenem Hsc70 oder überexprimiertem Hsc70-GFP wird nur während des 
Oxidativen Stresses, nicht aber während der Apoptose beobachtet. Ausserdem zeigen Hsc70-GFP 
überexprimierende Zellen verminderte Anfälligkeit gegenüber Effekten des Oxidativen Stresses, aber 
nicht gegenüber der Apoptose. 
Aldolase und überexprimiertes Aldolase-GFP werden vorwiegend in Kernnähe und am Ansatz 
von Axonen im Cytoplasma exprimiert. Währendem sich die Aldolase-Expression nach Induktion von 
Oxidativem Stress im Kern erhöhte, wurde sie durch Apoptose weder in Zellen mit noch ohne Aldolase-
GFP Ueberexpression beeinflusst. 
Bei Oxidativem Stress translosziert Ulip vom Cytoplasma in den Kern, währenddem Ulip-GFP 
auch häufig in intrazellulären Aggregaten zu finden ist.  
Von den fünf Proteinen des PMO Komplexes, zeigt die cytoplasmische Exxpression von Enolase 
die geringsten stress-induzierten Veränderungen. 
 Die gleichzeitige Ueberexpression verschiedener dieser PMO Komponenten steigerte den Kern-
Import während des Oxidativen Stresses zusätzlich. 
Wir schliessen aus dieser Studie, dass die Translokation der PMO assozierten Proteine, speziell 
von GAPDH und Hsc70, eine bedeutende Rolle während der Apoptose und des Oxidativen Stresses 
spielen. Zudem können die Effekte dieser Proteine bei Ueberexpression scheinbar nicht durch Bcl-2 
verhindert werden
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2 Introduction 
 
2.1 Oxidative stress 
 
During the course of evolution, aerobic organisms adapted to oxygen, partially by using oxygen as an 
electron acceptor in the process of generating energy. However, reactive oxygen species (ROS) are 
formed as by-products in this process. These ROS include the superoxide anion, the hydroxyl radical, the 
oxygen singlet and hydrogen peroxide. Superoxide anions originate from a single electron transfer to 
molecular oxygen. They have a relatively short diffusion radius inside the cell but may be converted by 
superoxide dismutase to hydrogen peroxide, the most stable and diffusible ROS. Aerobic organisms are 
therefore equipped with a large enzymatic and non-enzymatic anti-oxidant system, in order to protect 
other cellular components against the harmful effects of these reactive oxygen metabolites. Under some 
conditions however, ROS are generated in such quantities that the anti-oxidants capacities are 
insufficient, leading to situations described as oxidative stress. All aerobic cells are subject to endogenous 
oxidative stress. This process implicates reactions with O2 or ROS. In several biological processes ROS 
are produced in a controlled fashion. These species are able to control gene regulation through the 
activation of transcription factors that are dependent on the cellular redox state (Abate et al., 1990, 
Demple and Amabile-Cuevas, 1991, Schreck et al., 1992). However, uncontrolled production of ROS 
leads to oxidative stress, resulting in cellular damage, because ROS can react with and damage cellular 
macromolecules including DNA, proteins and lipids (Ames et al., 1993, Ames et al., 1995, Cerutti, 1985, 
Shigenaga et al., 1994, Stadtman, 1992).  
 
Oxygen intermediates act as signal transducers and represent a versatile cellular control mechanism for 
gene regulation. Earlier evidence has shown that the redox environment of the cell plays a regulatory role 
in controlling the activation and DNA binding of several transcription factors (Abate et al., 1990, Schreck 
et al., 1992, Schulze-Osthoff et al., 1992). The first inducible transcription factors identified in this 
context were the proto-oncogenes c-fos and c-jun which function co-operatively in signal transduction 
processes (Abate et al., 1990). Their protein products, Fos and Jun, form a heterodimeric complex that 
interacts with the DNA regulatory element known as the activator protein-1 (AP-1) binding site. 
Dimerisation occurs via interaction between leucine zipper domains and serves to bring into proper 
juxtaposition a region in each protein that is rich in basic amino acids and that forms a DNA-binding 
domain. DNA binding of the Fos-Jun heterodimer was modulated by reduction of a single conserved 
cysteine residue in the DNA-binding domains of the two proteins. Furthermore, a nuclear protein was 
identified that reduced Fos and Jun and stimulated DNA-binding activity in vitro. This raises the 
possibility that transcriptional activity mediated by AP-1 binding factors is regulated by a redox 
mechanism. 
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Evidence for redox regulation was provided by studies on the tumour necrosis factor α (TNFα)-mediated 
cytotoxicity. Inhibitors with different sites of action modulated TNFα cytotoxicity, however, with 
contrasting effects on final cell viability (Schulze-Osthoff et al., 1992). Inhibition of mitochondrial 
electron transport at complex III (cytochrome c reductase) by antimycin A resulted in a marked 
potentiation of TNFα-mediated injury. In contrast, when the electron flow to ubiquinone was blocked, 
either at complex I (NADH- ubiquinone oxidoreductase) with amytal or at complex II (succinate- 
ubiquinone reductase) with thenoyltrifluoroacetone, cells were markedly protected against TNFα 
cytotoxicity. Neither uncouplers nor inhibitors of oxidative phosphorylation nor inhibitors of complex IV 
(cytochrome c oxidase) interfered significantly with TNFα-mediated effects, ruling out the involvement 
of energy-coupled phenomena. In addition, the toxic effects of TNFα were counteracted by the addition 
of antioxidants and iron chelators. Treatment of cells with TNFα led to an early degeneration of the 
mitochondrial ultrastructure without any pronounced damage of other cellular organelles. Analysis of the 
mitochondrial electron flow revealed that TNFα treatment led to a rapid inhibition of the mitochondria to 
oxidise succinate and NADH-linked substrates. Different effects observed with the mitochondrial 
respiratory chain inhibitors provided evidence that mitochondrial production of oxygen radicals is a 
causal mechanism of TNFα cytotoxicity. 
 
Oxygen radicals also play an important role in the activation of NF-κ B and HIV-1 (Schreck et al., 1992). 
Dithiocarbamates which are considered for the treatment of AIDS and neurodegenerative diseases can 
potently block the activation of nuclear factor kappa B (NF-κ B), a transcription factor involved in human 
immunodeficiency virus type 1 (HIV-1) expression, signalling, and activation of immediate early genes 
during inflammatory processes. Micromolar amounts of the pyrrolidine derivative of dithiocarbamate 
(PDTC reversibly suppressed the release of the inhibitory subunit IκB from the latent cytoplasmic form 
of NF-κ B in cells treated with phorbol ester, interleukin 1, and tumour necrosis factor α, whereas other 
DNA binding activities and the induction of AP-1 by phorbol ester were not affected. The antioxidant 
PDTC also blocked the activation of NF-κ B by bacterial lipopolysaccharide (LPS), also suggesting a role 
of oxygen radicals in the intracellular signalling of LPS. Further, treatment of pre-B and B cells with LPS 
induced the production of O2- and H2O2. PDTC prevented specifically the κ B-dependent transactivation 
of reporter genes under the control of the HIV-1 long terminal repeat and simian virus 40 enhancer.  
 
Another report also showed that mitochondria-derived ROS intermediates are not only cytotoxic but, in 
addition, are required in their function as signal transducers of TNFα-induced gene expression (Schulze-
Osthoff et al., 1993). The activation of NFκB could be blocked by interference with the mitochondrial 
electron transport system. Furthermore, antimycin A, a mitochondrial inhibitor that increases the 
generation of ROS, potentiated TNFα-triggered NFκB activation. Further subclones which lacked a 
functional respiratory chain and were therefore depleted of the mitochondrial oxidative metabolism, 
resulted in resistance towards TNFα cytotoxicity, as well as in inhibition of NFκB activation and 
interleukin-6 gene induction by TNFα. This demonstrates that mitochondria serve as common mediators 
of the TNFα-cytotoxic and gene-regulatory signalling pathways. 
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 On the other hand, the involvement of ROS as causal effectors in apoptosis has been established 
(Shimizu et al., 1996, Slater et al., 1995b, Slater et al., 1995a). It was shown that one of the most 
reproducible inducers is mild oxidative stress (e.g. via exposure to hydrogen peroxide, redox-cycling 
quinones or thiol-alkylating agents) (Slater et al., 1995b, Slater et al., 1995a). It had also been observed 
that oxidative stress more readily modifies proteins and lipids  in cells undergoing apoptosis in response 
to non-oxidative stimuli such as glucocorticoids or topoisomerase II inhibitors than in normal cells. 
Further, apoptosis was typically accompanied in its initial steps by a depletion of intracellular reduced 
glutathione (GSH). Pre-treatment of cells with antioxidants was shown to protect cells against 
programmed cell death. 
 
Further, cell death due to reoxygenation after hypoxia was characterised in primary cultured hepatocytes 
(Shimizu et al., 1996). Reoxygenated hepatocytes revealed morphological characteristics of apoptosis, 
including chromatin condensation, nuclear fragmentation, and formation of apoptotic bodies. However, 
also few necrosis, defined by loss of plasma membrane integrity, mitochondrial swelling, and formation 
of large vacuoles, was observed.  Production of oxygen radicals was enhanced by reoxygenation of 
hypoxic cells, and reoxygenation-induced apoptosis was inhibited by oxygen radical scavengers. 
 
Concerning neurodegenerative disorders, such as Parkinson's and Alzheimer's disease, it is possible that a 
gradual impairment of cellular defence mechanisms leads to cell damage by apoptosis. 
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2.2 Apoptosis 
 
Apoptosis is the most common form of physiological cell death (for recent reviews see (Adams and Cory, 
1998, Ashkenazi and Dixit, 1998, Green, 1998, Green and Reed, 1998, Hofmann, 1999, Raff, 1998, 
Salvesen and Dixit, 1997, Thornberry and Lazebnik, 1998, Vaux, 1997, Vaux and Korsmeyer, 1999, 
Wolf and Green, 1999)) and plays an important role in animal development and homeostasis, controlling 
cell numbers in both vertebrate and invertebrate tissues (Oppenheim, 1991, Raff et al., 1993) Recently, 
several families of molecules that regulate apoptosis in different settings have been identified (for review, 
see (Hengartner and Horvitz, 1994)). The Ced-9Bcl-2 family of apoptosis regulators is composed of a 
large number of intracellular proteins with opposing effects in regulating cell death. Some family 
members, including Bcl-2 (Bakhshi et al., 1985, Hengartner and Horvitz, 1994) and Bcl-xL (Boise et al., 
1993), function to inhibit apoptosis, whereas other members such as Bax (Oltvai et al., 1993), Bcl-xS 
(Boise et al., 1993), Bad (Yang et al., 1995), and Bak (Chittenden et al., 1995, Farrow et al., 1995, Kiefer 
et al., 1995) function to promote apoptosis. It appears that homodimerization and heterodimerization 
between the various death-promoting and death-inhibiting family members regulates the activation of 
caspases, which execute the cell death program (Reed, 1997, Yang et al., 1995). Although most of the 
analysis of these molecules has been done in extraneural tissues, there is now compelling evidence that 
their actions are quite general including in neurones. 
 
The time course of transcription factor expression in tissues undergoing apoptosis, as well as the effect of 
transcription and translation inhibitors on neuronal injury, suggest that some transcription factors may 
participate in the regulation of the destructive process (Hughes et al., 1997, Pittman et al., 1994). One 
such transcription factor is NF-κB. NF-κB is expressed in neurones and glia throughout the mammalian 
CNS (Kaltschmidt et al., 1993, Kaltschmidt et al., 1994) and can be activated by glutamate receptor 
agonists (Guerrini et al., 1995, Kaltschmidt et al., 1995). Increased NF-κB levels have recently been 
observed in areas of neuronal degeneration in animal models of ischemia, as well as in patients with 
Alzheimer's disease and Parkinson's disease (Kaltschmidt et al., 1997). Although recently it was shown 
that inhibition of NF-κB potentiates amyloid β-mediated neuronal apoptosis (Kaltschmidt et al., 1999), its 
role in the regulation of apoptosis is still rather controversial (Baeuerle and Baltimore, 1996, Baichwal 
and Baeuerle, 1997, Lin et al., 1995). Evidence suggesting that NF-κB protects dividing cells against 
apoptosis derives mainly from studies of tumour necrosis factor-induced cell death (Beg et al., 1993, Van 
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Antwerp et al., 1996) but has been observed in certain other situations, including an NF-κB p65 subunit 
knock-out animal model (Beg et al., 1993, Wu and Lozano, 1994).  
 
The activation of cell death program is also responsible for pathological cell death in neurodegenerative 
disorders, including Alzheimer's disease (Thompson, 1995). Known elements of this program include 
members of the Bcl-2 gene family, Apaf-1, and proteases of the caspase family (Cohen, 1997, Reed, 
1997, Reed, 1997, Salvesen and Dixit, 1997). Once thought to be merely the centre of cellular ATP 
production, mitochondria are increasingly implicated as sensors and executioners in the cell's decision to 
live or die  and may even influence the mode of cell death, necrosis or apoptosis, depending on their 
functional state (Reed, 1998, Reed et al., 1998). Mitochondria are capable of releasing pro-apoptotic 
factors into the cytosol, including apoptosis-inducing factor (AIF), which induces chromatin condensation 
and oligonucleosomal DNA fragmentation in isolated nuclei (Susin et al., 1999, Susin et al., 1998, 
Zamzami et al., 1998), and cytochrome c, which activates procaspase-9 and the caspase cascade with the 
help of Apaf-1 and (d)ATP (Li et al., 1998). What remains as yet unresolved is the mechanism by which 
pro-apoptotic factors are released into the cytosol. One candidate, the so-called mitochondrial 
permeability transition pore (PTP) (Marzo et al., 1998), is triggered by an increase in matrix Ca2+, pro-
oxidants, and mitochondrial depolarisation and is responsible for unspecific transport of low molecular 
weight products (<1.5 kDa) across the inner mitochondrial membrane (Zoratti and Szabo, 1995). Because 
this results in inner membrane permeability to protons, PTP is associated with a decrease in mitochondrial 
transmembrane potential (Zoratti and Szabo, 1995). The opening of PTP is probably not sufficient to 
release cytochrome c directly but could trigger cytochrome c release by causing mitochondrial swelling 
and/or rupture of the outer mitochondrial membrane (Vander Heiden et al., 1997).  
 
A reduction in mitochondrial transmembrane potential has been observed in a number of models of 
apoptosis (Ankarcrona et al., 1996, Heiskanen et al., 1999, Wadia et al., 1998, Zamzami et al., 1998). On 
the other hand, however, studies in non-neuronal cells have suggested that this is not a primary event in 
apoptosis (Vander Heiden et al., 1997). Thus, although the importance of mitochondria in programmed 
cell death seems fairly clear with respect to the release of pro-apoptotic factors, the events preceding this 
release remain unresolved. 
 
Reactive oxygen species (ROS) also act as mediators of cell death that occurs in mitotic cells during their 
normal turnover, in neurones during development of the nervous system, and in neurodegenerative 
 12 
disorders (Benzi and Moretti, 1995, Mattson, 1996). Examples include the killing of lymphocytes by 
tumour necrosis factor and chemotherapeutic drugs (Schreck et al., 1991), trophic factor withdrawal-
induced apoptosis of sympathetic neurones (Greenlund et al., 1995), and neuronal apoptosis induced by 
amyloid-β-peptide (Loo et al., 1993). Although these studies have documented increased signs of 
oxidative stress in cells undergoing apoptosis, the specific ROS involved, their subcellular sources, and 
their mode of action in inducing apoptosis are poorly known. Mitochondria, a major subcellular source of 
ROS (Dugan et al., 1995, Piantadosi and Zhang, 1996), may play pivotal roles in apoptosis (Kroemer et 
al., 1997). Alterations occur in mitochondria before nuclear manifestations of apoptosis, including 
impairment of energy charge and redox state, disruption of mitochondrial transmembrane potential, 
permeability transition, and release of cytochrome C (Zamzami et al., 1996a). Radical scavengers, thiol 
reducing agents, and cyclosporin A block both mitochondrial permeability transition and apoptosis in 
several paradigms (Marchetti et al., 1996, Zamzami et al., 1996b), suggesting essential roles for 
mitochondrial ROS generation and permeability transition in apoptosis. Superoxide anion radical is the 
major ROS generated in mitochondria and can interact with nitric oxide (NO) to form peroxynitrite, 
which may damage cells by promoting membrane lipid peroxidation and nitration of proteins on tyrosine 
residues (Beckman and Crow, 1993). NO donors and peroxynitrite can induce, and NO synthase 
inhibitors can prevent, apoptosis in many types of cultured cells including neurones (Estevez et al., 1995, 
Szabo, 1996). Superoxide accumulation is prevented by its conversion to hydrogen peroxide, a process 
catalysed by the superoxide dismutases Cu/ZnSOD and MnSOD (Weisiger and Fridovich, 1973). 
Correlation between expression of mitochondrial MnSOD and increased resistance to cell injury and 
death have been established in several paradigms, including resistance of tumour cells to killing by TNFα 
(Wong and Goeddel, 1988) and resistance of cardiac myocytes treated with TNFα to ischemic injury 
(Nelson et al., 1995). Despite such correlation, it is not known whether and how mitochondrial MnSOD 
exerts its anti-apoptotic function.  
 
Recent evidence implicates the mitochondrion as a critical site at which different apoptotic signals 
converge. Findings in some non-neuronal models of cell death suggest that a death signal induces 
translocation of a BH3 (homology domain)-containing, pro-apoptotic Bcl-2 family member to the 
mitochondria, followed by the release of mitochondrial proteins, such as cytochrome c, via an unknown 
mechanism that may involve the permeability transition pore (PTP) and/or a channel formed by pro-
apoptotic Bcl-2 family proteins (Gross et al., 1999, Li et al., 1998, Luo et al., 1998, Shimizu et al., 1999). 
Once released, cytochrome c forms a complex with Apaf-1 and procaspase-9, which in the presence of 
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ATP or dATP, becomes activated, resulting in further caspase activation, cleavage of cellular substrates, 
and cell death. 
 
Bcl-2 is a widely expressed cytoplasmic protein that plays a key role in regulating cell survival in the 
immune system and nervous system. Mice with targeted null mutations in the Bcl-2 gene have markedly 
reduced numbers of B and T cells attributable to increased apoptosis (Nakayama et al., 1994, Nakayama 
et al., 1993, Veis et al., 1993), whereas mice carrying a transgene causing high levels of Bcl-2 expression 
in the immune system show extended survival of B and T cells (McDonnell et al., 1989, McDonnell et al., 
1990). Overexpression of Bcl-2 in cultured neurones prevents their death after neurotrophin deprivation 
(Allsopp et al., 1993, Garcia et al., 1992), and mice expressing a Bcl-2 transgene under the control of 
neurone-specific enolase promoter have increased numbers of neurones in several regions (Martinou et 
al., 1994). The survival response of cultured cranial sensory neurones to neurotrophins during the phase 
of naturally occurring neuronal death is markedly reduced by antisense Bcl-2 RNA (Allsopp et al., 1995). 
Likewise, cranial sensory neurones from Bcl-2(-/-) embryos do not survive in vitro with neurotrophins as 
well as wild-type embryos during the peak period of naturally occurring neuronal death and are lost to a 
greater extent than wild-type neurones during this period of development in vivo (Pinon et al., 1997). 
Sympathetic neurones from postnatal Bcl–2(-/-) mice die more rapidly after nerve growth factor (NGF) 
deprivation in vitro than wild-type neurones (Greenlund et al., 1995), and postnatal Bcl-2(-/-) mice have 
significantly fewer sensory, autonomic, and motor neurones than wild-type mice (Michaelidis et al., 
1996). Furthermore, Bcl-2 is structurally and functionally similar to the ced-9 gene product of 
Caenorhabditis elegans that also prevents programmed cell death (Hengartner and Horvitz, 1994). 
Recently, Bcl-2 has been shown to prevent both apoptotic and necrotic cell death induced by a variety of 
stimuli in several systems (e.g. (Rosse et al., 1998, Shimizu et al., 1999, Zhivotovsky et al., 1998); for 
review, see (Allen et al., 1998, Chao and Korsmeyer, 1998)) 
 
In addition Bcl-2 also influences neuronal differentiation. Its overexpression in a neural crest-derived line 
enhances neurite outgrowth and increases the expression of neurone-specific enolase (Zhang et al., 1996). 
Midbrain-derived dopaminergic lines stably expressing Bcl-2 extended longer neurites than control-
transfected cells (Oh et al., 1996), and Bcl-2 enhances the differentiation of the PC12 cells grown in 
serum-free conditions (Batistatou et al., 1993).  
 14 
2.3 PMO  
 
It is known that transplasma membrane electron transport, which exists in both plant and animal cells 
(reviewed in Barr et al., 1991, Barr et al., 1988, Brightman et al., 1992, Crane, 1989b, Crane et al., 1989a, 
Crane et al., 1991, Dreyer, 1990), may play an important role in the response mechanisms to oxidative 
stress and in apoptosis. The nature and components of the electron transport system and the mechanism 
by which proton release is activated is only poorly understood to date. Reduced pyridine nucleotides are 
substrates for the plasma membrane dehydrogenases. Oxidants such as ferricyanide (FeCN) are used to 
probe the activity. Stimulation of electron transport with impermeable oxidants and hormones activates 
proton release from cells. Inhibitors of electron transport, such as certain anti-tumour drugs, inhibit proton 
release. In some cells transmembrane electron transport has been shown to cause cytoplasmic pH changes 
or to stimulate protein kinases which may be the basis for activation of proton channels in the membrane. 
The redox-induced proton release causes internal and external pH changes which can be related to 
stimulation of animal and plant cell growth by external, impermeable oxidants or by oxygen. 
 
More evidence that the transmembrane electron transport is associated with proton release involved in 
internal pH control was given by studies in Tetrahymena (Barr et al., 1991). Transmembrane ferricyanide 
reduction by Tetrahymena was not inhibited by mitochondrial inhibitors such as antimycin A, 2-n-heptyl-
4- hydroxyquinoline N-oxide, or potassium cyanide, but it responded to inhibitors of glycolysis. Thus, 
transmembrane ferricyanide reduction by Tetrahymena appears to involve a plasma membrane electron 
transport chain similar to those of other animal cells. 
 
NADH/acceptor oxidoreductase activities using oxygen as electron acceptor have been demonstrated 
most unambigously with isolated plasma membranes. NADH oxidase activity of plasma membranes was 
stimulated by growth factors and hormones 2- to 3-fold. In contrast, NADH oxidase was inhibited up to 
80% by several agents known to inhibit growth or induce differentiation, like retinoic acid, calcitriol, and 
the monosialoganglioside, GM3. The growth factor-responsive NADH oxidase of isolated plasma 
membranes was not inhibited by common inhibitors of oxidoreductases of endoplasmic reticulum or 
mitochondria. As well, NADH oxidase of the plasma membrane was stimulated by concentrations of 
detergents which strongly inhibited mitochondrial NADH oxidases and by lysophospholipids or fatty 
acids. Growth factor-responsive NADH oxidase, however, was inhibited greater than 90% by chloroquine 
and quinone analogues. Addition of coenzyme Q10 stimulated the activity and partially reversed the 
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analogue inhibition. Coenzyme Q is an important electron and proton carrier within the lipid phase of 
membranes (Crane and Navas, 1997, Crane et al., 1994). The first function of coenzyme Q was defined in 
the energy transduction process in mitochondria. Later it was shown that the presence of coenzyme Q in 
other cellular membranes has dynamic rather than passive significance. Coenzyme Q functions in the 
plasma membrane electron transport involved in the activation of signalling protein kinases related to 
gene activation for cellular proliferation. Furthermore, the antioxidant potential of the reduced coenzyme 
Q is significant in the evidence that the reduced quinone can act to maintain tocopherol in the reduced 
state in membranes and ascorbate reduced both inside and outside the cell. 
 
Very recent findings suggest the potential participation of the plasma membrane NADH oxidase as a 
terminal oxidase of plasma membrane electron transport from cytosolic NAD(P)H via naturally occurring 
hydroquinones to acceptors at the cell surface (Kishi et al., 1999). 
 
Although electron transport across biological membranes is a well-known feature of bacteria, 
mitochondria and chloroplasts, where it provides motive forces for vectorial transport processes, electron 
transport is generally not found in the plasma membrane of eukaryotic cells, because it would possibly 
interfere with electric processes at the plasma membrane. An exception is provided by the phagocyte 
NADPH oxidase, which generates superoxide through electron transfer from cytosolic NADPH to 
extracellular oxygen (Brightman et al., 1992). The enzyme is essential for host defence, and patients with 
chronic granulomatous disease, who lack the functional enzyme, suffer from severe infections.  
 
Neutrophils possess a unique membrane-associated NADPH oxidase system, which only becomes 
activated upon exposure to the appropriate stimuli and catalyses the one-electron reduction of molecular 
oxygen to superoxide, O2- (Umeki, 1994). Oxidase activation involves the assembly of membrane-bound 
and cytosolic constituents of the oxidase system, which are disassembled in the resting state. The oxidase 
system consists of two plasma membrane-bound components: a low-potential cytochrome b558 and a 
flavoprotein related to the electron transport between NADPH and heme-binding domains of the oxidase. 
Recent reports have indicated that FAD-binding sites of the oxidase are contained in cytochrome b558 
(flavocytochrome b558). Cytosolic components are known to translocate to the plasma membrane, 
ensuring assembly of an active O2(-)-generating NADPH oxidase system. Further, the membrane (Raps) 
and cytosolic (Racs) GTP-binding proteins have been established as essential to oxidase assembly. In 
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summary this oxidase is controlled by hormones, growth factors and other ligands which bind to 
receptors in the plasma membrane, as well as by oncogenes.  
 
The electrogenic nature of electron transfer by the NADPH oxidase was demonstrate by using the whole-
cell patch-clamp technique (Schrenzel et al., 1998). It was the first study to demonstrate electron currents 
across the plasma membrane of a eukaryotic cell. This generation of electron currents by the NADPH 
oxidase was shown in human eosinophil granulocytes. The currents were absent in granulocytes of 
sufferers of chronic granulomatous disease and under conditions of low oxygen. Generation of electron 
currents across the plasma membrane of eukaryotic cells had not been observed previously and might be, 
independently of the generation of superoxide, a physiologically relevant function of the phagocyte 
NADPH oxidase. The precise functions of the NADPH oxidase in host defence remain to be defined, 
however. Interestingly NADPH oxidase can generate large currents, even against major electrical 
gradients. 
 
Several studies investigated the role of PMOs in the antioxidant defence of the brain to oxidative stress 
(reviewed in (May, 1999, Wilson, 1997)). Oxidative injury has been implicated in degenerative diseases, 
epilepsy, trauma, and stroke. It is a threshold phenomenon that occurs after antioxidant mechanisms are 
overwhelmed. Oxidative stress is initiated by numerous factors: acidosis; transition metals; amyloid β-
peptide; the neurotransmitters dopamine, glutamate, and nitric oxide; and uncouplers of mitochondrial 
electron transport. Antioxidant defences include the enzymes superoxide dismutase, glutathione 
peroxidase, and catalase, as well as the low molecular weight reductants α- tocopherol (vitamin E), 
glutathione, and ascorbate (reduced vitamin C). Cells like astrocytes maintain high intracellular 
concentrations of certain antioxidants, making these cells resistant to oxidative stress relative to 
oligodendrocytes and neurones. Following reactive gliosis, the neuroprotective role of astrocytes may be 
accentuated because of increases in a number of activities: expression of antioxidant enzymes; transport 
and metabolism of glucose that yields reducing equivalents for antioxidant regeneration and lactate for 
neuronal metabolism; synthesis of glutathione; and recycling of vitamin C. In the latter process, 
astrocytes take up oxidised vitamin C (dehydroascorbic acid, DHAA) through plasma membrane 
transporters, reduce it to ascorbate, and then release ascorbate to the extracellular fluid, where it may 
contribute to antioxidant defence of neurones. Vitamin C can also interact with the plasma membrane by 
donating electrons to the α-tocopheroxyl radical and a trans-plasma membrane oxidoreductase activity. 
Ascorbate-derived reducing capacity is thus transmitted both into and across the plasma membrane. 
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Recycling of α-tocopherol by ascorbate helps to protect membrane lipids from peroxidation. The 
oxidoreductase activity has typically been studied using extracellular ferricyanide as an electron acceptor. 
Whereas an NADH-ferricyanide reductase activity is evident in open membranes, ascorbate is the 
preferred electron donor within cells. The oxidoreductase may be a single membrane-spanning protein or 
may only partially span the membrane as part of a trans-membrane electron transport chain composed of 
a cytochrome or even hydrophobic antioxidants such as α-tocopherol or ubiquinol-10. Proposed functions 
for the oxidoreductase include stimulation of cell growth, reduction of the ascorbate free radical outside 
cells, recycling of α-tocopherol, reduction of lipid hydroperoxides, and reduction of ferric iron prior to 
iron uptake by a transferrin-independent pathway. Diferric transferrin and ceruloplasmin which stimulate 
proliferation also stimulate membrane oxidase activity measured by the reduction of ferricyanide. The 
oxidants activate growth-related signals such as cytosolic alkalinisation and calcium mobilisation. 
Antiproliferative agents such as adriamycin and retinoic acid inhibit the plasma membrane electron 
transport (for reviews see Crane et al., 1994, Medina et al., 1997, Rauchova et al., 1995). 
 
Our group recently identified and characterised a new trans-plasma-membrane NADH-dichlorophenol-
indophenol oxidoreductase (PMO) in neuronal synaptic plasma membranes, in synaptic vesicles and in 
the murine neuroblastoma cell line NB41A3 (Yong and Dreyer, 1995, Yong and Dreyer, 1995, 
Zurbriggen and Dreyer, 1994, Zurbriggen and Dreyer, 1996). We were able to purify this PMO from 
bovine brain, rat brain and from NB41A3 cells (Bulliard et al., 1997). Several purification steps were 
performed to isolate the PMO activity: protein extraction with detergents, (NH4)2SO4 precipitation, 
stringent chromatography and native PAGE. Finally enzyme activity could be attributed to a very tight 
complex of several proteins that could not be separated except by SDS/PAGE. By SDS/PAGE we were 
able to isolate and identify five components: Hsc70, Ulip (TOAD-64), glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH), brain specific enolase γ and brain specific aldolase c (zebrin II). The 
association of PMO in a tight complex was confirmed by its immunoprecipitation from extracts of 
NB41A3 using antibodies directed against any of the five proteins of the complex followed by 
immunodetection with antibodies directed against the other members. 
 
Little is known about the molecular mechanism and about the proteins involved in the response to 
elevated ROS concentrations during the oxidative stress. Therefore we wanted to characterise in more 
detail the function of each of the 5 proteins that are aggregated in the neuronal PMO complex.  
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2.3.1 GAPDH 
 
The major component of the PMO complex, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), is a 
tetramer composed of four identical 37 kDa subunits. It is a central glycolytic protein with pivotal role in 
energy production. It was used as a paradigm not only for analysis of protein structure and function but 
also for model studies on gene structure and expression. Recent studies demonstrated that GAPDH or 
some of its isoforms (>200) display a number of activities unrelated to its glycolytic function as a 
dehydrogenase.  
 
Initial studies identified the structural association of GAPDH with cell membranes (Allen et al., 1987, 
Kliman and Steck, 1980, Lin and Allen, 1986, Tsai et al., 1982). Two-dimensional gel electrophoresis 
were used in theses investigations to detect a series of GAPDH variants. It was shown that GAPDH 
colocalised with the band 3 anion exchanger protein in erythrocytes (Ercolani et al., 1992). Its glycolytic 
activity was diminished by its protein-protein interaction. Competition was observed with NAD+. Later 
studies revealed a functional role for GAPDH in membrane fusion (Glaser and Gross, 1995). Facilitated 
membrane fusion by plasmenylethanolamine was catalysed by GAPDH in a highly 
plasmenylethanolamine- and cholesterol-specific manner. Intriguingly, these investigations suggested that 
an isoform of GAPDH, lacking its glycolytic dehydrogenase activity, was the active species. GAPDH 
fusogenic activity was inhibited by glyceraldehyde-3-phosphate but not by koningic acid, an effective 
inhibitor of the dehydrogenase activity. Further, the composition of synthetic phospholipid membranes 
influenced both the binding and fusogenic capacity of rabbit GAPDH (Kaneda et al., 1997). This results 
were substantiated by the finding that under physiological conditions the GAPDH isoform bound to 
naturally occurring membranes and was able to fuse them (Han et al., 1998). Furthermore, another group 
identified GAPDH as a Ca2+ -dependent fusogen in human neutrophil cytosol (Hessler et al., 1998). In 
neutrophil degeneration membrane fusion is required for invagination of the plasma membrane to engulf 
foreign particles. Robbins provided the first mutational evidence to demonstrate the role of GAPDH in 
membrane fusion (Robbins et al., 1995). 
 
GAPDH was identified as a tubulin binding protein, catalysing tubulin bundling into microtubule bundles 
(Durrieu et al., 1987, Durrieu et al., 1987, Kumagai and Sakai, 1983, Muronetz et al., 1994). Tubulin 
bundling by GAPDH, which was able to modulate the cytoskeletal structure, was inhibited by ATP 
(Huitorel and Pantaloni, 1985). The functional role of tubulin-bound GAPDH was demonstrated by 
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analysis of mutant CHO cells deficient in endocytosis (Robbins et al., 1995). It was shown that a 
mutation in microtubule-associated GAPDH was causing the deficiency. 
 
GAPDH was identified as a specific mRNA binding protein in experimental protocols used to identify 
specific proteins that interact with either cellular or viral 5'-UTR or 3'-UTR mRNA sequences (De et al., 
1996, Nagy and Rigby, 1995, Schultz et al., 1996). These sequences seem to be important for the 
translational regulation of gene expression and are necessary for viral infection of eukaryotic cells. 
Competition experiments indicated that GAPDH-RNA binding was inhibited by poly(U) or NAD+. These 
results suggest the involvement of the NAD+ binding site within GAPDH. Furthermore GAPDH 
increases the activity of TNFα in vitro and in vivo. Its binding to GAPDH was inhibited by NAD+ and 
ATP (Sioud and Jespersen, 1996).  
 
Initial investigations identified GAPDH as a DNA binding protein (Tsai and Green, 1973) and as a non-
histone nuclear protein important in enhancement of gene expression (Morgenegg et al., 1986). Recent 
studies have indicated more nuclear functions of GAPDH in mammalian cells. Singh and Green identified 
GAPDH as a nuclear tRNA export protein (Singh and Green, 1993). Normal and export-defective tRNA 
were used in mobility shift assays to purify GAPDH as the export protein. Human erythrocyte GAPDH 
exhibited tRNA binding that was competitively inhibited by NAD+. 
 
Investigating the role of AP4A in DNA replication and DNA repair with the help of photoaffinity probes, 
GAPDH was identified as AP4A binding protein (Baxi and Vishwanatha, 1995). The physiological 
significance of this Mg2+ dependent interaction is indicated by previous studies demonstrating the 
physical association of mammalian GAPDH with replicating DNA (Lee and Sirover, 1989). 
Radiolabeling with (35S)methionine demonstrated that the biosynthesis of nuclear GAPDH paralleled its 
DNA association. Different studies indicate a role of GAPDH in DNA repair. Initially, nuclear GAPDH 
was identified as a uracil DNA glycosylase (UDG) based on its ability to release uracil from a poly(dA)-
poly(dU) substrate (Meyer-Siegler et al., 1991). This report was confirmed by findings that the purified 
AP4A binding protein exhibited UDG activity (Baxi and Vishwanatha, 1995). Physiological significance 
was demonstrated in vivo showing that human cells, treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD), increased GAPDH gene transcription and translation. 
 
Several independent studies provide evidence that mammalian GAPDH exhibits 
phosphotransferase/kinase activity and described autophosphorylation of GAPDH (Duclos-Vallee et al., 
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1998, Kawamoto and Caswell, 1986, Wu et al., 1997). One of these studies demonstrate that GAPDH 
may also phosphorylate other proteins. It was suggested that GAPDH is a cellular kinase which might 
interfere in the life-cycle of hepatitis B virus (HBV). Other roles for GAPDH in phosphate group transfer 
recently discovered, related to its phosphorylation by a number of cellular protein kinases, including 
protein kinase C, epidermal-growth-factor kinase and Ca2+/calmodulin-dependent protein kinase II 
(Ashmarina et al., 1988, Engel et al., 1998, Reiss et al., 1996, Reiss et al., 1986, Reiss et al., 1996, Reiss 
and Schwartz, 1987, Sergienko et al., 1992). 
 
Furthermore, GAPDH is known to be a specific target of nitric oxide (NO), which catalyses the non-
enzymatic covalent modification of GAPDH by NAD+ (Brune and Lapetina, 1995, Brune and Lapetina, 
1996, McDonald and Moss, 1993, McDonald and Moss, 1994).  
 
Initial indications for the role of GAPDH in apoptosis were demonstrated first in cerebellar granular cells 
(Ishitani and Chuang, 1996a, Ishitani et al., 1996c, Ishitani et al., 1996b, Ishitani et al., 1997, Sunaga et 
al., 1995). Mature cerebellar granular cells underwent an age-induced apoptotic death in culture between 
day 15 and day 17 in vitro. This apoptosis was closely associated with an enhanced level of 38-kDa 
protein in the particulate fraction, which was identified as GAPDH. Moreover, GAPDH antisense, but not 
sense, oligodeoxyribonucleotides specifically suppress the age-induced accumulation of GAPDH mRNA 
and protein before apoptotic neuronal cell death. GAPDH overexpression in the particulate fraction has 
also been implicated in ara-C and low potassium chloride-induced apoptosis. Analysis of the subcellular 
regulation of GAPDH during apoptosis showed that overexpressed GAPDH in cells undergoing apoptosis 
is localised in the nuclear compartment (Ishitani et al., 1998, Saunders et al., 1999, Sawa et al., 1997). 
This was established using cell fractionation coupled with immunoblot analysis or immunocytochemistry 
to detect the presence of nuclear GAPDH. Antisense GAPDH studies demonstrated that its inhibition of 
apoptosis precluded the appearance of nuclear GAPDH. Furthermore the absence of GAPDH glycolytic 
activity subsequent to its translocation into the nucleus was demonstrated by enzymatic analysis. 
 
Recently it was shown that GAPDH exerts a very interesting role in neurodegenerative disease. Studies 
have identified interrelated characteristics of a series of age-related, autosomal dominant, 
neurodegenerative disorders (Albin and Tagle, 1995, Gusella and MacDonald, 1996, Nasir et al., 1996). 
They are characterised by the expansion of CAG repeats in the coding region of the primary gene 
defective in the respective disorder. The resulting mutant protein containing polyglutamine tracts in its N-
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terminal region are detected in a wide variety of cells. Since disruption of the respective gene does not 
result in the abnormal phenotype (Ambrose et al., 1994, Mangiarini et al., 1996), it was hypothesised that 
the molecular mechanisms that underlie each disease are based on a gain of function involving protein-
protein interaction. Studies have identified GAPDH binding as a specific protein-protein interaction in 
each disorder. These include its binding to huntingtin, the gene product deficient in Huntington's disease 
(HD) (Burke et al., 1996); atrophin, the gene product deficient in dentatorubral-pallidoluysian atrophy 
(DRPLA) (Burke et al., 1996); ataxin, the molecular defect in spinocerebellar ataxia type-1 (Koshy et al., 
1996); and the androgen receptor, the gene product which underlies spinobulbar muscular atrophy (Koshy 
et al., 1996). In each case, high affinity binding of GAPDH was demonstrated by yeast two-hybrid studies 
and by in vitro analysis. 
 
The pathology of HD is marked by a preferential loss of neurones in the striatum and cortex (Cudkowicz 
and Kowall, 1990, de la Monte et al., 1988, Graveland et al., 1985, Myers et al., 1991). The genetic 
mutation in HD is an unstable and expanded CAG repeat in the gene that encodes huntingtin (Group, 
1993). The CAG triplet repeat produces a poly-glutamine domain in the expressed proteins. Larger poly-
glutamine expansions in huntingtin are associated with earlier onset and increased severity of the disease 
(Duyao et al., 1993, Stine et al., 1993). A pathogenic process involving interaction of mutant huntingtin 
with other proteins to produce a change of function has been suggested as the basis for neurodegeneration 
in HD. GAPDH has been identified as one of the proteins that interact more avidly with NH2-terminal 
products of mutant huntingtin than with wild-type (Burke et al., 1996). Analysis of the HD brain with an 
antiserum that recognises an internal region of huntingtin in wild-type and mutant proteins showed that 
the subcellular distribution of huntingtin in the cytoplasm of neurones was abnormal, but the contribution 
of mutant huntingtin to these changes was unclear. Finally in a recent study of HD transgenic mice 
expressing an NH2-terminal mutant huntingtin fragment with 115 to 156 glutamine repeats, it was found 
that intraneuronal nuclear inclusions reactive to NH2-terminal antiserum to huntingtin developed in the 
brain (Davies et al., 1997). 
 
Studies showing interactions between β-amyloid precursor protein (βAPP) and GAPDH (Schulze et al., 
1993) indicate another role of GAPDH, namely in apoptosis. βAPP has been intensively described in 
studies with Alzheimer's Disease (Checler, 1995, Selkoe, 1994). βAPP is a membrane bound protein 
containing a cytoplasmic tail. Its improper cytoplasmic processing results in the formation of a β-amyloid 
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protein (βAP) which is deprived of the carboxyterminal end of βAPP. There is ample evidence that βAP 
is a major factor in the formation of senile plaques in Alzheimer's Disease. 
 
Recent work by Kratgen et al. indicates that GAPDH may also be involved in Parkinson's disease. They 
showed that GAPDH is the putative target of the anti-apoptotic compounds CGP 3466 and R-(-)-
deprenyl. R-(-)-Deprenyl (Selegiline) represents one of the drugs currently used for the treatment of 
Parkinson's disease. The compound was shown to protect neurones or glia cells from programmed cell 
death in a variety of models. CGP 3466 is a structurally related analogue of R-(-)-deprenyl that exhibits 
virtually no monoamine oxidase type B inhibiting activity but is neuro-protective in the picomolar 
concentration range. Specific binding of CGP 3466 to GAPDH was shown by means of affinity binding, 
affinity labelling, and BIAcore(R) technology. The importance of this interaction for mediating drug-
induced inhibition of programmed cell death was established by apoptosis assays in the human 
neuroblastoma cell line PAJU. 
 
In contrast to the definitive studies described above, the specific role of GAPDH in the phenotype of 
these disorders is unknown at the present time. A proposed scenario is that GAPDH binding to each 
protein diminishes glycolytic activity. As neuronal cells depend on glycolysis for ATP production, such 
inhibition would have severe consequences in vivo. Recent studies suggest that GAPDH glycolytic 
activity was unaltered in brain samples from patients with CAG triplet repeat disorders (Kish et al., 
1998). In contrast, studies in fibroblasts from Huntington's disease patients indicated a difference in their 
regulation of GAPDH dehydrogenase activity (Cooper et al., 1998). GAPDH glycolytic catalysis 
increased 8-fold in control cells but only 3-fold in Huntington's disease cell strains. Other studies indicate 
normal GAPDH activity in Huntington's disease brain (Tabrizi et al., 1999). Another possibility examined 
was the effect of transglutaminase on GAPDH. This analysis demonstrates inhibition of GAPDH 
dehydrogenase activity (Cooper et al., 1997). 
 
In summary, these recent studies demonstrate selective interactions of GAPDH with proteins intimately 
involved in neurodegenerative disease. However, at this time the functional consequences of these 
interactions are unknown. 
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Finally a function of GAPDH in cellular phenotype of prostate cancer has been proposed by studies that 
quantified GAPDH mRNA levels in rat prostatic adenocarcinoma cell lines in comparison with normal rat 
ventral tissue, showing high GAPDH mRNA levels in highly metastatic cells (Epner et al., 1993). 
Investigations using patient samples also demonstrated that GAPDH mRNA levels were greater in 
neoplastic tissue than in benign prostate tissue (Sharief et al., 1994). Recent studies have described 
further changes in GAPDH gene expression in prostatic cancer cells and showed that androgen responsive 
human prostate cancer cells regulate both GAPDH mRNA and GAPDH glycolytic activity as a function 
of hormone exposure (Epner and Coffey, 1996, Ripple and Wilding, 1995).  
 
 
 
2.3.2 Ulip 
 
 
The second protein of the neuronal PMO complex that we have described (Bulliard et al., 1997) was a 
member of the Ulip (Unc-33-LIke Phosphoprotein) family. Investigations by several independent groups 
identified unknown proteins which all belong to this common phosphoprotein family. The encoding 
genes of their members show homology to liver dihydropyrimidinase (DHPase) (Wang and Strittmatter, 
1997) and to the unc-33 gene from Caenorhabditis elegans, a gene associated with neuritic outgrowth 
and axonal guidance (Desai et al., 1988, Li et al., 1992, McIntire et al., 1992). The Ulip family is highly 
conserved throughout evolution. The various members of the family within a single species display about 
75% similarity. There exist highly similar domains and subdomains, including a 32-aminoacid region 
highly conserved from bacterial hydantoinase to human Ulips. The first identification of a member of this 
family resulted from a search for proteins whose expression was regulated as an early marker of 
differentiated neurones in the rat cortex and in the rat spinal cord (Geschwind et al., 1996, Minturn et al., 
1995b, Minturn et al., 1995a). Using two-dimensional gel electrophoresis, membrane-associated proteins 
that were up-regulated over the course of neurogenesis were identified. One of these, TOAD-64 (Turned 
On After Division, 64 kDa), was expressed early in neuronal differentiation and was dramatically down-
regulated in the adult. In later studies it was shown, that TOAD-64 corresponds to Ulip2 (Byk et al., 
1998). Northern blot and in situ hybridisation showed that TOAD-64 mRNA was enriched in the nervous 
system and is developmentally regulated in parallel with the protein. TOAD-64 is transiently expressed in 
postmitotic spinal cord neurones early in their development and sharply down-regulated after the second 
postnatal week. In the adult spinal cord, TOAD-64 expression is remarkably restricted to a subset of 
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primary afferents to the spinal cord. It was suggested that TOAD-64 may have a fundamental role in axon 
pathfinding. 
 
This hypothesis was substantiated by the results of Goshima et al. with another protein corresponding to 
Ulip2 (Goshima et al., 1995). They used a Xenopus laevis oocyte expression system to identify molecules 
involved in collapsin signalling. Collapsin, a member of the semaphorin family, contributes to axonal 
pathfinding during neural development by inhibiting growth cone extension. They isolated a collapsin 
response mediator protein (CRMP-62) required for collapsin-induced inward currents. CRMP-62 
(=Ulip2) was localised exclusively in the developing chick nervous system. Introduction of anti-CRMP-
62 antibodies into dorsal root ganglion neurones blocked collapsin-induced growth cone collapse. 
CRMP-62 appeared to be an intracellular component of a signalling cascade initiated by an unidentified 
transmembrane collapsin-binding protein. 
 
A major work in the field of the Ulip-family was performed by the group of Sobel (Byk et al., 1996, Byk 
et al., 1998). The search for intracellular phosphoproteins implicated in the regulation of neuronal 
differentiation led to the identification of four complete coding sequences for members of the Ulip family 
in the mouse, Ulips 1-4, all preferentially expressed in the nervous system. The expression level and 
phosphorylation pattern of Ulip1 were shown to be strongly regulated during development and neuronal 
differentiation. Furthermore, two Ulip sequences, Ulips A and Ulips B, could be identified in C. elegans. 
The Ulip family is highly conserved throughout evolution (more than 96% for Ulips 1-3 and 92.5% for 
Ulip4 between mouse and human) and the various members of the family within a single species display 
about 75% similarity. Two-dimensional immunoblot analysis of in vitro translated Ulips 1-4 
demonstrated the existence, for each Ulip protein, of several, most probably differentially phosphorylated 
forms, in agreement with the presence of conserved phosphorylation consensus sites within their 
sequences. The expression of Ulips 1-4 mRNAs was differentially regulated during development and 
NGF-induced neuronal differentiation of PC12 cells. 
 
Recently, several cDNA sequences corresponding to members of the Ulip family were isolated and their 
biological function has been characterised in more detail in various species (Gaetano et al., 1997, 
Hamajima et al., 1996, Kamata et al., 1998, Kamata et al., 1998, Quach et al., 1997, Torres and 
Polymeropoulos, 1998, Wang and Strittmatter, 1996, Wang and Strittmatter, 1997). It was shown that 
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brain collapsin response mediator protein (CRMP/Ulip) forms heterotetramers similar to liver 
dihydropyrimidinase, an enzyme that corresponds to Ulip5. 
 
In relation with their likely biological roles in the nervous system, Ulip proteins are also implicated in 
pathological disorders since Ulips were identified as the antigens against which autoantibodies from 
patients with paraneoplasic neurological syndromes were directed (Antoine et al., 1999). 
The presently available data suggest that the proteins of the Ulip family may be involved in the 
differentiation and the functional integrity of the nervous system, through the control of neurite 
elongation and axonal furdance, their potential stability or the transduction of extracellular collapse 
signals. Taken together, these studies suggest a differential, possibly complementary, multi-functional 
role of phosphoproteins of the highly conserved Ulip family in the control of neuronal differentiation, in 
relation with the development and plasticity of the nervous system.  
 
 
2.3.3 Hsc70 
 
The third protein identified in the neuronal PMO complex was the 70kD heat shock cognate protein 
(Hsc70) (Bulliard et al., 1997). Hsc70 and the heat shock protein 70 (Hsp70) are molecular chaperones 
that participate in many important cellular processes. Molecular chaperones were originally defined as a 
group of proteins that mediate the correct assembly of other proteins, but are not themselves components 
of the final functional structures (Ellis, 1987, Gething and Sambrook, 1992, Hendrick and Hartl, 1993, 
Rothman, 1989). They occur ubiquitously and are classified as stress proteins, although they have 
essential functions under normal growth conditions. Later chaperones have been defined as proteins that 
bind to and stabilise an otherwise unstable conformation of another protein. They catalyse the correct fate 
of the protein they bind to in vivo, like folding, oligomeric assembly, transport to a particular subcellular 
compartment, or disposal by degradation (Hendrick and Hartl, 1993). Molecular chaperones (Laskey et 
al., 1978) prevent incorrect interactions within and between non-native polypetides, thus increasing the 
yield but not the rate of folding reactions.  
 
Based on their striking heat inducibility, it was proposed that the Hsp70s aid the repair or degradation of 
polypeptides that denature under stress (Hightower, 1980, Pelham, 1986). Later studies indicated that 
Hsc70 has an equally important role under non-stress conditions in stabilising the folding and assembly 
intermediates of newly synthesised polypeptides in the ER (Gething and Sambrook, 1992, Haas and 
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Wabl, 1983). Similarly in yeast, cytosolic Hsc70 associates with newly synthesised precursor 
polypeptides, stabilising them for uptake into the mitochondrion and the ER (Chirico et al., 1988, 
Deshaies et al., 1988, Zimmermann et al., 1988). Mammalian Hsc70 was shown to interact with nascent 
polypeptide chains in the cytosol (Beckmann et al., 1990) by binding hydrophobic peptide segments in an 
ATP-dependent manner (Flynn et al., 1991). 
 
The most compelling evidence that protein folding in vivo requires molecular chaperones was provided 
by Escherichia coli cells with mutations in the gene coding for the chaperonin, GroEL (Coppo et al., 
1973, Georgopoulos et al., 1973). They were shown to be defective in assembling bacteriophage particles. 
The significance of this finding was demonstrated by showing that before assembly in chloroplasts, the 
ribulose biphosphate carboxylase oxygenase (Rubisco) subunits form a complex with a homlogue of 
GroEL and of Hsp60 from which they dissociate in an ATP-dependent reaction (Barraclough and Ellis, 
1980, Cannon et al., 1986, Davidoff and Mendelow, 1993, Hemmingsen et al., 1988, McMullin and 
Hallberg, 1988). Purified GroEL allowed the reconstitution of correctly assembled bacterial Rubisco in 
vitro (Goloubinoff et al., 1989). Finally, evidence was provided that the chaperonins mediate the folding 
of monomeric proteins, rather than actively promoting assembly (Ostermann et al., 1989). 
 
It was demonstrated that the Hsp70 and chaperonin families can cooperate functionally in vitro (Langer et 
al., 1992). The Hsp70 homologue of E.coli, DnaK, and its partner chaperone DnaJ maintain an unfolded 
polypeptide in a soluble, folding competent confirmation, in which it can be transferred to GroEL for 
folding the native state. Cycling of DnaK between different nucleotide states is regulated by the 
chaperone cofactors DnaJ and GrpE in a ATp-dependent manner (Hartl, 1996, McCarty et al., 1995).  
 
Later, Hip was identified as another chaperone cofactor of the cytosolic and nuclear Hsc70 (Hohfeld et 
al., 1995). The mechanism for the regulation of Hsp70 family members in the eukaryotic cell by Hip was 
distinct from the GrpE-mediated dissociation of chaperone-substrate complexes observed in prokaryotes 
(Frydman and Hohfeld, 1997). Hip appeared to stabilise the ADP-bound form of Hsc70 by interacting 
with its ATPase domain (Hohfeld et al., 1995). 
 
Moreover, evidence involving Hsc70 in the response to oxidative stress was provided by a study that 
determined whether anti-oxidants prevented the stress gene expression in the focal brain injury regions 
(Turner et al., 1999). Another report showed protection against nitric oxide mediated by hsp70 even in 
the absence of heat stress in the rat insulinoma cell line RINm5F into which the human hsp70 gene was 
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stably transfected (Bellmann et al., 1996). Constitutive expression of hsp70 caused protection from NO-
induced cell lysis which was of the same extent as seen after heat stressing cells. These results identify 
hsp70 as a defence molecule against nitric oxide. NO and TNFα play important roles in the pathogenesis 
of liver disease during acute inflammation. Pre-treatment of primary cultures of rat hepatocytes with the 
NO donor S-nitroso-N- acetylpenicillamine (SNAP) induces the expression of HSP70 mRNA and protein 
(Kim et al., 1997), which was associated with thermal tolerance and cytoprotection from TNFα and 
actinomycin D-induced hepatotoxicity and apoptosis. SNAP transiently changed the intracellular redox 
state by inducing glutathione (GSH) oxidation associated with the formation of S-nitrosoglutathione 
(GSNO). HSP70 mRNA was also induced by the GSH- oxidising agent diamide and the GSH-
conjugating agent N-ethylmaleimide, suggesting that NO induces HSP70 expression through GSH 
oxidation. The protective effect of SNAP pre-treatment on TNFα-induced apoptosis correlated with the 
level of HSP70 expression. SNAP pre-treatment inhibited reactive oxygen intermediate generation and 
lipid peroxidation effects that were reversed by blocking HSP70 expression using an antisense 
oligonucleotide to HSP70. Finally, endogenous NO formation, induced in hepatocytes stimulated with 
interferon-γ and interleukin-1β, led to the formation of GSNO and GSSG, induced HSP70, and attenuated 
TNFα-mediated cytotoxicity. These findings indicated that NO can also induce resistance to TNFα-
induced hepatotoxicity, possibly through the stimulation of HSP70 expression. 
 
Further, a study shows the relationship between oxygen radicals and posthypoxic injury of cellular 
proteins which leads to the synthesis of HSPs (Gebhardt et al., 1999). It was shown that various periods 
of hypoxia and 30 min of reoxygenation resulted in an increased generation of superoxide. The inhibitor 
of superoxide dismutase (SOD), diethyldithiocarbamate (DDC) increased and addition of SOD decreased 
intracellular superoxide levels. HSP70 synthesis was detectable after 2 h of hypoxia. Similar to 
superoxide production, DDC increased and SOD reduced the HSP70 synthesis. The production of 
superoxide correlates with HSP70 induction. Thus, hypoxia/reoxygenation seems to induce heat shock 
protein production by increased superoxide generation. 
 
Besides their function as inducible proteins by the physical stress to protect cells, recent evidence 
suggests that HSPs are likely involved in cell cycle control under normal conditions without stress. Hsc70 
seems to directly interact with P27Kip1, an inhibitor of cyclin-dependent kinases, during G1/S transition 
(Nakamura et al., 1999). 
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Other recent studies describe how regulation of Hsc70 may be modulated at the molecular level. 
Therefore the role of Hsc70 in regulating the activity of the heme-regulated eIF-2α kinase (HRI) in 
hemin- supplemented rabbit reticulocyte lysate (RRL) in response to heat and oxidative stress was 
examined and compared with the effect of Hsc70 on HRI activation in response to heme deficiency 
(Thulasiraman et al., 1998). Hsc70 suppressed eIF- 2α phosphorylation and maintained the guanine 
nucleotide exchange activity of eIF-2B in heme-deficient RRL and in hemin-supplemented RRL exposed 
to elevated temperatures (42 degrees C), denatured protein (reduced carboxymethylated bovine serum 
albumin, RCM-BSA), oxidised glutathione or Hg2+. The ability of Hsc70 to inhibit HRI activation was 
mediated through its ability to inhibit the hyper-autophosphorylation of transformed HRI, which causes 
the hyperactivation of HRI. Further observations indicate that heat shock induced the accumulation of a 
sufficient quantity of Hsc70 binding substrates (e.g., denatured protein) to sequester Hsc70 and inhibit the 
ability of Hsc70 to suppress HRI activation. Hsc70 interacts with nascent HRI and with transformed HRI 
(Uma et al., 1999). Interaction of HRI with Hsc70 is required for the transformation of HRI. Clofibric 
acid disrupted the interaction of Hsc70 with transformed HRI that had been matured and transformed in 
the absence of the drug. Disruption of Hsc70 interaction with transformed HRI in heme-deficient RRL 
results in its hyperactivation. Furthermore, activation of HRI in response to heat shock or denatured 
proteins also results in a similar blockage of Hsc70 interaction with transformed HRI. Thus, Hsc70 may 
be required for the folding and transformation of HRI into an active kinase but is subsequently required to 
attenuate the activation of transformed HRI. Furthermore, Hsc70 may modulate the activation of HRI not 
only in heme-deficient RRL, but also in hemin-supplemented RRL in response to oxidative stress. 
 
Recently another, new role of Hsc70 was revealed in development of chicken embryo (de la Rosa et al., 
1998). Insights have emerged concerning insulin function during development, from the finding that 
apoptosis during chicken embryo neurulation is prevented by prepancreatic (pro)insulin. An insulin-
dependent regulation of Hsc70 was discovered. mRNA and protein levels of this chaperone were 
regulated in unstressed embryos during early development. More important, Hsc70 levels were found to 
depend on endogenous (pro)insulin, as shown by using antisense oligodeoxynucleotides against 
(pro)insulin mRNA in cultured neurulating embryos. Further, in the cultured embryos, apoptosis affected 
mainly cells with the lowest level of Hsc70. These results argue in favour of Hsc70 involvement in the 
prevention of apoptosis during early development and suggest a role for a molecular chaperone in normal 
embryogenesis. 
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The most spectacular recent findings on the HSP70 family concern their binding ability to the anti-
apoptotic protein BAG-1 (Bimston et al., 1998, Hohfeld, 1998, Hohfeld and Jentsch, 1997, Stuart et al., 
1998, Takayama et al., 1997, Takayama et al., 1998, Takayama et al., 1999). Evidence was shown that 
the protein BAG-1 is a potential modulator of the molecular chaperones, Hsp70 and Hsc70 (Takayama et 
al., 1997). BAG-1 binds to the ATPase domain of Hsp70 and Hsc70, without requirement for their 
carboxy-terminal peptide-binding domain. Purified BAG-1 and Hsp/Hsc70 efficiently form heteromeric 
complexes in vitro. BAG-1 inhibits Hsp/Hsc70-mediated in vitro refolding of an unfolded protein 
substrate, whereas BAG-1 mutants that fail to bind Hsp/Hsc70 do not affect chaperone activity. Further, 
the binding of BAG-1 to Bcl-2 depends on ATP. Overexpression of BAG-1 also protected certain cell 
lines from heat shock-induced cell death. The identification of Hsp/Hsc70 as a partner protein for BAG-1 
may explain the diverse interactions observed between BAG-1 and several other proteins, including Raf-
1, steroid hormone receptors and certain tyrosine kinase growth factor receptors. The inhibitory effects of 
BAG-1 on Hsp/Hsc70 chaperone activity suggest that BAG-1 represents a novel type of chaperone 
regulatory proteins and thus suggest a link between cell signalling, cell death and the stress response. 
Functional characterisation of BAG-1 revealed an unexpected versatility in the regulation of Hsc70 and 
appeared to provide a link between apoptosis and the cellular chaperone machinery (Hohfeld, 1998). 
Mechanistic basis for BAG-1 as a negative regulator of the Hsp70 chaperone was given by Bimston et al. 
(Bimston et al., 1998). Further sudies demonstrated that there exist three isoforms of human BAG-1 
(BAG-1, BAG-1M, and BAG-1L) which all retained the ability to bind Hsc70 (Takayama et al., 1998). 
Furthermore, experiments using a green fluorescence protein (GFP)-BAG-1 fusion protein demonstrated 
that overexpression of Bcl-2 cause intracellular redistribution of GFP-BAG-1, producing a membranous 
pattern typical of Bcl-2. 
 
BAG-1 also interacts with several steroid hormone receptors which require the molecular chaperones 
Hsc70 and Hsp90 for activation. It was shown that BAG-1 is a regulator of the Hsc70 chaperone 
(Hohfeld and Jentsch, 1997). BAG-1 bound to the ATPase domain of Hsc70 and, in co-operation with 
Hsp40, stimulated Hsc70's steady-state ATPase activity. BAG-1 accelerated the release of ADP from 
Hsc70. These results reveal an unexpected diversity in the regulation of Hsc70 and raise the possibility 
that the observed anti-apoptotic function of BAG-1 may be exerted through a modulation of the 
chaperone activity of Hsc70 on specific protein folding and maturation pathways. 
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2.3.4 Aldolase C 
 
Aldolase C (=Zebrin II) is the fourth protein associated with the neuronal PMO complex. Three isozymes 
of the phylogenetically ancient enzyme aldolase (fructose-1,6-bisphosphate aldolase) exist: aldolases A, 
B, and C, each of which is encoded by a separate gene. The kinetics of aldolase A favour the cleavage of 
fructose-1,6-bisphosphate to glyceraldehyde-3-phosphate and dihydroxyacetone phosphate, and its gene 
was found on human chromosome 16 (Tolan et al., 1987). Generally considered to be a muscle enzyme, 
the transcriptional regulation of this gene is unusually complex with three alternative promoters (Izzo et 
al., 1988, Joh et al., 1986, Maire et al., 1987, Mukai et al., 1986) that result in three different mRNA 
species. Curiously, the three transcripts differ only in their 5'-untranslated regions; each mRNA encodes 
the same structural enzyme. Of the three promoters, the 5'-most and 3'-most are expressed broadly in 
foetal tissues as well as in adult muscle and red blood cells. The central promoter (M-type or Hsc70-type) 
is highly active in skeletal muscle, particularly in fast-twitch fibres (Salminen et al., 1996, Salminen et al., 
1994). The 5'-most promoter is active, albeit at lower levels, in a range of other tissues, including brain 
(Mukai et al., 1986). In the nervous system, the exact cellular location of the aldolase A isozyme is 
uncertain; Northern analysis of cultured cells suggests that it is present in both neurones and glia 
(Popovici et al., 1990).  
 
Aldolase B, found on human chromosome 9 (Lebo et al., 1985), is generally considered to be a liver 
enzyme, although it is also found in kidney proximal tubule cells and enterocytes. This form of aldolase 
favours gluconeogenesis, befitting its higher concentration in the liver. During hepatic development, 
aldolase A and C are expressed earlier, but aldolase B soon takes over. Unlike the other isozymes, 
aldolase B is transcriptionally activated by signals from hormones and dietary factors (Weber et al., 
1984). A proximal promoter region, approximately 200 bp in length, has been identified that contains 
many of the elements (including overlapping hepatic nuclear factor binding sites) necessary for properly 
regulated expression if it is paired with sequences in the first intron (Gregori et al., 1991, Sabourin et al., 
1996, Tsutsumi et al., 1989).  
 
Aldolase C, found on human chromosome 17 (Tolan et al., 1987), has kinetic properties that are 
intermediate between those of the A and B isoforms. In the adult, aldolase C is considered to be the brain-
specific isozyme, with low but detectable activity in foetal tissues and hepatocarcinomas (Mukai et al., 
1991, Popovici et al., 1990, Royds et al., 1987, Schapira et al., 1970, Thompson et al., 1982). The exact 
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cellular location of aldolase C is controversial. Studies of mRNA by Northern blot analysis, in situ 
hybridisation, or transgene expression studies indicated that the gene is transcribed mostly in neurones 
(Arai et al., 1994, Mukai et al., 1991, Popovici et al., 1990). On the other hand, earlier studies using 
isozyme-specific antibodies reported its location in grey matter astrocytes and cells of the pia mater 
(Thompson et al., 1982, Wachsmuth et al., 1975). All reports agree that Purkinje cells of the cerebellum 
contain by far the highest levels of the enzyme. By sequence analysis, the aldolase C promoter region is 
typical of a "housekeeping" type of promoter. A normal TATA box is missing; instead a GC-rich region 
was found just upstream of the transcription start site (Vibert et al., 1989). A CAAT box was present, but 
it was located far upstream from its expected position (Buono et al., 1993). Northern analysis using a 
probe specific for aldolase C mRNA demonstrated a 1.6-kb band. There was no evidence of alternative 
splicing. Two DNase I-sensitive sites flank the transcription unit: one immediately 5' and the other about 
1.5 kb 3' to the nine exons of the gene. Several tissue-specific methylation sites have been identified in 
the immediate vicinity of the transcription unit (Makeh et al., 1994). In transgenic mice (Arai et al., 1994, 
Makeh et al., 1994) large rat genomic fragments (or fragments with short marker tags inserted) have been 
shown to direct central nervous system (CNS)-specific expression. Expression outside of the CNS was 
suppressed. Even a short, 115-bp promoter element contained sufficient cis-active sequences to drive 
marker gene expression solely in the CNS (Thomas et al., 1995). 
 
The interest in the aldolase isozymes grew with the discovery that aldolase C was identical to Zebrin II 
(Ahn et al., 1994). Zebrin II had long been recognised as a Purkinje cell biochemical marker of the 
sagittal compartments of the adult cerebellar cortex (reviewed in (Hawkes et al., 1993, Hawkes and 
Gravel, 1991, Hawkes and Herrup, 1995, Herrup and Kuemerle, 1997)).  
 
Already very early studies report about aldolase binding to F-actin (Arnold and Pette, 1970, Morton et al., 
1977). First evidence of interaction of aldolase with the regulatory proteins of skeletal muscle was 
provided by investigations of interactions of aldolase with regulatory proteins of rabbit skeletal muscle 
(Stewart et al., 1980, Walsh et al., 1980). A salt-dependent interaction of troponin, tropomyosin and the 
tropomyosin-troponin complex with aldolase was detected, the tropomyosin-troponin complex displaying 
a greater affinity for the enzyme than did either regulatory protein alone. The results indicate that aldolase 
possesses multiple binding sites for these cytoskeletal proteins. Quantitative studies of the binding of 
aldolase to actin-containing filaments showed the interaction to be influenced markedly by the presence 
of these regulatory proteins on the filaments. Later studies first located binding sites for aldolase and 
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GAPDH on the actin monomer in microfilaments (Mejean et al., 1989). That led to the identification of 
an actin binding region in aldolase (O'Reilly and Clarke, 1993). The sequence of this region is highly 
homologous to a region of sequence near the C-terminus of actin itself and which is also found in the 
actin binding domains of a number of other actin binding proteins. The molecular nature of the F-actin 
binding activity of aldolase was confirmed by site-directed mutants (Wang et al., 1996). Most recent 
studies show that aldolase mediates the association of F-actin with the insulin-responsive glucose 
transporter GLUT4 (Kao et al., 1999). 
 
Finally, some studies show that under conditions of oxidative stress the induction of aldolase is markedly 
reduced (Hamm-Kunzelmann et al., 1997, Schafer et al., 1997, Schafer et al., 1996). Furthermore, 
reactive oxygen intermediates dramatically decrease the transcriptional activities of the Sp1-dependent 
aldolase A promoters. This indicates that cellular redox changes can regulate gene expression by 
reversible oxidative inactivation of Sp1 binding. Another study reported that ROS  cause self-inactivation 
of aldolase (Gupta et al., 1993). Aldolase was paracatalytically modified in the presence of fructose 1,6-
bisphosphate and hexacyanoferrate(III).  
 
 
2.3.5 Neurone-specific enolase γ (NSE) 
 
The last identified component of the neuronal PMO multi-protein complex is neurone-specific enolase 
γ (NSE). As one of the classical enzymes in the glycolytic pathway, enolase is usually considered to be a 
soluble cytoplasmic protein. The enzyme is dimeric with three types of isozymes: αα, ββ and γγ, each 
encoded by different genes (Marangos and Schmechel, 1987, Schmechel et al., 1980). Only the γγ enolase 
form is present at high levels in brain and at intermediate levels in peripheral nervous tissue and various 
neuroendocrine glands, such that it is considered to be a specific marker for neurones or endocrine cells 
and their derived tumours (Hayashi et al., 1987, Marangos and Schmechel, 1987). It can account for up to 
1.5% of total protein in some neurones and thus may have functions other than enzymatic (Kivela, 1986, 
Molnar et al., 1984, Schmechel et al., 1980). cDNA analysis indicates that NSE does not contain the usual 
leader sequence thought to facilitate the extracellular secretion of proteins (Sakimura et al., 1985). 
However, other studies reported the extracellular presence of NSE in some tumour (Hayashi et al., 1987) 
and its localisation in at least one extracellular matrix, the retinal interphotoreceptor matrix of the neural 
retina (Li et al., 1995). 
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Another interesting observation is the close relationship of α-enolase with tau-Crystallin (Wistow et al., 
1988). Tau-Crystallin possesses enolase activity, but the activity is greatly reduced with age, probably 
because of age-related posttranslational modification. Tau-Crystallin  is up-regulated in differentiation 
(Deloulme et al., 1996). 
 
Along with its enzymatic role in glycolysis, evidence indicates that NSE can act as a neuronal survival 
factor in the central nervous system (Takei et al., 1991). Neuronal survival factors in the central nervous 
system were investigated by using a primary culture of embryonic rat neocortical neurones. One factor 
found to significantly promote survival of these cells over a 4-6 day period was identified as NSE. This 
was confirmed by showing that commercially available NSE itself also possessed neuronal survival 
activity for the cultured neocortical neurones and that the effects of NSE  were inhibited completely by 
anti-NSE polyclonal antibody. Furthermore, highly purified NSE supported the survival of cultured 
neurones in a dose-dependent manner, and the neurotrophic effect was inhibited by anti-NSE monoclonal 
antibody. 
 
 
Recent studies use NSE as a sensitive marker for various brain damage or disease. Levels of NSE were 
increased in patients after seizures (Buttner et al., 1999, Correale et al., 1998, DeGiorgio et al., 1999). 
Furthermore expression of NSE was raised in patients with neuroendocrine tumors (Bajetta et al., 1999), 
with benign lung diseases (Szturmowicz et al., 1998), with Creutzfeldt-Jakob disease (Evers et al., 1998, 
Kropp et al., 1999) and with hyperglycemic cortical ischemic stroke (Sulter et al., 1998) 
 
 
2.4 Aims of this thesis 
 
As listed above, numerous studies have been performed to investigate the structure, regulation and 
function of each of the 5 proteins (GAPDH, Ulip, Hsc70, aldolase c and enolase γ) which we isolated in a 
tight complex as a neuronal PMO. Recent studies have revealed new, intriguing observations concerning 
specific functions of the proteins. GAPDH and Hsc70 seem to be directly involved in cell death or in cell 
survival decisions, and may have key roles in different neurodegenerative diseases. Neurone specific 
enolase γ is already being used as sensitive marker in various brain damage and diseases. Furthermore, 
the phospoprotein Ulip is involved in neuronal differentiation and axon guidance. 
 
 34 
There is growing evidence that these proteins have a high impact on major cellular processes and they are 
essential factors in various neurodegenerative diseases. However, although a considerable number of 
reports exist that underline their importance at physiological level, much less is known about the 
molecular mechanisms and the cellular dynamics of these proteins in the cell. Furthermore, up to date 
nothing is known about the interaction of the members of the multi-protein-complex, its function and its 
relevance in biological processes. 
 
Thus, we aimed at obtaining knowledge about these five proteins by characterising the expression and the 
subcellular localisation of the five proteins. We hoped to receive additional information by 
overexpression of the proteins and comparison with endogenous expression. We therefore amplified 
cDNA of the five proteins by means of PCR from total RNA that was isolated from NB41A3 cells. We 
then constructed chimeric green fluorescent protein (GFP) and blue fluorescent protein (BFP) fusion 
proteins for each member of the multi-protein-complex. The protein-GFP hybrids were transfected into 
neuronal and non-neuronal cell lines and detected together with endogenous protein expression by direct 
or indirect immunofluorescence with a confocal laser scanning microscope. The chimerical BFP 
constructs were used in double transfections.  
 
Since PMOs are known to be involved in the response to oxidative stress, we first compared cellular 
distribution of the endogenous proteins and of the overexpressed proteins coupled to GFP (or BFP) 
before and after induction of oxidative stress. 
 
Our observations, together with the latest findings published on apoptosis, convinced us to expand our 
studies by observing changes in expression and subcellular localisation in cells exposed to apoptotic 
agents. 
 
By using this approach based on immunofluorescence and confocal microscopy, we wanted to increase 
our understanding on the response of each protein to both oxidative stress and induction of apoptosis. In 
order to investigate whether the effects observed with endogenous proteins in untransfected cells changed 
when the appropriate protein was overexpressed, each of these proteins was overexpressed in control cells 
and in cells exposed to apoptotic drugs or to stress agents. We used two different cell lines, NB41A3 and 
R6, to compare, which of the observed effects are neuroblastoma specific and which were also 
reproducible in embryonal fibroblasts. We also were interested to detect observations that indicate 
interactions between members of the protein-complex, especially by co-transfection experiments. Finally, 
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to extend our knowledge of the molecular processes during apoptosis, a cell line that stably expresses 
Bcl-2 (R6Bcl-2) was used for investigations together with members of the complex. 
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3 Methods 
(For details see Appendix) 
 
3.1 Cell culture growth 
 
Cells of the clonal mouse neuroblastoma line NB41A3 were obtained from the American Type Culture 
Collection (Bethesda, MD) and maintained according to Augusti-Tocco and Sato (Augusti-Tocco and 
Sato, 1969) as monolayers on tissue culture plastic flasks at 37° C in 5% CO2. The growth medium was 
Dulbecco's modification of Eagle's medium (DMEM) at pH 7.4 containing 3.7 g/l NaHCO3, 4.5 g/l D-
glucose, 0.11 g/l sodium pyruvate and 0.58 g/l glutamine, 10% foetal calf serum, 50 units/l of penicillin 
and 50 µg/l of streptomycin. 
 
The rat embryo fibroblast cell line 6 (R6) and the rat embryo fibroblast cell line 6 stably overexpressing 
Bcl-2 (R6Bcl-2) were obtained through the courtesy of Dr Christoph Borner, Institute of Biochemistry, 
Fribourg, Switzerland, who has described the construction of R6Bcl-2 earlier (Borner, 1996). Both cultures 
were grown at 37° C in Dulbecco's modification of Eagle's medium (DMEM) at pH 7.4 containing 3.7 g/l 
NaHCO3, 4.5 g/l D-glucose, 0.11 g/l sodium pyruvate and 0.58 g/l glutamine , 5% foetal calf serum, 50 
units/l of penicillin and 50 µg/l of streptomycin in a humidified atmosphere of 5% CO2 / 95% air.  
 
For all cell lines the medium was changed every 3 days; starving of the cultures and growth to post 
confluence were strictly avoided. The cells were trypsinised in the presence of 0.25% trypsin and 0.1% 
EDTA for splitting or harvested for RNA or protein extracts when they were subconfluent.  
 
3.2 S1 nuclease protection assay 
 
Total RNA from cells was purified by the "IsoHi" method described in the appendix. For S1 nuclease 
protection assay, 1 pmol of linearised and dephosphorylated DNA, was radioactively labelled with (γ-
32P)-ATP. We used four different probes of 114, 203, 250 and 395 nt of length. The mixture was 
incubated for 40 min at RT together with T4 polinucleotide kinase. After heat-inactivation of the enzyme 
and subsequent digestion of the fragment, the resulting probe was purified by electrophoresis on 
preparative agarose gel. Approximately 100000 cpm of single-stranded probe was mixed with 40 µg of 
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total RNA isolated from NB41A3 cells that were synchronised as described by Zurbriggen and Dreyer 
(Zurbriggen and Dreyer, 1996) and stressed for 1 h in the presence of DCIP (0-400 µM). After overnight 
hybridisation, S1 nuclease buffer and 150 units of S1 nuclease (Sigma) were added, and the mixture was 
incubated at RT for 1 h. The protected fragments were electrophoresed on an 8.3 M urea/6% 
polyacrylamide gel. The results were quantified by densitometric scanning of different film exposures. 
Evaluation of relative transcripzion was performed against the internal control β-actin (122 nt).  
 
 
3.3 Construct of plasmids 
 
The coding regions of enolase, Hsc70 II, aldolase, Ulip2 and Ulip3 were amplified by PCR with the 
Advantage Klentaq polymerase mixture (CLONTECH) from mouse cDNA (mouse brain Marathon 
cDNA, CLONTECH) with the following downstream (dp) and upstream primer (up) pairs: 
 
Primer Oligo sequence in 5'  -->  3' direction 
Hsc70 (dp) AAAACCCGGGGGTACCACCTCCATCGACCTCTTCAATAGTGGGGCCTG 
Hsc70 (up) TCGTCGTCAGCGCAGCTGGGCCTACA 
Enolase (dp) AAAACCCGGGGGTACCACCTCCAAGCACACTAGGATTTCGGAAATTAT 
Enolase (up) GCCGCCGCCGTCACCACCGCCACTGC 
Aldolase (dp) AAAACCCGGGGGTACCACCACCGTAGGCATGGTTGGCGATGTAGAGGG 
Aldolase (dp) CCGCGGCTGACTGGCTGAGTGACTGG 
Ulip2 (dp) AAAACCCGGGGGTACCACCTCCTCCTAGGCTGGTGATGTTGGCACGGC 
Ulip2 (up) TTTGCTTTAAAGCTGTCCTCTTGAAA 
Ulip3 (dp) AAAACCCGGGGGTACCACCTCCACCGAGGCTGGTGATGTTGGAGCGGC
Ulip3 (up) CTTTCATCCCTCCCTGGCCTTTGTCG 
 
All downstream primers were designed in such a way, that the stop codon was replaced by nucleotides 
(red letters) coding for three gly in a row. Additionally, two artificial restriction sites were added: 
KpnI/Asp718I (GGTACC, underlined letters) (Tomassini et al., 1978) to perform frameshift if necessary 
and XmaI (GGGCCC, bold letters) to facilitate ligation. Frameshifted clones were produced either by 
using KpnI which produces a 4-base 3' extension which was subsequently digested in a T4 DNA 
polymerase reaction or by using Asp718I (=Acc65I) which produces a 4-base 5' extension which was 
used as template to add the missing nucleotides by Klenow fragment. Blunt end re-ligation with the KpnI 
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cut fragment(s) produces a -1 nucleotide frameshift, whereas the Asp718I cut fragment(s) produce a +1 
nucleotide frameshift. 
 
The complete coding region of GAPDH was amplified as two overlapping pieces by RACE from mouse 
brain Marathon cDNA (CLONTECH) according to the manufactures instruction. The 3'-end and the 
overlapping 5' end were created with Adapter primer 1 (AP1) and the GAPDH specific downstream 
(GAPDH sdp), or upstream primer (GAPDH sup), respectively. 
 
Primer Oligo sequence in 5'  -->  3' direction 
GAPDH sup CTCACGGCAAATTCAACGGACCAG 
GAPDH sdp TTGGCAGGTTTCTCCAGGCGGCAC 
AP1 CCATCCTAATACGACTCACTATAGGGC 
 
The amplified products were subcloned into the pKS+ Bluescript cloning vector (Stratagene, La Jolla, 
CA, USA) and the correct sequence confirmed by sequencing (Microsynth). Subsequently, the amplified 
DNA sequence was cut out of pKS+ Bluescript and subcloned in-frame with the GFP-coding sequence in 
pEGFP-N1 (Clontech) or pEBFP-N1 (Clontech), respectively. 
 
In the case of GAPDH, the obtained 5'-RACE fragment and the 3'-RACE fragment were joined at their 
common NsiI restriction site found in the overlapping sequence. To remove the stop codon of the 3'-
RACE fragment, both fragments were cloned together with the help of an adapter (see figure 1 below), 
which was ligated to the SfiI restriction site located 15 bp in front of the stop codon, in-frame into the 
appropriate expression vector. 
 
Adapter for GAPDH 
 
5'-   TGGCCTCCAAGGAGGGGGGTGGTAC    -3' 
3'-TGTACCGGAGGTTCCTCCCCCCACCATGGGCC-5' 
  
 Red letters:  Nucleotides coding for three gly which replace the stop codon 
 Underlined:  Complement sequence to SfiI restricted 3'-RACE fragment 
 Bold letters: Complement sequence to XmaI restricted expression vector 
 
Figure 1: Sequence of the oligonucleotide adapters for GAPDH. The adapter was used to clone GAPDH fragments in-frame 
into the pEGFP vector. 
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To construct negative controls not expressing the GFP protein, but only the inserted gene, either the 
complete GFP sequence was cut out with restriction enzymes or otherwise disrupted by a frame-shift 
mutation at the artificial KpnI/Asp718 restriction site between the 3'-end of the subcloned gene and the 
start codon of GFP. All plasmids were purified on QIAGEN Midi columns according to the manual of the 
Qiagen Plasmid purification kit. 
 
 
3.4 Transfection 
 
Unless explicitly mentioned, cells grown on glass coverslips of 1.2 cm diameter in 6 well plates were 
transfected at 80 - 90% confluence using SuperFect transfection reagent (Quiagen) according to the 
manufactures instruction. 1 µg of plasmid DNA suspended in 60 µl fresh DMEM without serum and 5 µl 
SuperFect transfection reagent were mixed together, briefly vortexed and then incubated for 10 min to 
allow complex formation. 600 µl of complete growth medium was then added to the complex mixture and 
all together immediately transferred to the PBS washed cells. After 3-4 hours of incubation at 37° C / 5% 
CO2, cells were washed once with PBS. 
 
To produce stable NB41A3 cell lines overexpressing enolase-GFP, aldolase-GFP or GAPDH-GFP, 
NB41A3 cells plated on tissue culture plastic were transfected. Cells were splitted 2 days later in medium 
containing 0.75 mg/ml G418 (Life Technologies). Selection medium was changed every 3 d for a period 
of 3 weeks, after which G418-resistant colonies were selected and analysed under the microscope for 
GFP expression. For each transfection, all G418 resistant clones expressing GFP were pooled together to 
obtain mixed bulk populations of cells stably overexpressing either enolase-GFP (NB41enolase-GFP), 
aldolase-GFP (NB41aldolase-GFP) or GAPDH-GFP (NB41GAPDH-GFP). 
 
 
3.5 Induction of oxidative stress and 
apoptosis 
 
Immediately after transient transfection, cells were trypsinised, splitted 1:3 and plated on glass coverslips 
of 1.2 cm diameter in 6 well plates. After 24 h the growth medium was replaced by either a) new growth 
medium (control) or b) new growth medium containing either 300 µM FeCN, 100 µM H2O2, 1.5 µM 
proteasome inhibitor MG132 (carbobenzoxyl-leucinyl-leucinyl-leucinal-H) or 200 nM staurosporine. 
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Staurosporine, is a potent inhibitor of protein kinases (Bertrand et al., 1994) and is widely used to activate 
apoptosis in neuronal and non-neuronal cells. 
 Unless specified otherwise, cells were exposed for 3 h to 300 µM FeCN or 100 µM H2O2 and for 6 h and 
24 h to 200 nM staurosporine or 1.5 µM MG132. Growth medium without phenolred was used in 
experiments where cells were directly analysed after incubation under the microscope without prior 
fixation. 
 
 
3.6 Antibodies 
 
For immunocytochemistry the following primary antibodies were used: mouse anti-Hsc70 monoclonal 
antibody (Mab) (IgG) (Affinity BioReagents), mouse anti-GAPDH Mab (IgG), mouse anti-neurone 
specific enolase γ Mab (Chemicon International Inc.), rabbit anti-NSE γ polyclonal antibody (Chemicon 
International Inc.), mouse anti-zebrin II Mab (IgG) (obtained through the courtesy of Dr R. Hawkes, 
University of Calgary, Calgary, Alberta, Canada), rabbit anti-Ulip3 polyclonal antibody (IgG) (generation 
of antibody as described by Bulliard et al., 1997) and rabbit anti-GFP polyclonal antibody (IgG) 
(Clontech Laboratories, Inc., Palo Alto, CA, USA). 
 
As secondary antibodies Texas Red dye-conjugated goat anti-mouse IgG, Texas Red dye-conjugated goat 
anti-rabbit IgG, fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgG or Fluorescein 
isothiocyanate (FITC)-conjugated goat anti-rabbit IgG (all from Jackson ImmunoResearch Laboratories, 
Inc., Bar Harbor, ME, USA) were used for immunocytochemistry. For Western blotting horseradish 
peroxidase conjugated goat anti-rabbit IgG or horseradish peroxidase conjugated goat anti-mouse IgG 
(both from SIGMA) was used. 
 
 
3.7 Immunocytochemistry 
 
When native GFP fluorescence was used to localise the GFP fusion proteins, the coverslip containing the 
adherent cells was directly placed on top of a drop of growth medium without phenolred on a microscope 
slide and immediately analysed. 
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Otherwise cells were rinsed twice in PBS and fixed for 15 min in 4% p-formaldehyde in 0.1 M PIPES 
(pH 6.8) containing 0.1% Hoechst 33342. Cells were rinsed in PBS twice, permeabilised for 5 min with 
0.05% saponin in PIPES, again rinsed twice in PBS and then incubated for 10 min at -20° C in acetone. 
After 2 washes with PBS cells were incubated in 1% BSA (in PBS) for 2 h on the coverslip with the first 
antibody. Subsequently cells were rinsed twice in PBS and then incubated for 2 h with the fluorescent 
secondary anti-IgG before two further washes in PBS. Fluorescence was extended by using SlowFade 
(Molecular Probes, Leiden, Netherlands) according to the manufacture's instruction. All incubations were 
performed in a light protected environment and, except for acetone, at room temperature.  
 
 
3.8 Fluorescence microscopy 
 
Cells were examined with a Nikon Eclipse E800 microscope under a 100x oil immersion objective 
(Nikon Inc.) using a MRC-1024 Bio-Rad laser confocal microscope system equipped with an 
Krypton/Argon laser (Bio-Rad Labs, Hercules, CA, USA) and the LaserSharp acquisition software (Bio-
Rad). Serial sections (at 0.5 - 1.5 um intervals) in the z-axis of cells were collected in the slow scanning 
mode (~160 Hz) with 1.5 - 4.5 mm-diam iris aperture by averaging pictures by Kalman (3 scan). Green 
fluorescence (GFP or FITC) and Texas Red were detected in parallel at 512 x 512 pixels. The pictures 
were processed with the LaserSharp processing software (Bio-Rad) or alternatively with 
ConfocalAssistant before picture files were transferred to Adobe Photoshop 4.0 and printed on a Kodak 
printer. 
 
Additionally a 100x oil immersion Plan-Neofluar objective (Zeiss) with a inverted Zeiss Axiovert 135 TV 
microscope equipped with a HBO 100-XBO 75 lamp was used to visualise DNA staining with Hoechst 
33342. 
 
 
3.9 Quantification 
 
The serial sections through the z-axis of the cell were collected within a linear range of fluorescence 
intensity, superimposed to a 3D stack and analysed as a 2D projection. To compare GFP expression in 
different subcellular structures, the mean pixel intensity in a selected area was determined (for details see 
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instruction manual for LaserSharp processing software from Bio-Rad) and normalised by subtracting the 
background. 
 
In short the procedure was as follows: To compare the expressed amount of proteins between different 
cells or between different subcellular compartments within one cell, all sections collected in the z-axis of 
the appropriate picture by LSCM are stacked to a two-dimensional projection in which the intensities of 
the various sections are accumulated. A histogram is then prepared by defining the area to be analysed in 
the 2D-projection. The histogram is evaluated by looking at the mean pixel intensity and at the 
distribution of different pixel intensities by looking at the standard deviation. A high mean pixel intensity 
correlates to high amount of expressed protein, whereas a high standard deviation indicates a patchy, 
irregular expression in the specific area. 
 43 
4 RESULTS 
 
4.1 Construction of plasmids and stable cell 
lines 
 
4.1.1 Construction of Hsc70-, enolase-, aldolase- and Ulip-
GFP hybrids in expression vectors 
 
The construction of the different vectors used for transfection is described in detail in the methods 
section. In short, cDNAs of Hsc70, enolase, aldolase-C (zebrin II) and different Ulip (MMUNC33) 
isoforms were isolated from NB41A3 mouse neuroblastoma mRNA and from mouse brain Marathon 
cDNA (CLONTECH) by means of PCR. All lower (downstream) primers were designed in such a way, 
that the stop codon of the gene is removed and replaced by a sequence coding for 3 glycine in a row. A 
suitable upper primer was selected with the help of the software program OLIGO (see methods section). 
We looked for primers with preferentially high melting temperatures to enable touch down PCR and 
modified primers to avoid hairpin, duplex and dimer formation. Ulip-3 (1857 bp), Hsc70 (1997 bp), and 
aldolase C (1159 bp) were amplified very specifically as one fragment by touchdown PCR at an 
annealing and elongation temperature of 72° C.  The 1412 bp fragment of enolase was produced together 
with a much less abundant fragment of 1050 bp by touchdown PCR at a less restrictive temperature of 
68° C. At the same conditions the Ulip-2 fragment (1789 bp) was specifically amplified. 
 
The ends of all amplified fragments were made blunt by T4 DNA polymerase treatment and subsequently 
cloned into pKS+ Bluescript vector. Their correct sequence was confirmed by sequencing the cloned 
fragment from the 5’- as well as from the 3’-end. The cDNAs of the different proteins were then cut out 
of pKS+ Bluescript vector and cloned individually in-frame into the expression vector pEGFP-N1 and 
pEBFP-N1 (Clontech, figure 2a, figure 2b). Each of this vectors was tested for expression after 
transfection in cultured cell lines. 
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a 
 
b
 
 
Figure 2: Maps of (a) pEGFP-N1 and (b) pEBFP-N1. All sites shown are unique. The Xba I site (*) is methylated. The Not I 
site follows the EGFP stop codon. All proteins were ligated in frame with either EGFP or EBFP with help of the multiple 
cloning site (MCS). Reference: Living ColorsTM application notes of Clontech. 
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Control vectors for each protein were constructed by inhibiting the expression of GFP by either a frameshift 
mutation (aldolase, Ulip and enolase) or by deletion (Hsc70) of the complete coding region for GFP. Correct 
expression of these vectors was confirmed by immunofluorescence  assays in transfected cells. 
 
 
Construction of GAPDH-GFP hybrids in expression vectors 
 
Since its known that several isoforms of GAPDH do exist, we tried to obtain various isoforms of GAPDH 
by rapid amplification of 5’- and 3’-cDNA ends (5’-RACE and 3’-RACE) with the Marathon-Ready 
mouse brain cDNA of Clontech. Therefore, four different specific upstream (up) and four different 
downstream primers (dp) were used together with AP1 (see method section): 
 
Primer Oligo sequence in 5'  -->  3' direction 
GAPDH 1 (up) GCCGGTGCTGAGTATGTCGTGGAG 
GAPDH 1 (dp) GCATCGAAGGTGGAAGAGTGGGAG 
GAPDH 2 (up) GTGAAGGTCGGTGTGAACCCATTT 
GAPDH 2 (dp) CATTGGGGGTAGGAACACGGAAGG 
GAPDH 3 (up) CTCACGGCAAATTCAACGGACCAG 
GAPDH 3 (dp) TTGGCAGGTTTCTCCAGGCGGCAC 
GAPDH 4 (up) GACCACAGTCCATGCCATCACT 
GAPDH 4 (dp) TCCACCACCCTGTTGCTGTAG 
 
All reactions produced fragments of the size expected from the known GAPDH sequence available in the 
gene bank (figure 3). We did not observe any RACE reactions producing additional fragments. I.e. if 
different isoforms were present, they seemed to be of the same length. After subcloning the fragments 
into pKS+ Bluescript vector, 10 clones of each 5'- and 3'-RACE reaction were investigated by means of 
restriction analysis. All clones showing different restriction patterns were sequenced. Quite surprisingly, 
besides their different orientation in the vector, no different isoforms were found. All fragments 
corresponded to mouse GAPDH sequence found in the gene bank. 
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Figure 3: 0.8% agarose gel showing results of RACE experiment. 3 ul of PCR product from reaction A-L were loaded per 
lane. The 3'-RACE fragments were produced in reaction A by adding primer GAPDH 4 (up), in G with GAPDH 3 (up) , in H 
with GAPDH 2 (up) and in I with GAPDH 1 (up), whereas the 5'-RACE fragments were produced in B with GAPDH 4 (dp), in J 
with GAPDH 3 (dp) , in K with GAPDH 2 (dp) and in L with GAPDH 1 (dp). C is the positive control where the GAPDH 
fragment was amplified with the primer pair GAPDH 3 (up) and GAPDH 3 (dp), and D is the negative RACE control containing 
AP1 alone. E: 100 bp Marker, F: lambda Marker. All fragments are of the expected size. 
 
 
Finally,  the 5’-Race and the appropriate 3’-Race fragment were cut out of the cloning vector and ligated 
together with a special oligo adapter (figure 1), which replaces the stop codon by a sequence coding for 3 
gly, in-frame into pEGFP or pEBFP expression vector. Control vectors for GAPDH were constructed by 
inhibiting the expression of GFP by deletion of the complete coding region for GFP. Correct expression 
of these constructs was confirmed by immunofluorescence  assays in transfected cells.  
 
Therefore the sequence of all fusion-proteins are organised similarly: At the NH2-terminus is the 
appropriate protein to be investigated, followed by three glycines replacing the stop codon and than, in-
frame with the protein, the GFP- or BFP-tag at the COOH-terminus of the fusion protein. These 
constructs ensure that GFP- or BFP-expression is coupled to the expression of the protein to be analysed. 
 
 
4.1.2 Establishing stable NB41A3 cell lines expressing GFP-
fusion proteins 
 
To obtain stable cell lines overexpressing the proteins of the neuronal PMO complex, we selected for 
neomycin+ cells, since the transfection vector contains a neomycin resistance gene. Survival tests at 
different concentrations of G418 have been performed (see figure 4a). 
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Figure 4: Analysis of (a) resistance to G418 (neomycin) and  (b-d) transfection efficiency and cell viability in NB41A3 
cells. (a) Cells were transfected by SuperFect with either pEGFP (which contains a neo+ gene) alone or with pEGFP containing 
Ulip, GAPDH, aldolase or enolase gene. Additionally one set of cells was transfected with a mixture of Ulip-GFP, GAPDH-
GFP, aldolase-GFP and enolase-GFP plasmids. As negative controls cells transfected with pBluescript or untransfected cells 
were used. NB41A3 cells were grown in normal growth medium containing different amounts of G418. Dead cells were counted 
by trypan blue method. (b) Influence of exposure time on lipofection. NB41A3 cells were transfected according to the 
lipofection method described in the appendix. Incubation time of pEGFP/DOTMA complex on cell plates was between 1 h 45 
min up to 4 h. Efficiency increased, whereas cell condition decreased with time. (c) Influence of DNA purification on 
transfection. pEGFP plasmids were purified either by CsCl-method, Midi columns (Qiagen) or Midi columns using Endofree 
buffers and solutions (see protocols), and subsequently tested by CaPO - or DOTMA-transfection method. (d) Comparing 
different transfection methods. pEGFP purified on Midi columns was transfected by different, optimised methods. For figures(b-
d) transfection efficiency and the condition of cells was analysed 36 h after start of transfection in various experiments. The 
efficiency was defined as percentage of cells expressing GFP. Transfection efficiency is compared with SuperFect transfection 
with pEGFP purified on a Midi-column of Qiagen which corresponds to 100 %, since maximal transfection efficiency (up to 
20%) was observed under these conditions. Cell condition was quantified by comparing the percentage of cell death and with the 
one of untransfected control cells (100%). 
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After one week exposure to 500 µg/ml of G418, 7% untransfected NB41A3 cells survived. The survival 
rate was very similar (8%) in cells transfected with control pKS+ Bluescript vector devoid of neomycin 
resistance gene. Cells expressing GFP alone or transfected with 1 µg of each hybrid-GFP vector had a 
two fold higher survival rate under the same conditions, but other cells transfected with pEGFP vector 
containing either GAPDH, Hsc70, aldolase or Ulip had survival rates between only 2-7%.  
 
Whereas 750 µg/ml G418,  untransfected cells were no more alive after one week, at least 1% transfected 
cells were still alive after one week exposure to 1250 µl/ml G418. Thereby cells transfected with pEGFP 
vector alone showed highest resistance, 2-4 fold higher than the other cells. We therefore chose 750 
µg/ml G418 as an appropriate concentration to select for stably transfected cells. 
 
After transfection the selection medium containing 750 µg G418/ml was changed every 3 days. After 
seven passages G418-resistant colonies were selected and analysed under the microscope for GFP 
expression. By handling the cell clones as described in the method section, we obtained stable NB41A3 
cell lines overexpressing GAPDH (NB41GAPDH-GFP), aldolase (NB41aldolase-GFP) and enolase 
(NB41enolase-GFP). 
 
 
4.2 Optimisation of transfection and 
incubation conditions 
 
4.2.1.1 Optimisation of transfection 
 
Different transfection methods were tested in respect to their transfection efficiency and their influence on 
cell viability. We tested four different transfection procedures (see methods section and appendix): two 
CaPO4- methods, a lipofection method with Dotma and SuperFect (Quiagen). Incubation time and DNA 
purification method was optimised separately for each method (see e.g. figure 4b  and figure 4c). 
Transfection efficiency was higher with Qiagen-column-purified than with CsCl-purified DNA in all 
tested transfection methods, whereas the cell viability is unchanged. SuperFect transfection from Qiagen 
purified cDNA produced the best results regarding high transfection efficiency as well as in terms of low 
cytotoxicity (figure 4d) and was therefore used routinely in all our experiments.  
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The SuperFect procedure was optimised in a series of investigations. Varring the amount of totally 
transfected plasmid DNA, the ratio of DNA to SuperFect reagent and the incubation times of 
DNA/SuperFect complexes with the. With the optimised conditions for suspected transfection of 1 µg 
plasmid DNA, 5 µl SuperFect, 3-4 h incubation time on cells, we obtained 15-20% transfection 
efficiency, what is extraordinary high for neuroblastoma cell lines. 
 
4.2.1.2 Influence of SuperFect transfection on protein-GFP expression 
 
Whether the interval between transfection and start of exposure to oxidative stress was 24 h, 36 h, 48 h or 
72 h did not influence the results of the experiments. The cell confluency  does not affect the effects of 
oxidative stress. Nevertheless we standardised the growth of cells to 60 % confluency before incubation 
with FeCN or H2O2. 
 
The efficiency of transfection was about 5-15 % for all GFP constructs, so over 85 % of the cells did not 
express heterologous GAPDH. Comparing the endogenous GAPDH pattern in these cells with the 
GAPDH pattern of cells which never had been used for transfection showed that  GAPDH distribution is 
not influenced by the transfection procedure. This was also confirmed for the four other proteins of the 
PMO complex. 
 
4.2.1.3 Optimisation of induction of apoptosis and oxidative stress 
 
Cells were oxidatively stressed with different concentrations of H2O2 and of FeCN. The stressing agent 
was directly added to fresh medium (containing 10 % FCS) in which NB41A3 cells at 80% confluency 
were incubated for 3 h. Cell death was then evaluated by trypan blue in a Neubauer cell chamber. The 
percentage of dead cells correlated logarithmically with increasing concentrations of H2O2 and FeCN. 50 
% of cells were dead with 300 µM H2O2 or 1 mM FeCN. Thus, for standard experiments 100 µM H2O2 
and 300 µM FeCN were used, i.e. concentrations where less than 20 % dead cells was observed. Hoechst 
staining, that at these concentrations there was no significant nuclear fragmentation and therefore that the 
death cells had not died from apoptosis. For R6 cells, although these cells were more sensitive to 
oxidative stress, they also did not show nuclear fragmentation in cells stressed by100 µM H2O2 or 300 
µM FeCN. 
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For investigating apoptosis we tested three potent inducers of apoptosis at different concentrations: FAS 
APO(100 ng/ml and 400 ng/ml), MG132 (1 µM, 2uM and 3 µM) and staurosporine (100 nM, 200 nM and 
500 nM). The number of dead NB41A3 and R6 cells was estimated after 6, 12, 18, 24 and 48 h. We 
found that FAS APO did not efficiently induce cell death. After 24 h 200 nM staurosporine yielded 
apoptosis in about 25% NB41A3 cells and in over 50 % R6 cells. With 1 µM MG132 the rate of dead 
cells at different time points was always smaller, while at 2 µM MG132 they were too high. We therefore 
used 1.5 µM MG132, yielding 20 % cell death for NB41A3 cells and 70 % cell death for R6 cells after 
24h exposure.   
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4.3 Controls for transfection experiments 
 
4.3.1 GFP 
 
Using the transfection conditions described above, we observed GFP expression in about 15 % of the 
cells. In NB41A3 cells (picture 1a), as well as in R6 cells (picture 1b) GFP was uniformly expressed all 
over the cell, except in the nucleolus. No binding of GFP to cytoskeletal structures was found. In none of 
the cells was the nucleus fragmented. Independent of the level of GFP expression, no differences in 
morphology or cell viability were observed compared to untransfected neuroblastomas.  
 
It was shown in control experiments by immunocytochemistry, that polyclonal anti-GFP Ab specifically 
detected only GFP.  
 
Induction of oxidative stress did not change the cell morphology nor the expression of GFP. It was still 
distributed all over the cell. After exposure to pro-apoptotic reagents, the percentage of GFP-transfected 
apoptotic NB41A3 and R6 cells were comparable to untransfected cells (see table 1). These cells were 
shrivelled up, and showed slightly increased levels of GFP compared to non-apoptotic cells, but no 
increased molecular translocation of GFP. 
 
 
4.3.2 Influence of the GFP- or BFP-tag on protein-
expression 
 
4.3.2.1 GAPDH 
 
To establish that the GFP-tag or BFP-tag did not influence the expression of GAPDH, cells were 
transfected with either the GAPDH-GFP (or GAPDH-BFP) expression vector or with an analogous vector 
without an immunofluorescent tag. 
 
The distribution of GAPDH as detected by the Texas-Red fluorescence was identical in cells transfected 
with GAPDH alone or in GAPDH-GFP transfected cells, independently of whether cells were unstressed 
(picture 1c) or stressed with either FeCN (picture 1d) or H2O2 (picture 1e). Also the number of cells 
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showing an effect to exposure to apoptotic agents was comparable in both cases. These observations 
suggest that the coupled GFP does not influence the expression and localisation of GAPDH. 
 
In the cells transfected with GAPDH-GFP, the green fluorescence from GFP and the red fluorescence 
from Texas-Red co-localised. This observation was confirmed in cells stressed by H2O2, suggesting that 
the endogenous GAPDH co-localises with GAPDH-GFP in transfected cells. Cells that did not contain 
any GAPDH-GFP were also stained by Texas-Red, indicating that endogenous GAPDH is detected by 
these antibodies. 
 
4.3.2.2 Hsc70 
 
The distribution of Hsc70-GFP and Hsc70 (without GFP tag) was identical, indicating that the GFP-tag 
did not influence the localisation of the tagged protein. Also after apoptosis, both, the tagged and the 
untagged Hsc70 behaved in the same manner. However, after oxidative stress it seemed that transfected 
untagged Hsc70 translocated more into the nucleus than the tagged protein. 
 
4.3.2.3 Aldolase 
 
Again, to test whether the GFP tag could influence the pattern of expression after aldolase-GFP 
transfection, cells were plated and transiently transfected either with the aldolase-GFP expressing vector 
or with a plasmid expressing untagged aldolase only. The immunofluorescence pattern of  cells 
transfected by aldolase only was identical to the one of aldolase-GFP transfected cells. The effects to 
oxidative stress or apoptosis were identical in both cell types. Finally cells were co-transfected with both 
of these vectors, one carrying aldolase-GFP and the other one carrying untagged aldolase, yielding a 
complete colocalisation between GFP and antibodies against aldolase. These data further substantiated 
that the GFP-tag does not influence the expression and localisation of aldolase. 
 
4.3.2.4 Ulip 
 
First, we examined whether Ulip coupled to GFP gives the same results like Ulip coupled to BFP. 
Distribution of both of them, Ulip-GFP and Ulip-BFP, was detected by confocal microscopy and by 
fluorescence microscopy. Although the fluorescence of BFP was much weaker than the one of GFP, the 
distribution was comparable. Further, immunofluorescence studies showed identical distribution of anti-
ULIP antibodies after transfection with either ULIP alone or ULIP tagged with GFP or BFP.  
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We also checked whether the polyclonal Ab against Ulip specifically recognised Ulip-GFP by comparing 
the distribution of Ulip-GFP with the distribution of Texas-Red-coupled antibody, which bound with high 
affinity to a anti-ULIP polyclonal antibody. 90% co-localisation between GFP and Texas-Red was 
observed in oxidatively stressed cells as well as in unstressed cells transiently transfected with Ulip-GFP. 
All cell areas where GFP was expressed were also stained by Texas-Red. However additional Texas-Red 
staining near the cell plasma membrane was also observed, where no GFP was expressed. This means 
either that some endogenous Ulip is expressed in the cell plasma membrane and weakly also in the 
nucleus where transfected Ulip-GFP is not expressed, or that the Texas-Red staining was due to another 
isoform of Ulip detected by the polyclonal antibody, or that GFP-tag changed Ulip-GFP expression in 
those specific regions. The last hypothesis could be ruled out however, since immunostaining in cells 
transfected either by ULIP-GFP or by an Ulip-vector devoid of GFP, was identical, displaying a strong 
patchy staining in the cytoplasm with some Texas-Red at the cell membrane.  
 
4.3.2.5 Enolase 
 
The immunofluorescence pattern in cells transfected by enolase alone was identical to the one in enolase-
GFP transfected cells. Also the small changes observed after oxidative stress treatment were identical. 
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4.4 GAPDH 
 
4.4.1 NB41A3 
 
4.4.1.1 Untransfected cells 
 
 
 
The intensity of endogenous GAPDH expression in most unstressed NB41A3 cells was about the same in 
the cytoplasm and in the nucleus (picture 1f, figure 5a). None of the cells were apoptotic (table 1). 
 
After oxidative stress with H2O2, 70% of GAPDH was expressed in the nucleus of untransfected cells 
(picture  1i, figure 5a). Treatment with 300 µM FeCN had the same effects as 100 µM H2O2 and did not 
promote translocation to the cytoplasm: 75% of GAPDH expression was nuclear. The "speckled" 
GAPDH pattern associated with cell surface blebbing was only seen very infrequently. 
 
Staurosporine caused nuclear translocation of GAPDH. 6 h after exposure to 200 nM staurosporine, 
nuclear GAPDH expression was twice as high as the cytoplasmic expression (figure 6a). Whereas in the 
vast majority of non-apoptotic cells, the GAPDH levels increased only by about 50%, in apoptotic cells 
(about 5%) GAPDH expression increased up to 300%, but is excluded from the fragmented DNA (picture 
1g, 1h). After 24 h of staurosporine exposure, the number of apoptotic cells is about 20% (figure 6b). 
Interestingly, later on some apoptotic cells become depleted of GAPDH (picture 1j, 1k).  
 
MG132 had effects very similar to staurosporine (figure 6c). 6 h after exposure, 90% of GAPDH was 
expressed in the nucleus (picture 1m, 1n). Some of these cells also had changed to a hedgehog like 
morphology, other cells (picture 1l) were round and formed blebs containing GAPDH but did not have 
nuclear fragmentation. The percentage of apoptotic cells was slightly higher than in untreated cells. After 
24 h, however,  20% of the cells were apoptotic and had very high GAPDH expression, which later on 
disappeared sometimes, similar to the effects induced by staurosporine. 
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 Control MG132 
 6h  
MG132  
24h 
Staurosporine 
6h 
Staurosporine 
24h 
NB41A3 untransfected 0 2 20 5 20 
NB41A3 transiently 
transfected 
10 15 35 20 40 
NB41A3GAPDH-GFP 
 
5 15 35 15 35 
R6 untransfected 
 
0 10 70 10 50 
R6 transfected 
 
10 50 90 70 85 
R6Bcl-2 untransfected 
 
0 2 20 5 15 
R6Bcl-2 transfected 
 
10 50 85 60 90 
 
Table 1: Apoptosis in untansfected and GAPDH-GFP transfected cells. The percentage of apoptotic cells after 6 h and 24 h 
of incubation with either MG132 (1.5 µM) or staurosporine (200 nM) is indicated. Cells showing chromatin condensation or 
nuclear fragmentation, which was visualised by Hoechst blue staining, were considered as apoptotic cells. Standard deviation is 
smaller than 5 % in all tested conditions. 
 
 
 
 
 
 
 
 
 
 
Í 
 
Picture 1: Subcellular localisation of endogenous GAPDH after oxidative stress or apoptosis in NB41A3 neuroblastoma 
cells. 
(a-e) Controls: effects of transfection on cellular localisation of GFP or GAPDH. (a-b): controls of transfection with 
pEGFP: (a)  NB41A3 neuroblastoma cells cells or (b) R6 retinoblastoma cells were transfected with pEGFP (a control vector 
devoid of GADPH gene) to test viability and distribution of the GFP. (c-e) : NB41A3 cells were transfected with pGAPDH (a 
vector devoid of GFP-tag) and the expression of  GAPDH was tested, as detected by TR immunohistochemistry, in (c) 
unstressed cells and  in cells stressed with(d) 300 µM FeCN or with (e) 100 µM H2O2, respectively.  
(f-n) Subcellular localisation of GAPDH in untransfected NB41A3 cells. 
 (f, i) Distribution of endogeneous GAPDH in untransfected NB41A3, either (f) unstressed or (i) stressed with 100 µM H2O2 
detected by TR-immunohistochemistry. (g, h) Apoptosis induced in NB41A3 after exposure to 200 nM staurosporine for 6 h. (j, 
k) Apoptotic cells devoid of GAPDH observed at later stages of apoptosis (200 nM staurosporine for 24 h). (m, n) Nuclear 
translocation and (l) bleb-forming cell after induction of apoptosis for 6h with 1.5 µM MG132.  
DNA is detected by Hoechst staining (g, j, m). See methods for details. Scale bar is 50 µm 
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Figure 5: Subcellular localisation of GAPDH in NB41A3 cells. (a) Untransfected, (b) transiently transfected and (c) stably 
transfected cells were analysed under unstressed conditions or after 3 h of oxidative stress with either 100 µM H2O2 or 300 µM 
FeCN. The percentage of total GAPDH (or of GAPDH-GFP for transfected cells) in the nucleus and in the cytoplasm is 
indicated. Standard deviation is smaller than 5 % in all tested conditions. (d) GAPDH-GFP expression was analysed after 
oxidative stress with regard to its intensity and to its uniformity/patchiness in NB41A3 and R6 cells. Histograms of GAPDH 
expression in cells exposed to 100 µM H2O2 for 3 h were evaluated regarding the mean intensity and the variation (= standard 
deviation squared) of expression. Intensity (=expression level) and variation (=patchiness) are presented for nucleus and 
cytoplasm. Both cell lines show higher and less patchy GAPDH expression in the nucleus. Expression in R6 cells is more patchy 
than in NB41A3 cells.   
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Figure 6: Induction of apoptosis by staurosporine and MG132. Induction of apoptosis by staurosporine (200 nM) and  
MG132 (1.5 µM) in NB41A3 cells was performed as described for 0, 6 or 24 h.(a) Untransfected cells exposed to staurosporine: 
the percentage of total endogenous GAPDH in the nucleus and in the cytoplasm is indicated.  (b, c) The percentage of cells 
showing nuclear fragmentation or chromatin condensation after exposure to (b) staurosporine and  (c) MG132 is indicated in 
NB41A3 cells expressing endogenous GAPDH or transfected GAPDH-GFP. 
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Figure 7: Effects of oxidative stress to GAPDH-GFP transfected NB41A3 cells. (a) Percentage of total GAPDH-GFP 
expressed in the cytoplasm of transiently transfected NB41A3 cells exposed to either to either H2O2 (0-300 µM) or FeCN (0-
1000 µM) for 3 h. (b) Percentage of cells exposed for different time (from 0-6 h) to 100 µM H2O2 or to 300 µM FeCN forming 
GAPDH-GFP positive speckles. Additionally, a set of cells (24+3) was first stressed for 6 h, incubated further for 18 h in normal 
growth medium and then stressed again for 3 h. 
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4.4.1.2 Transiently GAPDH-GFP transfected cells 
 
Controls 
The distribution of GAPDH in transfected neuroblastoma cells was different to the one in untransfected 
cells (figure 5b). Most of the transfected GAPDH-GFP (65%) was concentrated in the nucleus under 
basal conditions (picture 2a). No GAPDH-GFP fluorescence could be detected in the nucleolus of any 
cells examined under various experimental conditions. Further, no formation of GAPDH-GFP speckles 
was observed in the cells. The cellular distribution of GAPDH-GFP did not depend on the shape of the 
neuroblastoma cells.  
 
Nuclear fragmentation was seen in 10% of GAPDH-GFP transfected neuroblastoma cells in the absence 
of apoptotic reagents (table 1). These apoptotic cells expressed 3 times more GAPDH-GFP than other 
cells (picture 2b, 2c).  
 
Induction of Oxidative Stress 
 
After treatment with 300 µM FeCN, the majority of GAPDH-GFP fluorescence (80%) was found in the 
cytoplasm (picture 2e, figure 5b). Compared with unstressed cells, a 0.4 fold increase of GAPDH-GFP in 
the cytoplasm was observed. 
 
The ratio between cytoplasmic and nuclear GAPDH-GFP expression varied from 1.5:1 up to 4:1. This 
variation may be due to the phenotypic heterogeneity of NB41A3 cells, which may in particular involve 
their response to oxidative stress, and the cell to cell variability of transfection. 
 
This translocation was dose-dependent (figure 7a): Cells stressed with only 100 µM FeCN showed 
qualitatively similar changes but, the percentage of cells displaying a change of pattern was only about 
40% and the effect was less pronounced (ratio cytoplasm : nucleus from 1:1 to 3:1). Incubation with 1000 
µM of FeCN killed about 50% of the cells, but in the surviving cells 90% GAPDH-GFP was expressed 
predominantly in the cytoplasm. The majority of these cells were rounded up; additionally, in few cells 
GAPDH-GFP was associated with cell surface blebs (picture 2f). 
 
In contrast, exposure to H2O2 enhanced nuclear expression of GAPDH-GFP (picture 2g). Most cells 
treated with 30 µM of H2O2 for 3 h, like control cells, expressed 1-3 fold more GAPDH-GFP in the 
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nucleus than in the cytoplasm. 100 µM H2O2 raised the nuclear GAPDH-GFP fluorescence from 65% to 
80%. For both concentrations no expression was observed in the nucleolus. A minority of cells (5%) 
accumulated GAPDH-GFP in small intracellular speckles (picture 2h). 
 
The relationship between this "speckled" phenotype and oxidative stress was explored by incubating cells 
with either 300 µM FeCN or 100 µM H2O2 for 2 h to 6 h. On one plate cells were stressed for 4 hours, re-
incubated with standard medium for another 20 hours and again exposed for 4 hours with the stressing 
agent, before examination under the microscope. The percentage of cells forming GAPDH-GFP 
"speckles" increased with the duration of the stress from less than 4% after 2h up to 20% after 5 h with 
H2O2 or 15% with FeCN (figure 7b). These results indicate that the accumulation of GAPDH-GFP 
"speckles" correlates with oxidative stress. Some cells were in an intermediate stage, changing from 
nuclear or cytoplasmic GFP-pattern to a speckled pattern (picture 2i). 
 
Oxidative stress by both 100 µM H2O2 or 300 µM FeCN did not increase the percentage of nuclear 
fragmentation in GAPDH-GFP overexpressing cells. Nevertheless, a phenomenon that was exclusively 
observed in stressed cells overexpressing GAPDH-GFP (mostly at very high amounts) was that in few 
cells GAPDH-GFP fluorescence was associated with pronounced blebbing of the cell surface membrane. 
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Picture 2: Subcellular localisation of GAPDH-GFP in transiently or stably transfected NB41A3 neuroblastoma cells. 
(a-j) GAPDH-GFP expression in transiently transfected cells. 
(a) Expression of  GAPDH-GFP in transiently transfected  NB41A3 neuroblastoma cell under unstressed conditions. (b, c) 
Apoptotic cell under unstressed condition, detected by (b) Hoechst staining or (c) as GFP fluorescence. (e) Cytoplasmic 
translocation and (f) formation of GAPDH-GFP blebs after oxidative stress induced  (e) by 300 µM and (f) 1 mM FeCN.  (g) 
Nuclear translocation in the majority and (h) speckle formation accumulating GAPDH-GFP in a minority of cells, observed after 
oxidative stress with 100 H2O2. (i) Stressed cell in an intermediate stage changing from nuclear to speckled expression pattern. 
(d, j) Induction of apoptosis for 6 h with 200 nM staurosporine, displaying (d) apoptotic cells or (j) network-like structures. (k-
o) Hedgehog like cell after apoptosis induced with 1.5 µM MG132 for 6 h. While (k-n) are confocal images of single planes at 
different z-axis values, (o) is a x-y projection of all sections trough the z-axis. (p-r) Permanent expression of GAPDH-GFP in 
NB41A3GAPDH-GFP cell line, under (p) unstressed conditions, or after oxidative stress with (q) 100 µM H2O2 or (r) 300 µM 
FeCN, respectively. The green fluorescence displays GADPH-GFP expression. In (q) and (r), the cytoplasm was made visible 
by immunostaining with anti-enolase-γ. 
The scale is the same for all figures, except for (j).  Scale bars are 50 µm. 
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Induction of Apoptosis 
 
In contrast to untransfected cells, most of the GAPDH-GFP transfected cells change their morphology 
after 6 h of incubation with 200 nM staurosporine. Many cells contain only a small cytoplasmic area and 
have very long axons which form together a network-like structure (picture 2j). These non-apoptotic cells 
express high levels of GAPDH (about 50% more per cell  than control cells) at same the intensity in 
nucleus and cytoplasm. The apoptotic cells (20%) (figure 6b) are shrivelled up, have fragmented nuclei 
and are much smaller than non-apoptotic cells (picture 2d). They express GAPDH at very high levels in 
the nucleus, over 3 times over baseline. After 24 h exposure to staurosporine more than one third of the 
neuroblastoma cells have fragmented nuclei (table 1). 
 
High GAPDH expression is found all over after 6 h exposure to MG132. The number of hedgehog shaped 
cells, all showing an unfragmented nucleus, increased nearly twofold compared to untransfected cells 
(picture 2k-2o). The remaining 15% cells were apoptotic (figure 6c). After 24 h of treatment, except for 
the higher percentage of apoptotic cells, the observations were similar as for untransfected cells under 
similar conditions (table 1).  
 
Co-transfections of GAPDH-GFP with other proteins 
 
We wanted to test whether any of the other four proteins (enolase, Ulip, Hsc70, and aldolase) known to 
form a complex together with GAPDH influences GAPDH-GFP expression if it is co-transfected. In these 
co-transfection experiments one protein was coupled to GFP and the other one to BFP. 
 
Co-transfection of GAPDH-GFP and enolase-BFP together did not change the pattern of GAPDH 
expression in unstressed cells. After oxidative stress (100 µM H2O2 or 300 µM FeCN) the percentage of 
cells forming intracellular GAPDH-speckles or concentrating GAPDH-GFP at the plasma membrane was 
about doubled compared to cells expressing GAPDH-GFP only. 
 
Similar effects were also seen with Ulip. While in absence of oxidative stress no significant difference 
was observed, 30% of the cells stressed with FeCN or H2O2 showed either intracellular GAPDH-speckles 
or very brightly stained plasma membranes. In addition, in cells exposed to FeCN, 40% of GAPDH was 
displayed in the nucleus (against less than 10% in cells only carrying the GAPDH plasmid). Since cells 
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transfected with Ulip-GFP alone show considerable translocation of Ulip into the nucleus after oxidative 
stress (results shown later), we suggest that Ulip somehow interacts with GAPDH.  
 
We observed that concomitant overexpression of GAPDH with either aldolase or Hsc70, both of which 
are expressed predominantly in the cytoplasm, increased cytoplasmic GAPDH expression in unstressed 
and stressed cells. Prior to oxidative stress 55%, and after exposure to 100 µM H2O2 for 3 h, 40% of 
GAPDH was expressed in the cytoplasm of these cells. I.e., overexpression of Hsc70 and aldolase 
partially prevents nuclear translocation of GAPDH. 
 
 
4.4.1.3 Stable cell line overexpressing GAPDH-GFP (NB41GAPDH-GFP) 
 
Controls 
 
In a bulk population of cells stably overexpressing GAPDH-GFP, 5% NB41A3 show nuclear 
fragmentation due to high GAPDH-GFP expression (table 1). Most non-apoptotic cells (80%) express 2-4 
fold more GAPDH-GFP in the nucleus than in the cytoplasm (picture  2p, figure 5c). Cells forming 
GAPDH-positive speckles or blebs were not found. 
 
Induction of oxidative stress 
 
Cells stressed with 100 µM H2O2 for 3 h showed slightly increased nuclear expression (picture 2q). 
Nevertheless, the nucleoli are devoid of GAPDH-GFP. FeCN incubation showed more effects (figure 5c): 
the proportion of cells expressing mostly cytoplasmic GAPDH-GFP increased from 15% to 40%, yet over 
50% had still a higher nuclear expression (picture  2r). The amount of apoptotic cells after oxidative 
stress was very small (5-10%) and not higher than in unstressed cells and cells forming GAPDH-GFP 
"speckles" were rarely found. 
 
Induction of apoptosis 
 
The effects of staurosporine and MG132 on NB41GAPDH-GFP were very similar to those ones observed in 
transiently transfected NB41A3, resulting in increased GAPDH-GFP expression all over the cell and 
hedgehog-like cell shape. The overexpressed GAPDH-GFP leads to over 30% apoptotic cells after 24 h of 
MG132 or staurosporine exposure, twice more than in untransfected cells (figure 6b, 6c, table 1). 
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4.4.2 R6 and R6Bcl-2 
 
4.4.2.1 Untransfected cells 
 
Controls 
 
To test whether the expression of GAPDH protein described above is specific for neuronal cells or 
whether similar localisation and differential translocation can be also observed in non-neuronal cells, 
embryonic R6 fibroblasts were used. In addition a R6 cell line permanently overexpressing Bcl-2 (R6Bcl-2) 
was used to investigate the influence of Bcl-2 during apoptosis and oxidative stress. In contrast to what is 
observed in NB41A3 cells, the endogenous GAPDH is expressed along cytoskeletal fibres in the 
cytoplasm, especially in the perinuclear area of untransfected R6 cells (picture 3b, 3d) and R6Bcl-2 cells 
(picture 3e). 80% of total GAPDH was expressed in cytoplasm, although in about 30 % of the cells 
GAPDH expression level in the cytoplasm and in the nucleus was about equal (figure 8a). No signs of 
apoptosis were observed in untransfected fibroblasts before treatment with apoptotic agents (picture 3a, 
table 1).  
 
 
 
 
 
 
 
 
Î 
 
 
Picture 3: Subcellular localisation of endogenous GAPDH in untransfected R6 and R6Bcl-2 fibroblast cells 
Cytoplasmic localisation of GAPDH in  unstressed (a-d) R6 or (e) R6Bcl-2 cells. 
(d) Overlay of a-c. The three upper untransfected cells (red) show similar GAPDH expression like the two lower transfected 
cells (yellow=green+red). The nuclei (blue) are not fragmented. (f-i) Nuclear translocation of endogenous GAPDH in (f) R6 and 
(h) R6Bcl-2 cells, and accumulation of GAPDH in speckles in (g) R6 and (i) R6Bcl-2 cells after exposure to 100 µM H2O2 for 3 h. 
(j) 60% of R6 cells with intact nuclei still have cytoplasmic expression of endogenous GAPDH after exposure to 1.5 µM MG132 
for 6 h, whereas (p, q) 10% are apoptotic. (k,l,m,n,o,r) Translocation of GAPDH after exposure to 200 nM staurosporine. (m-o) 
Unchanged cytoplasmic localisation of GAPDH after 2 h. (o) Overlay of m & n. (k, l) Increasing amount of nuclear expression 
after 6 h. (r) Apoptotic cells after 24 h. 
(a,d,j,k,p) Visualisation of DNA by Hoechst blue staining. Detection of GAPDH by (b,d,e,f,h,i,j,l,m,o,q,r) TR or (g) FITC 
staining of anti-GAPDH Ab. (c,d,n,o) Visualisation of transfected GAPDH by GFP tag. Scale bar is 50 µM. 
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Figure 8: Subcellular localisation of GAPDH after oxidative stress in R6 cells. (a) Untransfected and (b) transiently 
transfected cells were analysed under unstressed conditions or after 6 h of oxidative stress with either 100 µM H2O2 or 300 µM 
FeCN. The percentage of total GAPDH (or of GAPDH-GFP  for transfected cells) in the nucleus, in the cytoplasm or in speckles 
is indicated. Standard deviation is smaller than 5 % in all tested conditions. 
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Figure 9: Apoptosis in R6 and R6Bcl-2 cells. (a, b) R6 and (c, d) R6Bcl-2 cells were exposed to (a, c) MG132 (1.5 µM) or (b, d) 
staurosporine (200nM). The percentage of cells showing nuclear fragmentation or chromatin condensation in cells expressing 
endogenous GAPDH or transfected GAPDH-GFP is indicated after 0, 6 and 24 h of exposure time. 
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Induction of oxidative stress 
 
After oxidative stress for 6h with 100 µM H2O2 or 300 µM FeCN translocation of GAPDH from the 
cytoplasm to the nucleus was observed in 40%-50% of R6 cells (figure 8a). R6 cells did not show a 
uniform distribution of GAPDH, neither in the nucleus nor in the cytoplasm (picture 3f, figure 5d), but 
higher concentrations of GAPDH were found around the nucleolus. In addition, GAPDH spots 
accumulated at the cell membrane after oxidative stress resembling the "speckled" pattern described in 
NB41A3 cells (picture 3g). Stable overexpression of Bcl-2 in R6Bcl-2 cells does not change the percentage 
of nuclear translocation (picture 3h) nor the formation of GAPDH positive speckles (picture 3i) in 
response to oxidative stress induced by H2O2 or FeCN. 
 
Induction of apoptosis 
 
R6 cells were examined after 6 h of exposure to MG132. 60% cells display unchanged perinuclear 
distribution of GAPDH, similar to controls (picture 3j), whereas 30% express GAPDH predominantly in 
the nucleus. In both cases cells have no visible signs of apoptosis. The 10% remaining cells display 
nuclear fragmentation (picture 3p, 3q, figure 9a, table 1) and the expression of GAPDH is about 2-3 
times higher. Under similar experimental conditions R6Bcl-2 cells display only 2% apoptotic cells, all 
showing very high expression of endogenous GAPDH (figure 9c, table 1), and 10% of those also showed 
nuclear translocation of GAPDH but no nuclear fragmentation. 
 
After 24 h of incubation with MG132 only one third of the R6 cells show the usual perinuclear GAPDH 
ring around the nucleus without changes in their immunohistochemical pattern, whereas most of the other 
R6 cells are apoptotic and accumulate very high amounts of GAPDH. Interestingly, in a number of 
apoptotic cells GAPDH has already fainted away completely (similar to picture 1j, 1k).  
Under similar conditions R6Bcl-2 cells show apoptotic features only in 20% cells (figure 9c). Together 
these observations are consistent with the fact that Bcl-2 protects cells from apoptosis. 
 
In experiments where apoptosis was induced by the protein kinase inhibitor staurosporine (200 nM and 
750 nM) we obtained similar results as for MG132-induced apoptosis (figure 9b). Half the untransfected 
R6 cells exposed to 200 nM staurosporine for 24 h were apoptotic. The GAPDH pattern changes during 
staurosporine induced apoptosis as follows: initially, endogenous GAPDH is mainly concentrated at the 
perinuclear area and along the cytoskeleton (picture 3m, 3o). About 6 h after addition of the apoptotic 
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agent, the cells start to accumulate GAPDH in the nucleus (picture 3l). Most of the cells do not show 
apoptotic features such as nuclear fragmentation(picture 3k). But a few hours later small shrivelled up, 
round apoptotic cells expressing GAPDH at very high levels (about 2-3 times more intense than in not 
apoptotic cells) can be detected (picture 3r). Another few hours later up to 10% of the apoptotic cells 
contain no detectable GAPDH any more (similar to picture 1j, 1k). 
 
In R6Bcl-2 cells, the protection against staurosporine-induced apoptosis was higher than against MG132 
(table 1, figure 9d). After 24 h exposure to staurosporine, GAPDH staining was unchanged in 50% of 
cells and comparable to controls. 35% of the cells had fewer processes than controls. GAPDH was not 
expressed predominantly in the perinuclear area, but distributed all over. Only 15% of untransfected 
R6Bcl-2 cells are apoptotic (figure 9b) and express 2-3 times higher levels of endogenous GAPDH.  
 
 
4.4.2.2 Transiently transfected cells 
 
Controls 
 
The expression of transiently transfected GAPDH-GFP in R6 fibroblasts and in R6Bcl-2 fibroblasts was 
quite similar. 30% of transiently transfected cells displayed predominantly perinuclear GAPDH 
expression, similar to untransfected cells (picture 4a). All other cells showed predominantly nuclear 
GAPDH-GFP expression subsequent to transfection (picture 4b, figure 8b). The percentage of nuclear 
expression in transfected R6 cells was thus smaller than in transfected NB41A3 neuroblastomas (see 
above). There was no direct correlation between the expression level of GAPDH-GFP and its localisation. 
GAPDH-GFP transfected R6 and R6Bcl-2 cells were in part apoptotic. In contrast to untransfected cells, 
after transient transfection with GAPDH-GFP nuclear fragmentation was observed in about 10% of cells 
(picture 4c, 4d, table 1). These apoptotic cells were shrivelled up and they expressed 2-3 fold higher 
levels of GAPDH-GFP around the segmented DNA. The rate of apoptotic R6Bcl-2 cells transfected with 
GAPDH-GFP was not different from the one seen in R6 cells (table 1).  
 
Induction of oxidative stress 
 
Exposure of R6 cells to H2O2 induced drastic changes in GAPDH-GFP localisation already after 3 h. In 
all cells GAPDH-GFP exerted a punctuated expression pattern. While most R6 fibroblasts accumulated 
GAPDH-GFP in the nucleus, it is sometimes distributed all over the cell or arranged in speckles, as 
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described for NB41A3. Cells with very high expression levels of GAPDH-GFP formed GAPDH-GFP 
positive blebs at the cell surface (picture 4f) but had no fragmented nucleoli (picture 4e). Speckles 
formation was much more frequent than in untransfected R6 cells. In contrast to observations with 
untransfected fibroblasts, FeCN did not induce nuclear translocation of GAPDH-GFP (figure 8b). Quite 
the opposite, punctuate GAPDH-GFP expression is observed in many R6 cells predominantly in the 
perinuclear area of the cytoplasm (picture 4g). However, like with H2O2, many cells start forming 
GAPDH-GFP positive speckles at the cell surface. About 15% cells showed nuclear fragmentation. 
 
Changes in GAPDH-GFP localisation were also seen in R6Bcl-2 cells. H2O2 and FeCN both induced 
GAPDH-GFP expression in the nucleus and in speckles at the plasma membrane (picture 4h). 
Additionally, many cells with a hedgehog like shape expressing GAPDH-GFP all over the cell were 
observed. Cells, where GAPDH-GFP was bound to cytoskeletal structures were not found. Interestingly, 
about 20% of GAPDH-GFP transfected R6Bcl-2 cells were apoptotic, i.e. 5% more than in R6 cells. 
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Picture 4: Subcellular localisation of GAPDH-GFP in transfected R6 and R6Bcl–2 cells  
(a) 30 % of GAPDH-GFP transfected, unstressed R6Bcl-2 cells (green) show similar perinuclear GAPDH-GFP localisation like 
endogenous GAPDH detected by TR in untransfected cells (red), while (b) 60 % express GAPDH-GFP predominantly in the 
nucleus and (c, d) 10 % are apoptotic. (e, f) R6 cell with unfragmented DNA forming GAPDH-GFP positive blebs at the cell 
surface after exposure to 100 µM H2O2 for 3 h. (g, h) Perinuclear localisation of GAPDH-GFP and formation of cells with 
GAPDH-GFP positive spikes and speckles at the cell surface after exposure to 300 µM FeCN for 3 h in (g) R6 and (h) R6Bcl-2 
cells. (i, j) Hedgehog like R6 cells forming speckles and spikes attached two the cell surface shown in two different confocal 
planes. (k-p) Formation of long processes and high expression of GAPDH-GFP in transfected (k-m) R6 and (n-p) R6Bcl-2 cells, 
but not in untransfected cells after exposure to 200 nM staurosprine for 6h. (k, n) TR staining by anti-GAPDH, (l, o) GAPDH-
GFP fluorescence, (n, p) overlay of GFP and TR fluorescence.  
(c, e) Visualisation of DNA by Hoechst blue staining. Scale bar is 50 µM. 
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Induction of apoptosis 
 
After exposure to MG132 for 6 h or 24 h, 40%, respectively 85% of the GAPDH-GFP transfected R6 
cells were apoptotic (figure 9a), indicating that cells overexpressing GAPDH-GFP were more sensitive to 
MG132 than untransfected cells. The non-apoptotic cells generally expressed nuclear GAPDH-GFP 
levels close to the baseline. Some cells had a hedgehog like shape and showed a speckled pattern of 
GAPDH-GFP expression or blebs (picture 4i, 4j). The percentage of apoptotic cells as well as the number 
of cells forming GAPDH-GFP positive blebs was about the same in R6Bcl-2 cells transiently transfected 
with GAPDH-GFP (figure 9c). Our observations indicate that the sensitivity of GAPDH-GFP transfected 
cells to apoptosis is dependent on the amount of expressed GAPDH-GFP protein. This observation is 
supported by the fact that transfected R6Bcl-2 cells that expressed GAPDH-GFP at levels close to that of 
endogenous GAPDH were less sensitive to MG132 induced apoptosis.  
 
GAPDH transfected R6 or R6Bcl-2 cells were affected at similar rate by staurosporine (figure 9b, 9d). 
Several non-apoptotic GAPDH-GFP transfected R6 and R6Bcl-2 cells formed a network of interconnected 
long processes. This network contained junctions where the processes formed enlarged knots (picture 4k-
4p). The whole network including the knots and the main cell body expressed twice more GAPDH-GFP 
compared to controls. Although no nuclear fragmentation was detected, these cells were not always in a 
good shape and some of them seemed to be dying. After 6 h about 30% and after 24 h only  5-10% of 
both R6 and R6Bcl-2 cells were still normal and showed no signs of cell death (figure 9b, 9d). This 
confirmed our findings, that Bcl-2 is able to prevent apoptosis in untransfected cells or in transfected cells 
that express levels of GAPDH protein close to control, but not in transfected cells overexpressing 
GAPDH at high levels. 
 
 
4.4.3 GAPDH translocation 
 
Overexpression of GAPDH-GFP alone is sufficient to raise the expression of nuclear GAPDH-GFP in 
NB41A3 cells and in R6 cells.10 % of the cells overexpressing GAPDH-GFP are apoptotic. We 
established a stable NB41A3GAPDH-GFP cell line constitutively overexpressing GAPDH-GFP that shows the 
same effects. This is a specific phenomenon and not an effect of transfection because cells transfected 
with GFP alone or with e.g. aldolase-GFP show neither nuclear translocation nor increased levels of 
apoptotic cells.  
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Transfection of GAPDH-GFP into neuronal and non-neuronal cell lines not only induces apoptosis per se, 
but also makes the cells more susceptible to apoptosis induced by different agents (table 1). Cells 
transiently or permanently overexpressing GAPDH show no difference with respect to staurosporine 
induced apoptosis (table 1). Compared to untransfected cells, not only the number of cells showing 
chromatin condensation and nuclear fragmentation, but also the percentage of cells expressing GAPDH-
GFP in the nucleus and of cells forming blebs and speckles is increased significantly after 6-24 h 
exposure to 200 nM staurosporine or to 1.5 µM MG132, respectively. Cells forming speckles do 
concentrate the vast majority of GAPDH-GFP in the intracellular speckles so that there is practically no 
diffuse GAPDH-GFP in the cytoplasm or in the nucleus. We were not yet able to better characterise these 
intracellular speckles, but they were different in cells forming extracellular GAPDH-GFP structures. High 
resolution CLSM made it possible to identify these as blebs filled with high density of GAPDH-GFP still 
attached to the cell membrane. These cells express GAPDH-GFP also in the cytoplasm, but none of the 
cells expressing high amounts of GAPDH-GFP in the nucleus, in intracellular speckles or in blebs 
showed nuclear fragmentation. This differential translocation of GAPDH observed after apoptosis is 
intriguing: why do cells that show membrane blebbing, a phenomena that is often observed in context 
with apoptotic cells, express GAPDH or GAPDH-GFP mainly in the cytoplasm? On the other hand, a 
typical morphological change is observed in transfected and untransfected cells after exposure to 
apoptosis inducing drugs, namely the formation of a network of long processes. These cells may thus 
compensate a weaker adhesion to the culture plate or to the glass coverslip by extending long processes 
from the cell body. 
 
Transient overexpression of GAPDH-GFP in R6Bcl-2 cells showed the same effects as in R6 cells, i.e. 
apoptosis in 10 % cells even prior to treatment with apoptotic drugs. The percentage of apoptotic cells or 
the changes in morphology was not different between the two GAPDH-GFP transfected cell lines. Thus, 
Bcl-2 is able to efficiently decrease nuclear translocation and apoptosis in untransfected cells, but has no 
effects when GAPDH-GFP is overexpressed, neither in cells at rest nor in cells exposed to apoptotic 
agents.  
 
Our results demonstrate the role of GAPDH not only in apoptosis, but also in response to oxidative stress 
and show differential GAPDH translocation  in neuronal versus non-neuronal cells. NB41A3 
neuroblastoma cells are less sensitive to proapoptotic agents as well as to reagents inducing oxidative 
stress than R6 fibroblasts. Already 2 h after exposure to either 100 µM H2O2 or to 300 µM FeCN, 
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endogenous GAPDH was translocated into the nucleus in untransfected R6 and NB41A3 cells. It must be 
stressed out that under these conditions no increase in nuclear fragmentation over control cells is 
observed. 
 
However in contrast to its protective effects during apoptosis, Bcl-2 has no influence in response to 
oxidative stress induced by either H2O2 or FeCN, neither on GAPDH translocation nor on the percentage 
of cells forming GAPDH-positive speckles. This occurs independently of whether cells were transfected 
with GAPDH-GFP or not and indicates that translocation of GAPDH into the nucleus may be 
mechanistically different between apoptosis and oxidative stress. While nuclear translocation of 
endogenous GAPDH in response to apoptosis is influenced by Bcl-2, oxidative stress induces Bcl-2-
independent translocation into the nucleus. Also when GAPDH-GFP is overexpressed, its translocation 
after oxidative stress cannot be blocked by Bcl-2. 
 
Transfection of GAPDH-GFP per se  without induction of oxidative stress already leads to enhanced 
levels of GAPDH-GFP in the nucleus. After exposure to H2O2, the amounts of nuclear GAPDH-GFP 
increased even more. FeCN different than H2O2, induced translocation of GAPDH-GFP from the nucleus 
into the cytoplasm. 
 
Exposure to apoptotic agents induces a four-step translocation of endogenous GAPDH in R6 fibroblasts. 
First, GAPDH is localised in the perinuclear area of flat, typically fibroblastly shaped cells with clear the 
cytoskeletal structure. Then it is translocated into the nucleus of the fibroblasts. Although the cytoplasmic 
structure of the cytoskeleton was not clearly visible, the fibroblasts have not changed their morphology 
and their nuclei are not fragmented. In a next stage, the typical apoptotic cells which showed cell 
shrinkage and nuclear fragmentation overexpressed high amounts (3x more than base line levels) of 
GAPDH around the fragmented nuclei. The cells were rounded up and did not have any processes. In a 
last step, no GAPDH at all is visible anymore. In NB41A3 cells and in cells overexpressing GAPDH-GFP 
these steps are similar, but a significant amount of GAPDH is found in the nucleus already before 
exposure to apoptotic drugs. 
 
The first two steps were also observed in the translocation of GAPDH induced by oxidative stress. 
However, although nuclear translocation was observed after treatment of cells with reagents inducing 
oxidative stress, the cells did not undergo subsequent apoptosis. 
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4.5 HSC 70 
 
4.5.1 NB41A3 
 
4.5.1.1 Untransfected cells 
 
In untransfected NB41A3 cells about 70% of endogenous Hsc70 is expressed in the cytoplasm as shown 
by means of immunocytochemistry with anti-Hsc70 antibodies (picture 5a, 5c, figure 10a). The ratio of 
the measured Texas-Red fluorescence between cytoplasm and nucleus is constant in all cells. 
Nevertheless in many cells the cytoplasmic Hsc70 expression is not uniform. 
 
Oxidative stress by either H2O2 or FeCN raises the Hsc70 expression in the nucleus (picture 5d,  figure 
10a). Nuclear Hsc70 is often concentrated around the nucleolus. 
 
After 6 h or 24 h exposure to either staurosporine or MG132 no significant changes in subcellular Hsc70 
expression was seen in non-apoptotic cells (figure 10a). In contrast to what is observed with GAPDH, the 
20% of NB41A3 cells showing nuclear fragmentation (figure 10b) did not accumulate or overexpress 
endogenous Hsc70 (picture 5e, 5f). 
 
4.5.1.2 Transiently transfected cells 
 
Controls 
 
Hsc70-GFP transfected cells contained in the average about twice more GFP fluorescence in the 
cytoplasm than in the nucleus (picture 5g, figure 10a). This ratio was constant in all cells. Hsc70 was 
expressed at different intensities in the cytoplasm and displayed a patchy pattern (picture 5b). The 
nucleolus was devoid of Hsc70-GFP. The expression pattern of Hsc70-GFP was very similar among all 
unstressed cells and did not depend on the shape of cells. Signs of apoptosis were not detected (picture 
5c, figure 10b). 
 
Induction of Oxidative Stress 
 
After treatment with 300 µM FeCN for 4 h, most cells (80%) raised their Hsc70-GFP expression in the 
nucleus. As a consequence the Hsc70 expression was equal in the  
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nucleus and in the cytoplasm (picture 5h) , sometimes even higher in the nucleus (picture 5i). Nuclear 
Hsc70-GFP fluorescence accumulated in patches around the nucleolus and was weaker in other parts of 
the nucleus. Within the nucleolus or at the plasma membrane no Hsc70-GFP was expressed. Formation of 
Hsc70-GFP positive speckled spots was sometimes observed (5% of cells) (picture 5j). The percentage of 
cells expressing Hsc70-GFP in small speckles increased up to 15% after 6 h in parallel to the exposure 
time to 300 µM FeCN (figure 10c). In addition, the impact of the effects augmented with increasing 
concentrations of FeCN. However, staining of nucleolus was not observed, even at high concentration (up 
to 1000 µM FeCN) or after long exposure time (up to 6h).  
 
Oxidative stress with 100 µM H2O2 resulted in formation of speckles accumulating Hsc70-GFP in 25% of 
cells. The remaining cells were mostly of round shape, had short processes and their nuclear Hsc70-GFP 
expression was increased. In the average slightly more than 50% of Hsc70-GFP was expressed in the 
nucleus of stressed cells (picture 5k, figure 10a). A correlation between the exposure time to 100 µM 
H2O2 and the amount of speckles formation was also observed (figure 10c): Depending upon the 
incubation time, between 15 and 35% of the cells accumulated Hsc70-GFP fluorescence in speckles.  
Besides cells expressing Hsc70-GFP only in speckles and not in the nucleus or in the cytoplasm, we 
found cells in an intermediate state where speckles formation is observed in particular regions of the cell 
(5l).  
 
Together these results indicate that the formation of Hsc70-GFP positive speckles is directly correlated 
with the response to oxidative stress. Furthermore, also the amount of nuclear translocation increased in 
parallel with longer exposure times of cells to H2O2 or FeCN.  
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Picture 5: Subcellular localisation of Hsc70 and Hsc70-GFP in NB41A3 cells  
(a,c,d,f) Endogenous Hsc70 as detected by TR-immunohistochemistry 
(a-c) Cytoplasmic localisation in transfected and untransfected control cells. (c) Overlay of a, b and Hoechst staining. The most 
upper transfected cell (yellow=green+red) shows similar GAPDH expression like the other untransfected cells (red). The nuclei 
(blue) are not fragmented. (d) Increased expression of endogenous Hsc70 in the nucleus after exposure to 100 µM H2O2 for 3 h. 
(e, f) Apoptotic cells after exposure to 200 nM staurosporine for 24 h with neither overexpression nor nuclear accumulation of 
endogenous Hsc70. 
(g-m) Hsc70-GFP transfected cells. 
(g) Unstressed NB41A3 cells express Hsc70-GFP mainly in the cytoplasm, whereas (h-j) cells exposed to 300 µM FeCN show 
(h) increased nuclear localisation, (i) patchy accumulation in the nucleus and (j) speckles formation of Hsc70-GfP. (k) Nuclear 
translocation and (l) beginning of intracellular speckles formation in cells exposed to 100 µM H2O2 for 3 h. (m) 30% cells also 
show nuclear translocation 24 h after induction of apoptosis by 200 nM staurosporine. 
(c, e) Visualisation of DNA by Hoechst blue staining. Scale bar is 50 µM. 
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Figure 10: Analysis of Hsc70 expression and apoptosis in untransfected Hsc70-GFP transfected cells. (a) Untransfected and 
transiently transfected cells were analysed under unstressed conditions, after exposure to 100 µM H2O2 for 3 h or after exposure 
to 200 nM staurosporine for 24 h. The nuclear expression is indicated as percentage of total GAPDH (or of GAPDH-GFP for 
transfected cells). Standard deviation is smaller than 5 % in all tested conditions. (b) Apoptosis in R6 and R6Bcl-2 cells after 
exposure to staurosporine (200nM) or to MG132 (1.5 µM). The percentage of cells showing nuclear fragmentation or chromatin 
condensation in cells expressing endogenous Hsc70 or transfected Hsc70-GFP is indicated after 0, 6 and 24 h of exposure time. 
(c) Percentage of transfected cells exposed for different time (from 0-6 h) to 100 µM H2O2 or to 300 µM FeCN forming Hsc70-
GFP positive speckles. Additionally, a set of cells (24+3) was first stressed for 6 h, incubated further for 18 h in normal growth 
medium and then stressed again for 3 h. 
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Induction of Apoptosis 
 
After 6 h exposure to staurosporine or MG132 the majority of the cells had not changed their morphology 
and expressed Hsc70-GFP at 2 times higher levels in the cytoplasm than in the nucleus. However, in 
contrast to untransfected cells, after 24 h of incubation nuclear translocation of Hsc70-GFP was observed 
in 30% of the non-apoptotic cells (picture 5m). Nevertheless, the percentage of apoptotic cells was 
comparable to untransfected cells, i.e. 2-5% after 6 h, 20% after 24 h exposure to staurosporine or 
MG132 (figure 10b). In contrast to what is observed in GAPDH-GFP transfected cells, apoptotic cells did 
not significantly change their morphology and the expression of Hsc70-GFP was identical to the one in 
non-apoptotic cells. 
 
Co-transfections of Hsc70-GFP with other proteins 
 
When Hsc70-GFP was transfected together with enolase-BFP in neuroblastoma cells, no difference in 
Hsc70-GFP distribution was observed compared to cells transfected with Hsc70-GFP alone, but after 
oxidative stress with 100 µM H2O2, the percentage of cells forming intracellular Hsc70-GFP-speckles 
augmented to 50%. This effect was not observed after oxidative stress with 300 µM FeCN. Nuclear 
translocation of Hsc70-GFP was 10% higher under both conditions. 
 
Hsc70-GFP expression is not influenced by GAPDH-BFP co-overexpression in resting cells. But after 
exposure to 100 µM H2O2, elevated nuclear Hsc70 localisation was observed, i.e. 40% more in double-
transfected cells (85%) than in cells overexpressing Hsc70-GFP alone. Similar effects were also found 
with 300 µM FeCN.  
 
Aldolase-BFP or Ulip-BFP co-transfected with Hsc70 had no significant influence on Hsc70-GFP 
expression neither before nor after oxidative stress. 
 
 81 
 
4.5.2 R6 and R6Bcl-2 
 
4.5.2.1 Untransfected cells 
 
 
In resting R6 fibroblasts endogenous Hsc70 is predominantly in the cytoplasm and bound to the 
cytoskeleton (picture  6a). Its highest concentration is seen at the perinuclear area and at the plasma 
membrane. Nuclear Hsc70 levels are lower in R6 cells than in neuroblastoma cells (figure 10a), and 
identical to most R6Bcl-2 cells. However, 20% R6Bcl-2 cells are very flat and show volcanic-like Hsc70 
distribution (picture 6b). 
 
3 h after induction of oxidative stress with 100 µM H2O2, in spite of some nuclear translocation that is 
observed, most Hsc70 was still expressed in the perinuclear area of the cytoplasm (picture 6c). However, 
Hsc70 bound less tightly to cytoskeletal structures than in unstressed cells. In 20% of the cells it was 
translocated into the nucleus where it was often concentrated in nuclear patches or at the nuclear 
membrane. R6Bcl-2 and R6 showed similar localisation of endogenous Hsc70. 
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Picture 6: Subcellular localisation of Hsc70 and Hsc70-GFP in R6 and R6Bcl–2 cells 
(a-i) Untransfected cells. Endogenous Hsc70 detected by TR-immunohistochemistry. 
Cytoplasmic localisation of Hsc70 in  unstressed (a) R6 or (b) R6Bcl-2 cells. (c) R6 cell after exposure to 100 µM H2O2 for 3 h (d, 
e) Cells forming long processes after 6h induction of apoptosis by MG132. The arrow points to the only cell showing chromatin 
condensation. (e, f) Apoptotic R6 and (i) R6Bcl-2 cell after exposure to 1.5 µM MG132 for 6 h with neither overexpression nor 
nuclear accumulation of endogenous Hsc70. (h) Non-apoptotic R6Bcl-2 cell with intact nucleus (blue) also after exposure to 1.5 
µM MG132 for 6 h. 
(j-m) Hsc70-GFP transfected cells. 
(j) Some unstressed transfected R6 cells still express Hsc70-GFP mainly in the cytoplasm, whereas (k) a significant number of 
transfected R6 cells show increased nuclear localisation of Hsc70-GFP. (j) and (k) are both overlays showing besides the yellow 
(=green+red) staining of transfected cells also expression of Hsc70 in untransfected cells as detected by TR-
immunohistochemistry; in (j) additionally also Hoechst blue staining is shown of intact nuclei. (l, m) Nuclear translocation in 
R6Bcl-2 cells with intact nucleus (blue) 6 h after induction of apoptosis by 200 nM staurosporine leads to Hsc70-GFP expression 
in the entire cell. 
(d,f,h,i,j,l) Visualisation of DNA by Hoechst blue staining. Scale bar is 50 µM. 
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Although the response of R6 cells to staurosporine or to MG132 is more pronounced than in NB41A3, 
most cells do not changed their morphology and express Hsc70 predominantly in the cytoplasm. However 
many cells typically start to form long processes out of their rounded-up cell body leading to a net-like 
appearance (picture 6e). Endogenous Hsc70 is expressed in the cytoplasm, including within the 
processes. Some of these net-like cells (20%) concentrate Hsc70 in specific nuclear regions and are 
apoptotic (picture 6d). Other apoptotic cells are mostly round and express Hsc70 in the cytoplasm or all 
over the cell, at levels close to endogenous Hsc70 expression in non-apoptotic control cells (picture 6f, 
6g). The overall percentage of cells with fragmented nuclei after exposure to staurosporine or MG132 
raises from 10% after 6 h up to 60% after 24 h (figure 10b), comparable to those of GAPDH experiments. 
 
Bcl-2 protects from induction of apoptosis by MG132 or staurosporine (figure 10b). After 6 h exposure to 
staurosporine, about 95% of the cells did not display nuclear fragmentation. There, two types of Hsc70 
expression was observed: either all over the cell (including the nucleus) within a network of cells with 
long processes expressing Hsc70 or in a perinuclear ring within flat volcano like cells (picture 6h). 
Nuclear translocation of endogenous Hsc70 was observed in the other cells, with unchanged morphology. 
After 24 h of staurosporine treatment most cells had small rounded-up cell bodies and formed long 
processes. In contrast, after incubation with MG132 for 24 h Hsc70 was predominantly in the cytoplasm 
or in the blebs of the cells, of which the majority did not have any processes at all. The morphology and 
Hsc70 expression of apoptotic R6Bcl-2 cells (picture 6i) was similar to what was observed in apoptotic R6 
cells. 
 
4.5.2.2 Transiently transfected cells 
 
Most transfected R6 and R6Bcl-2 cells expressed Hsc70-GFP in the perinuclear area of the cytoplasm 
(picture 6j), similar to untransfected cells. In contrast, in some cells Hsc70-GFP is also localised at high 
levels in the nucleus (picture 6k). No change in shape or cell viability was observed compared to 
untransfected cells. 
 
After exposure to MG132 or staurosporine neither nets of long processes branching off from rounded-up 
cell bodies, nor volcano-like cells were observed. The number of apoptotic cells after 6h and after 24 h 
exposure was similar to untransfected R6 cells (figure 10b). Hsc70-GFP expression was not increased in 
these cells and often similar to non-apoptotic cells. 
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Most Hsc70-GFP transfected R6Bcl-2 cells exposed to staurosporine for 6 h had no signs of apoptosis 
(figure 10b, picture 6l) and expressed Hsc70-GFP along intracellular fibres within the entire cell (picture 
6m). Also 24 h after staurosporine induction of apoptosis the cell viability of Hsc70-GFP transfected 
R6Bcl-2 cells was about 80%, not significantly altered compared to untransfected R6Bcl-2 cells, but 
significantly higher than in Hsc70-GFP transfected R6 cells (figure 10b). 24 h incubation with either 
MG132 or staurosporine yielded comparable percentage of nuclear fragmentation, but the number of 
R6Bcl-2 cells with altered shape was much higher with MG132. Most cells were devoid of processes and 
the cell body had shrunk and was rounded up. 
 
4.5.3 Hsc70 translocation 
 
Endogenous Hsc70 is located predominantly in the cytoplasm in both unstressed NB41A3 and unstressed 
R6 cells. Whereas oxidative stress induces translocation of Hsc70 into the nucleus, apoptosis does not 
significantly change its expression. In contrast, while cell morphology of oxidatively stressed cells had 
not significantly changed, many apoptotic cells showed severe effects after treatment with apoptotic 
agents. As would be expected, the rate of apoptotic cells and of cells forming long processes is 
comparable to observations with GAPDH. R6Bcl-2 cells showed no difference in their Hsc70 expression 
and in their morphology compared to R6 cells. 
 
In control cells, the subcellular localisation of overexpressed Hsc70-GFP was not different than for 
endogenous Hsc70 in untransfected cells. Furthermore, none of the cells overexpressing Hsc70-GFP was 
apoptotic. After induction of oxidative stress by either H2O2 or FeCN, translocation of Hsc70-GFP into 
the nucleus was observed in all cell lines, NB41A3, R6 and R6Bcl-2. As a consequence, expression levels 
of Hsc70-GFP in the cytoplasm and in the nucleus were about the same. Like for GAPDH-GFP, speckle 
formation was observed. However, only very few cells were found which had a shrivelled cell body and 
formed long processes. In all three cell lines (NB41A3, R6 and R6Bcl-2), the percentages of cells showing 
nuclear fragmentation or chromatin condensation 24 h after exposure to apoptotic agents, was not 
significantly different in untransfected cells compared to Hsc70-GFP transfected cells. Furthermore, in 
contrast to GAPDH-GFP overexpressing cells, nuclear translocation of Hsc70-GFP in response to 
induction of apoptosis was observed. Moreover, apoptotic cells did not express increased levels of either 
endogenous Hsc70 or overexpressed Hsc70-GFP. Nuclear translocation of endogenous Hsc70 is only 
observed during oxidative stress and not during apoptosis. 
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4.6 Aldolase c 
 
4.6.1 NB41A3 
 
4.6.1.1 Untransfected cells 
 
Untransfected NB41A3 cells mainly display cytoplasmic aldolase expression, not as a uniform staining, 
but rather as accumulation of aldolase-positive dots and patches (picture 7a). Concentration of aldolase-
GFP fluorescence in the nucleus was not observed. 
 
After oxidative stress for 3h with 100 µM H2O2, spots with high aldolase concentration were found both 
in the cytoplasm and in the nucleus. In 25% of the cells, aldolase level was higher in the nucleus than in 
the cytoplasm, while 30% of the cells showed extensive expression of aldolase in the somal area at the 
bases of axons (picture 7b). In the remaining cells, aldolase was expressed in speckles along the plasma 
membrane or as a speckled circle (picture 7c). The spots were brighter than in unstressed cells. 
 
After exposure to staurosporine or MG132, some concentration and induction of aldolase was seen in 
apoptotic cells. Half of non apoptotic cells showed a uniform cytoplasmic aldolase expression (TR 
staining in picture 7d), the other cells displayed long aldolase containing processes but mostly no nuclear 
fragmentation. 
 
Endogenous aldolase was also examined in GAPDH-GFP overexpressing cells. At rest these cells 
expressed endogenous aldolase in a patchy pattern pre-dominantly in the cytoplasm and at the plasma 
membrane, but 15% of cells also expressed similar levels in the nucleus. After oxidative stress these cells 
exhibit no change on aldolase expression but immunostaining shows a more uniform cytoplasmic 
distribution. 
 
Î 
Picture 7: Subcellular localisation of aldolase and aldolase-GFP in NB41A3 cells 
(a-c) Untransfected cells in which endogenous aldolase detected by FITC-immunohistochemistry is green. (a) Punctuate 
expression in unstressed cells. (b) Concentration of aldolase at the bases of axons or (c) speckles formation after exposure to 100 
µM H2O2 for 3 h. In (c) and the entire cytoplasm was made visible by immunostaining with anti-enolase-γ  detected by TR-
immunohistochemistry. (d) Overlay of non-apoptotic cells 24 h after induction of apoptosis by 200 nM staurosporine, showing 
besides the red uniform cytoplasmic expression of endogenous aldolase in untransfected cells as detected by TR-
immunohistochemistry also yellow (=green+red) staining of transfected cells. 
(e-k) Transient and (j, k) stable overexpression of transfected aldolase-GFP. (e, j) Cytoplasmic localisation of aldolase-GFP in 
unstressed cells. (f) Nuclear translocation, (g) accumulation in a star patter at the nucleus or (h, i, k) intracellular speckles 
formation after exposure to 100 µM H2O2 for 3 h. (h, i) are two confocal images of single planes of the same cell at different z-
axis values.       Scale bar is 50 µM. 
 86 
 
 
 87 
 
a
.
Aldolase-GFP expression in unstressed NB41A3 cells
0
10
20
30
40
50
60
70
80
90
100
1 11 21 31 41 51 61 71 81 91 101 111 121 131 141 151 161 171
Pixel intensity
Pi
xe
l c
ou
nt
43±7 111±14
nuclear expression cytoplasmic expression
 
b
A l d o l a s e - GFP e x p r e s s i o n i n o x i d a t i v e l y  s t r e s se d  NB4 1 A 3  c e l l s
0
10
20
30
40
50
60
70
80
90
1 00
1 11 2 1 31 4 1 5 1 61 71 8 1 9 1 1 01 1 1 1 1 21 1 3 1 1 4 1 1 51 161 1 71
Pi x e l i nt e ns i t y
5 5 ±1 6
6 5 ±2 2
nuc l ear  e x p r ess i o n cy t o p l asm i c  e x p r e ss i o n
 P i
c
Hsc70-GFP expression in cytoplasm of NB41A3 cells before and after
exposure to oxidative stress
0
100
200
300
400
500
600
700
800
900
1000
unstressed NB41A3 cells (fig 11a) oxidatively stressed NB41A3 cells (fig 11b)
va
ria
tio
n 
in
 %
   
Figure 11: Intensity and patchiness of aldolase-GFP expression in nucleus and cytoplasm. Aldolase-GFP expression was 
analysed with regard to its intensity and to its patchiness in the nucleus and in the cytoplasm of transfected NB41A3 cells. 
Various histograms of aldolase-GFP were evaluated regarding the mean intensity and the variation (= standard deviation 
squared) of expression. (a) Prior to oxidative stress, aldolase-GFP intensity (= expression level) in the cytoplasm is about 2.5 
fold higher than in the nucleus. The cytoplasmic expression curve forms quite a narrow peak and has a relatively small standard 
deviation (12 %) indicating uniform aldolase-GFP expression. The mean intensity of fluorescence plus/minus standard deviation 
is indicated for each curve. (b) After exposure to 100 µM H2O2 for 3 h, in some cells (20%) aldolase-GFP expression is higher in 
the nucleus than in the cytoplasm. The cytoplasmic expression curve forms quite a broad peak with a higher standard deviation 
(29 %) indicating patchy aldolase-GFP expression. The mean intensity of fluorescence plus/minus standard deviation is indicated 
for each curve. (c) Variation (=patchiness) of cytoplasmic aldolase-GFP expression calculated prior and after oxidative stress 
from histogram (a) and (b). 
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4.6.1.2 Transiently transfected cells 
 
Controls 
 
Unstressed cells were clearly dominated by cytoplasmic expression pattern of aldolase-GFP (picture 7e). 
Aldolase-GFP expression is about 2.5 fold higher in the cytoplasm than in the nucleus (111 versus 43, see 
figure 11a), whereas the nucleolus appears devoid of aldolase-GFP. In most cells, the intense expression 
of aldolase-GFP is smooth and regular (indicated by small variation, figure 11c). Chromatin condensation 
was not found in any cell. 
 
Induction of Oxidative Stress 
 
After oxidative stress with 300 µM FeCN or 100 µM H2O2 for 4 h nuclear aldolase-GFP expression 
increased about 50% (picture 7f). Mean expression of aldolase-GFP was lower in the cytoplasm (55) than 
in the nucleus (65) (figure 11b). The aldolase-GFP expression is patchy in the nucleus as well as in the 
cytoplasm (indicated  in figure 11b & figure 11c by high standard deviation and variation), especially in 
those cells with high nuclear aldolase-GFP expression. Often high aldolase-GFP fluorescence was 
aggregated in a star like pattern at the nucleus (picture 7g). In 5% of the cells we can observe the 
formation of speckled circles at the membranes made by spots in which aldolase-GFP is concentrated 
(picture 7h, 7i).  
 
A correlation between the response to oxidative stress and the concentration of the stressing reagent resp. 
the exposure time was found. Treatment with either 100 µM FeCN or 30 µM H2O2 up to for 5 h showed 
only very weak effects on aldolase-GFP distribution, comparable with the ones obtained after only 2h of 
oxidative stress with either 300 µM FeCN or 100 µM H2O2 respectively. The most spectacular changes of 
aldolase-GFP level in the nucleus and in formation of speckled circles was observed with incubation with 
300 µM of FeCN for 5 h. After this treatment aldolase-GFP concentration was sometimes higher in the 
nucleus than in the cytoplasm. Almost the same response was achieved after 5 h incubation with 100 µM 
H2O2, but with 1 mM of FeCN 50% of the cells were dead after 3h. 
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Induction of Apoptosis 
 
After apoptosis induction the localisation of aldolase-GFP is not different to the one of endogenous 
aldolase (GFP staining in picture 7d). As for untransfected NB41A3, only 5%, respectively 20% cells 
were apoptotic after staurosporine or MG132 exposure for 6 h and 24 h. The majority of other cells 
showed unchanged morphology and expressed adolase-GFP in the cytoplasm. Only few cells made long 
processes as we described for untransfected neuroblastomas. So, apparently overexpression of aldolase 
did not influence apoptosis in NB41A3 cell. 
 
Co-transfections of aldolase-GFP with other proteins 
 
Co-transfection with either GAPDH, enolase, Ulip or Hsc70 did not change the distribution of aldolase-
GFP significantly, nor did this distribution be affected after oxidative stress. 
 
 
4.6.1.3 Stable overexpression in aldolase-GFP transfectants  
 
The intensity of aldolase-GFP expression is very variable between different cells, but at least 75% of the 
aldolase-GFP expression is cytosolic in 98% of the cells under unstressed conditions (picture 7j). The 
aldolase-GFP protein is expressed in the nucleus at low levels and is absent in the nucleolus.  
 
After oxidative stress aldolase-GFP expression raises in the nucleus. It is still more abundant in the 
cytosol than in the nucleus in 50% of the cells, but the ratio between the GFP fluorescence in the cytosol 
and in the nucleus is weaker compared to unstressed cells. In the other 50% of the cells this expression is 
about the same in the cytosol and in the nucleus or is stronger in the nucleus than in the cytosol. 
Aldolase-positive speckle formation was observed less frequently than in transiently transfected cells 
(picture 7k). 
 
In unstressed NB41aldolase-GFP cells endogenous GAPDH is found in about same amounts in the nucleus 
and in the cytoplasm. After oxidative stress with 100 µM H2O2 about 60% of endogenous GAPDH was 
localised in the nucleus. Thus, cytoplasmic expression of endogenous GAPDH in cells overexpressing 
aldolase was higher than in untransfected cells. 
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In NB41aldolase-GFP cells, endogenous Hsc70 shows a different expression than in untransfected controls. 
In the latter a high cytoplasmic expression of Hsc70 in the cytoplasm and a low nuclear expression is 
clearly observed, whereas in cells overexpressing aldolase the difference is not significant under rest. 
After oxidative stress with 100 µM H2O2 nuclear Hsc70 is concentrated around the nucleolus and its 
fluorescence is about as strong as in the cytoplasm. Such a rise of endogenous Hsc70 in the nucleus is 
small, however. 
 
 
4.6.2 R6 AND R6Bcl-2 
 
4.6.2.1 Untransfected cells 
 
In unstressed R6 and R6Bcl-2 cells endogenous aldolase expression was much more uniform than in 
NB41A3. It was spread all over the cytosol but did not show any fibril structure and was highest in the 
perinuclear area (picture 8a). At the plasma membrane, it was also sometimes present as bright spots. 
 
After oxidative stress no significant rise of aldolase levels in the nucleus was observed in R6 cells. The 
expression is still mostly cytoplasmic with highest aldolase-GFP expression in the perinuclear area and at 
the plasma membrane (picture 8b). Small aldolase-positive spots were seen in the nucleus in 40% of the 
cells, but concentration of aldolase in intracellular speckles was never observed. 
 
After 6 h incubation with staurosporine or MG132 10% of R6 cells and less than 5% R6Bcl-2 cells showed 
nuclear fragmentation (picture 8d). Aldolase expression was elevated and also some nuclear expression 
was observed in these cells (picture 8e). A majority of the remaining cells had not changed their 
morphology nor their aldolase localisation in the perinuclear area of the cytoplasm, but small wrinkled up 
cells and round cells with neurone-like shape and long processes were also observed (picture 8c). After 
24 h of apoptosis induction the percentage of apoptotic cells raised to over 50% for R6 cells and to about 
20% for R6Bcl-2 cells respectively. The number of cells with unchanged morphology and aldolase 
distribution was very low. Most cells with unfragmented DNA had no processes and were either rounded 
up or flat and had a volcano like staining by anti aldolase antibody. 
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4.6.2.2 Transiently transfected cells 
 
In unstressed, transiently transfected cells the aldolase-GFP distribution was identical to endogenous 
aldolase of untransfected cells. The cytoplasmic aldolase-GFP was most intense around the nucleus in the 
perinuclear area (picture 8f). No apoptosis nor nuclear translocation was observed in R6 or R6Bcl-2, even 
in cells with very high expression levels of aldolase-GFP.  
 
After apoptosis induction by staurosporine or MG132, fibroblasts transiently transfected with aldolase-
GFP acted similar to untransfected R6 and R6Bcl-2 cells. No correlation between the expression level of 
aldolase-GFP and changes in morphology or aldolase-GFP localisation was observed. Neither nuclear 
translocation nor formation of speckles was found, but the percentage of cells with long branched 
processes (picture 8g) or with a volcano-like aldolase distribution (picture 8h, picture 8i) was higher than 
in untransfected cells. The percentage of apoptotic and morphologically changed cells was identical to the 
one in untransfected cells, i.e. the number of apoptotic R6Bcl-2 cells was significantly smaller than in R6 
cells 24 h after adding the apoptotic agent. 
 
 
 
 
 
 
 
 
 
Í 
 
 
Picture 8: Subcellular localisation of aldolase and aldolase-GFP in R6 and R6Bcl–2 cells 
(a-e) Untransfected cells. Endogenous aldolase as detected by TR-immunohistochemistry. 
Perinuclear localisation of aldolase in (a) unstressed or (b) oxidatively  stressed (100 µM H2O2 for 3 h) R6 cells. (c) R6Bcl-2 cells 
forming long processes and (d, e) apoptotic cells after exposure to 1.5 µM MG132 for 24 h. The arrows point to the cells 
showing chromatin condensation.  
(f-i) aldolase-GFP transfected cells. 
(f) Intact nucleus in unstressed R6 cell expressing aldolase-GFP in the cytoplasm. (g) R6 cell forming long fine processes to 
enlarged knots which do not contain any DNA after exposure to 1.5 µM MG132 for 24 h. Volcano like (h) R6 or (i) R6Bcl-2 cells 
after exposure to 1.5 µM MG132 for 24 h.  
(b,d,f,g) Visualisation of DNA by Hoechst blue staining. Scale bar is 50 µM. 
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4.6.3 Aldolase and apoptosis 
 
The expression of aldolase was similar the one of Hsc70 under all tested conditions. In resting cells 
endogenous aldolase and aldolase-GFP were typically located in the cytoplasm, often bound to the 
cytoskeleton. After oxidative stress we observed nuclear translocation, which was more pronounced in 
NB41A3 cells than in R6 cells. 
 
The cellular response to apoptosis induced by either MG132 or staurosporine does not seem to be 
influenced by overexpressed aldolase-GFP. Different than in oxidatively stressed cells, neither in 
aldolase-GFP transfected nor in untransfected cells was translocation of aldolase to the nucleus observed. 
The percentage of apoptotic cells and of cells forming long processes was identical to untransfected cells. 
However, apoptotic cells showed 1-2 fold increased levels of aldolase compared to non-apoptotic cells. 
 
Like in NB41A3, aldolase-GFP transfected and untransfected fibroblasts react similar in their response to 
induction of apoptosis. Although little nuclear translocation of aldolase is observed and although aldolase 
concentrates in apoptotic cells, the percentage of apoptotic R6 cells transfected by aldolase-GFP is 
comparable to untransfected R6 cells. Furthermore, Bcl-2 also protects cells overexpressing aldolase-GFP 
efficiently from apoptosis, at the same rate as untransfected cells. 
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4.7 Ulip 
 
4.7.1 NB41A3 
 
4.7.1.1 Untransfected cells 
 
In unstressed cells endogenous Ulip displayed an uniform cytoplasmic expression (picture 9a), without 
significant concentration in patches (figure 12a, figure 12c) . The intensity of Ulip expression found in 
the nucleus of cells is about 1.5 times less than in the cytoplasm. Intracellular vesicles and the nucleolus 
are devoid of Ulip..  
 
After oxidative stress, endogenous Ulip is expressed at higher rates in the nucleus than in the cytosol in 
60% of the cells (picture 9b). The staining is still very uniform in all the cells. 
 
NB41GAPDH-GFP cells stably overexpressing GAPDH did not influence the localisation of endogenous 
Ulip, neither in unstressed nor in stressed cells. No increased Ulip-speckles-formation after oxidative 
stress was detected in NB41GAPDH-GFP. 
 
4.7.1.2 Transiently transfected cells 
 
Controls 
 
In transiently transfected cells the nucleus contained about 3-4 times less Ulip-GFP than the cytoplasm 
(picture 9c, figure 12b, figure 12c). More than 95% cells showed high Ulip-GFP expression limited to the 
cytoplasm. However, in contrast to untransfected cells, the Ulip-GFP pattern was not homogenous within 
the cytoplasm, but showed a patchy pattern, with Ulip-GFP concentrated in some specific areas, e.g. close 
to the Golgi apparatus (picture 9c, figure 12b, figure 12c). Ulip-GFP expression was also strong at the 
plasma membrane. While low levels of Ulip-GFP could also be detected in the nucleus, the nucleolus did 
not contain any Ulip-GFP. 
 
Induction of Oxidative Stress 
 
After exposure to 300 µM FeCN for 3 h we observed expression of high levels of Ulip-GFP 
predominantly at the membrane in about 15% cells (picture 9d). In about 10% of cells we detected 
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formation of intracellular spots which accumulated all the detectable Ulip-GFP fluorescence of the cell. 
Few cells raised their expression level in specific regions within the nucleus. 
 
Exposure to 100 µM H2O2 induced nuclear translocation, yet the majority of cells expressed Ulip-GFP 
predominantly in the cytoplasm. Ulip-GFP was most intense in areas near the nucleus and at the golgi of 
NB41A3 cells. These cells mostly did not make processes (picture 9e, 9f). 
 
Lower doses, e.g. 100 µM FeCN or 30 µM H2O2 up to 5 h resulted in very small changes on subcellular 
localisation of Ulip-GFP, comparable with changes attained after 2h with 300 µM  FeCN or 100 µM 
H2O2, respectively. Furthermore, the response of Ulip-GFP to oxidative stress is time dependent and the 
most pronounced changes in Ulip-GFP localisation were found after 6 h exposure to oxidative stress. 
After exposure to 100 µM H2O2 for 6h, a high percentage of cells display Ulip-GFP concentrated in small 
speckles that were arranged in a circle. Altogether, the changes of Ulip-GFP expression in response to 
oxidative stress correlates with the incubation time and the concentration of stressing agent, but were far 
not as intense as for GAPDH. 
 
 
 
 
 
 
 
 
 
 
 
 
Î 
 
 
Picture 9: Subcellular localisation of Ulip and Ulip-GFP in NB41A3 and R6 cells 
Distribution of endogeneous Ulip in untransfected NB41A3, either (a) unstressed or (b) stressed with 100 µM H2O2 detected by 
TR-immunohistochemistry. (c-f) Ulip-GFP expression in transiently transfected NB41A3 neuroblastoma cells. Ulip-GFP 
expression under (c) unstressed conditions and after oxidative stress induced by either (d) FecN or (e, f) H2O2, detected as GFP 
fluorescence. (e, f) are two confocal images of single planes of the same cells at different z-axis values. Distribution of 
endogeneous Ulip in untransfected R6 cells, either (g) unstressed or (h) stressed with 100 µM H2O2 detected by TR-
immunohistochemistry. 
Scale bars are 50 µm. 
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Figure 12: Intensity and patchiness of Ulip-GFP expression in nucleus and cytoplasm. Ulip expression was analysed with 
regard to its intensity and to its uniformity/patchiness in the nucleus and in the cytoplasm of (a) untransfected and (b) transfected 
NB41A3 cells. The mean intensity of fluorescence is indicated for each curve with standard deviation. (c) Combination of both 
(a) and (b) demonstrates that Ulip-GFP transfected cells have a more cytoplasmic and patchier expression than untransfected 
cells. 
 98 
Co-transfections of Ulip-GFP with other proteins 
 
No influence of overexpressed enolase-BFP on Ulip-GFP was observed in unstressed cells. After 
extended oxidative stress, however, Ulip-GFP levels in the nucleus raised to a higher extent than in cells 
transfected with Ulip-GFP alone. In 30% of the enolase-BFP co-transfected cells, Ulip-GFP expression 
was higher in the nucleus than in the cytosol. In addition, the number of cells concentrating Ulip-GFP 
either in speckles or at the plasma membrane in response to oxidative stress was about 50% higher in 
cells co-transfected with enolase-BFP. 
 
The effect of aldolase-BFP on Ulip-GFP was discrete. However, compared to cells transfected with Ulip-
GFP alone, before, as well as after oxidative stress, co-transfected cells expressed two fold less nuclear 
Ulip-GFP. 
 
Both, Hsc70-BFP and GAPDH-BFP influenced Ulip-GFP in the same manner. After stress Ulip-GFP 
concentrated in spots in the cell about twice more than in cells transfected with Ulip-GFP alone. Hsc70-
BFP and GAPDH-BFP were also concentrated in speckles, but no significant colocalisation was seen. 
 
 
4.7.2 R6 AND R6Bcl-2 
 
Prior to oxidative stress, endogenous Ulip was expressed along fibres all over the cell, but especially in 
the cytoplasm and at the plasma membrane (picture 9g). Although mostly fibres were smoothly stained, 
some intense spots where Ulip was concentrated at the fibres and at the plasma membrane were also 
observed. The smooth, regular expression of Ulip was slightly weaker in the nucleus than in the 
cytoplasm. 
  
After oxidative stress the nuclear Ulip expression raised considerably, so that in 80% of the cells Ulip was 
expressed 2 times more intensively than in the cytoplasm (picture 9h). The Ulip level in the cytoplasm 
was about the same as before, but the fibril structure could no more be detected. In many cells 
accumulation of Ulip in small points was found at the plasma membrane and at the nuclear membrane 
(picture 9h). The accumulation of Ulip at the nuclear membrane may be due to translocation of Ulip from 
cytosol into the nucleus after stress.  
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4.7.3 Ulip and oxidative stress 
 
In our experiments endogenous Ulip is expressed uniformly in the cytoplasm of untransfected NB41A3 
cells. After induction of oxidative stress a significant amount of Ulip translocated into the nucleus. Also 
in transfected NB41A3 cells Ulip-GFP was localised predominantly in the cytoplasm. Exposure to H2O2 
leads to an increase of nuclear Ulip-GFP expression, whereas exposure to FeCN in addition also raised 
Ulip-GFP positive speckles formation and concentration of Ulip-GFP at the cell membrane. R6 cells 
expressed endogenous Ulip along fibres all over the cell at higher levels in the cytoplasm than in the 
nucleus. However, after oxidative stress most cells expressed Ulip predominantly in the nucleus.  
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4.8 Enolase 
 
4.8.1 NB41A3  
 
4.8.1.1 Untransfected cells 
 
Untransfected NB41A3 cells mainly display a very diffuse and uniform enolase expression (picture 10a). 
The cytoplasm including the axons contains about 60% of the expressed enolase and the nucleus contains 
the remaining 40%, while the nucleolus did not contain any enolase This ratio of 1:1.5 between nuclear 
and cytoplasmic expression is very constant in all untransfected cells. 
 
The distribution of endogenous enolase did not change significantly after oxidative stress. The majority 
of cells showed uniform, predominantly cytoplasmic GAPDH expression. In some cells an accumulation 
of enolase in the Golgi region was observed (picture 10b). 
 
4.8.1.2 Transiently transfected cells 
 
In unstressed cells enolase-GFP was predominantly cytoplasmic (picture 10e). Most cells had few 
processes and overexpressed it at high levels uniformly all over the cytoplasm with some accumulation 
around the Golgi region and. The level of enolase-GFP fluorescence in the nucleus was around 3-4 times 
lower than in the cytoplasm and the nucleolus was devoid of enolase-GFP. Some cells with low enolase-
GFP fluorescence contained only about 30% more enolase in the cytoplasm than in the nucleus. The 
difference between cytoplasmic and nuclear enolase expression was more pronounced in transfected than 
in untransfected cells (picture 10f, figure 13). 
 
 
After oxidative stress with 300 µM FeCN or 100 µM H2O2 for 4h, because of nuclear translocation, the 
uniform enolase expression was only 1-2 times higher in the cytoplasm than in the nucleus (picture 10c). 
The effects were smaller in cells expressing low levels of enolase-GFP. DNA staining by Hoechst blue 
shows no nuclear fragmentation in the oxidatively stressed cells. Under these conditions greatest changes 
in cells highly overexpressing enolase-GFP were observed after 4-5 h. However, the effects of oxidative 
stress on enolase-GFP localisation were not only time-dependent, but also correlated with the level of 
total enolase-GFP expression. 
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Figure 13: Relation between total enolase expression and ratio of cytoplasmic to nuclear enolase expression. The ratio of 
cytoplasmic to nuclear enolase expression was measured in histograms. They were blotted against the total (nuclear + 
cytoplasmic) amount of enolase expression. The first point, with a ratio smaller than 1.5 of cytoplasmic to nuclear expression, 
corresponds to measurements in untransfected cells, whereas the last point corresponds to highly transfected cells that express 
about 5 times more enolase than untransfected cells. The figure shows that high enolase levels lead to a predominantly 
cytoplasmic enolase expression. 
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Picture 10: Subcellular localisation of enolase and enolase-GFP in NB41A3 and R6 cells 
Distribution of endogeneous enolase in untransfected NB41A3, either (a) unstressed or (b) stressed with 300 µM FeCN detected 
by TR-immunohistochemistry. (d-f) GAPDH-GFP transfected, unstressed NB41A3 cells (green) show higher difference between 
cytoplasmic and nuclear enolase expression localisation than endogenous enolase detected by TR in untransfected cells (red). 
(f) Overlay of confocal  pictures taken by the red (endogenous enolase) and the green (enolase-GFP) channel . (c) GAPDH-GFP 
transfected NB41A3 cells exposed to 100 µM H2O2. Distribution of endogeneous Ulip in untransfected R6 cells, either (g, h) 
unstressed or (i) stressed with 300 µM FeCN detected by TR-immunohistochemistry. In (h) additionally endogenous Hsc70 was 
made visible (green) by immunostaining with anti-Hsc70 detected by FITC-immunohistochemistry. 
Scale bars are 50 µm. 
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Co-transfection with either GAPDH-BFP, aldolase-BFP, Ulip-BFP or Hsc70-BFP did not change the 
expression of enolase-GFP. The predominantly cytoplasmic localisation of enolase-GFP was not 
influenced by these proteins, independent of whether the cells were stressed or unstressed. 
 
 
4.8.1.3 Stable overexpression in enolase-GFP transfectants 
 
The intensity of enolase-GFP expression was very variable between different cells. Cells overexpressing 
enolase at high levels had very high cytoplasmic expression, whereas in cells with weak enolase-GFP 
fluorescence, the difference between cytoplasmic and nuclear enolase-GFP was smaller. Similar to 
transiently transfected cells, the ratio of cytoplasmic over nuclear expression correlated with the total 
level of enolase-GFP expression (figure 13). Endogenous enolase was present at a constant concentration 
in the nucleus and in the cytoplasm of all cells, while overexpressed enolase-GFP was localised 
exclusively in the cytoplasm.  
 
NB41A3enolase-GFP cells stably expressing enolase-GFP reacted like transiently transfected cells to agents 
inducing oxidative stress. Thus, the highest rise of nuclear enolase-GFP was observed in cells 
overexpressing high levels of enolase-GFP.  
 
 
4.8.2 R6 cells 
 
Unstressed and untransfected R6 cells express enolase along the cytoskeleton, which leads to a fibrillar 
expression pattern in the cytoplasm (picture 10g). Like in untransfected NB41A3 cells, the amount of 
enolase in the nucleus is about 30% less than in the cytoplasm. The enolase distribution partly co-
localised with the expression of Hsc70 along the fibrils and around the nuclear membrane. However, the 
enolase pattern is smoother and less spotted than the Hsc70 staining (picture 10h).  
 
 
 
After oxidative stress, the nuclear expression of enolase was slightly raised and the fibrillar pattern was 
less pronounced compared to unstressed cells. We rather observed a diffuse enolase distribution all over 
the cell (picture 10i). 
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4.8.3 Enolase and oxidative stress 
 
In untreated control cells endogenous enolase as well as transiently or permanently overexpressed 
enolase-GFP is localised predominantly in the cytoplasm. The expression of enolase is diffuse and 
uniform. Overexpression of enolase-GFP has no visible effects on cell morphology which also means that 
overexpression does not induce apoptosis in cells. Of the five enzymes discussed, enolase is the one 
which shows the least effects following oxidative stress. After exposure to H2O2 or FeCN the distribution 
of endogenous enolase in neuroblastomas as well as in fibroblasts is unchanged. However, although in 
stressed NB41A3 cells enolase-GFP was overexpressed predominantly in the cytoplasm, an increase of 
nuclear enolase-GFP expression was measured. 
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5 Discussion 
 
5.1 GAPDH 
 
a) GAPDH expression is different in neuroblastoma cells than in fibroblast R6 cells 
 
The most prominent action of GAPDH (EC 1.2.1.12) takes place during glycolysis in the cytoplasm. Also 
more recent studies investigating the role of GAPDH during apoptosis in COS-7 cells (Tajima et al., 
1999), in S49 cells, primary thymocytes (Sawa et al., 1997) in PC12 cells, HEK 293 cells and COS-1 
cells (Sawa et al., 1997, Shashidharan et al., 1999), in epithelial cells (Epner et al., 1999) or in cultured 
cerebellar granule cells (Ishitani et al., 1998, Saunders et al., 1997, Saunders et al., 1999) all showed 
exclusive or at least highly predominant cytoplasmic expression of GAPDH in control cells in which 
apoptosis was not induced. Consistent to these studies, our R6 fibroblasts expressed endogenous GAPDH 
predominantly in the cytoplasm, whereas in control NB41A3 neuroblastoma cells GAPDH was 
predominantly localised in the nucleus. Thus, the subcellular localisation and expression level of 
endogenous GAPDH was different in the neuronal and non-neuronal cell lines that were used in this 
study. 
 
b) GAPDH expression in the nucleus does not induce apoptosis per se 
 
It has been proposed that nuclear localisation alone would be an early indication for apoptotic cells or 
even responsible for apoptosis (Epner et al., 1999, Ishitani et al., 1998, Saunders et al., 1997, Saunders et 
al., 1999, Sawa et al., 1997, Shashidharan et al., 1999, Tajima et al., 1999, Tatton, 1999). We show 
however that control NB41A3 cells, in spite of nuclear GAPDH expression, were not apoptotic (table 1, 
figure 6a, figure 6b). Nevertheless, the increased levels of nuclear GAPDH measured 24 h after induction 
of apoptosis by either MG132 or staurosporine in both cell lines, NB41A3 and R6, indicate that there is a 
correlation between nuclear translocation of GAPDH and programmed cell. But, nuclear localisation of 
GAPDH alone can not be the only reason for cellular apoptosis.  
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c) GAPDH expression in the nucleus is increased after exposure to apoptotic agents 
 
NB41A3 are more resistant to apoptosis: only 20% NB41A3 cells were apoptotic compared to 50% 
(staurosporine) or 70% (MG132) in R6 fibroblasts. R6Bcl-2 cells show nuclear fragmentation and 
chromatin condensation in only 15-20 % of the cells and three times less nuclear translocation. So not 
only did Bcl-2 protect cells from apoptosis (Allen et al., 1998, Chao and Korsmeyer, 1998), but also 
efficiently prevented translocation of GAPDH into the nucleus. Bcl-2 mediated inhibition of GAPDH 
translocation may be a protective mechanism against apoptosis. Most cells with nuclear GAPDH 
translocation do not have a fragmented nucleus nor show membrane blebbing, so translocation could be 
an early event in the apoptotic cascade, before the point of no return. Mainly in cells like R6 fibroblasts, 
where nuclear GAPDH expression is low in rest, higher levels of nuclear GAPDH may be an early 
marker for apoptosis. 
 
d) FeCN, but not H2O2, mediates cytoplasmic translocation of GAPDH-GFP in transfected cells  
 
FeCN, but not H2O2, mediated cytoplasmic translocation of GAPDH-GFP in transfected cells. This is 
surprising, because the responses to oxidative stress induced by H2O2 or FeCN were usually very similar 
for all other proteins of the PMO complex.  However, FeCN is a nitric oxide generator and a potent 
stimulant for oxidative stress, because NO is directly implicated in cell toxicity as a free radical (Coyle 
and Puttfarcken, 1993, Hibbs et al., 1987) resulting in the induction of DNA damage (Nguyen et al., 
1992, Wink et al., 1991). In contrast to H2O2, NO is an intracellular messenger and a paracrine 
extracellular agent (Marletta, 1993, Moncada et al., 1991). Initial studies identified cytoplasmatic 
guanylate cyclase as NO target, but other studies indicated a role for cGMP-independent pathways by 
post-translational modification of proteins (Stamler et al., 1992). Specific covalent binding of NAD+ to 
GAPDH has been demonstrated in vivo (Dimmeler and Brune, 1992, Dimmeler and Brune, 1993, Durrieu 
et al., 1987, Durrieu et al., 1987). GAPDH undergoes two NO-induced post-translational modifications at 
cys149(reviewed in (Brune and Lapetina, 1995)), leading first to S-nitrosylation which severely inhibits 
GAPDH glycolytic activity (Molina y Vedia et al., 1990), and second, to a covalent, NAD+ modification 
(Brune and Lapetina, 1995, Dimmeler and Brune, 1992, Dimmeler and Brune, 1993, Dimmeler et al., 
1992, Molina y Vedia et al., 1990, Zhang and Snyder, 1992). Wu et al. (Wu et al., 1997) isolated a series 
of glycolytic enzymes including GAPDH in the postsynaptic density (PSD) organelle and demonstrated 
the close relation between GAPDH and NO synthase. Reversible S-nitrosylation of GAPDH in the cell 
membrane modulates GAPDH/membrane interactions (Galli et al., 1998). From this and our studies it can 
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be postulated that in oxidative stress not the function of NO as cellular mediator, but its ability to induce 
post-translational modifications of GAPDH yields to specific translocation of GAPDH-GFP from the 
nucleus to the cytoplasm. 
 
e) GAPDH is differentially translocated after exposure to stress or apoptotic agents  
 
The recombinant GAPDH-GFP protein was translocated in some cells from the cytoplasm into the 
nucleus, whereas in some other cells it in intracellular speckles, or in extracellular membrane blebs and 
spikes. Experimental evidence and GAPDH sequence analysis suggest that the catalytic domain is 
involved in the regulation of the subcellular localisation of GAPDH. Studies in vivo indicate that amino 
acids within the glyceraldehyde-3-phosphate (G3P)  binding site determine GAPDH/membrane 
interactions, e.g. exposure of GAPDH to pyridoxal phosphate reduced its affinity for membranes (Eby 
and Kirtley, 1983, Robbins et al., 1995, Ovadi et al., 1973). Sequence analysis suggests that amino acids 
within the catalytic domain determine the nuclear, cytoplasmic or membrane localisation of GAPDH. 
Previous studies reveal a series of amino acid motifs which regulate intracellular protein localisation 
(reviewed in (Dingwall, 1991, Dingwall and Laskey, 1991, Jans, 1994, Yoneda, 1997)). Analysis of the 
GAPDH sequence reveals several regions which contain such motifs. 
 
However, whether GAPDH would requires such signals is unknown, especially for nuclear translocation, 
since proteins up to 45 kDa do not require active nuclear transport (reviewed in (Dingwall, 1991, 
Dingwall and Laskey, 1991, Jans, 1994, Yoneda, 1997)). Previous studies demonstrated the presence of 
the 37 kDa monomer in mammalian nuclei (Cool and Sirover, 1989). If GAPDH is transported into the 
nucleus as the 37 kDa monomer, an active nuclear transport would not be required. Alternatively, if 
GAPDH enters the nucleus as the tetramer (150 kDa), an active transport would be necessary. Studies 
suggest that apoptosis needs active import of at least some proteins (Yasuhara et al., 1997). From our 
results we presume that GAPDH itself may serve as a carrier for other proteins during apoptosis. 
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f) Intracellular translocation may have various mechanisms 
 
How do cells regulate the differential intracellular translocation of identical 37 kDa GAPDH monomers 
or 150 kDa GAPDH tetramers? The regulation may be based on structural signals within the GAPDH 
protein, because the catalytic G3P site contains potential nuclear localisation and export signals. 
However, as each GAPDH molecule would contain the identical sequences, it is unclear how such signals 
would enable a mammalian cell to distinguish between individual GAPDH molecules. 
 
A second possibility is the expression of alternative transcripts, as detected in a study in mature testis 
focusing on differential splicing at intron 1 of the GAPDH gene (Mezquita et al., 1998). 
 
Also post-translational modification results in the formation of singular GAPDH isozymes (Susor et al., 
1973, Kester et al., 1977, Lin and Allen, 1986, Soukri et al., 1995, Mazurek et al., 1996, Glaser and 
Gross, 1995). Ryzlak and Pietruszko reported differential subcellular localisation of GAPDH isozymes in 
human brain (Ryzlak and Pietruszko, 1988). Post-translational GAPDH modification susceptible to 
phosphodiesterase treatment suggested a mono-ADP-ribosylation (Soukri et al., 1996). 
 
g) Subcellular localisation and function of GAPDH change during apoptosis 
 
In R6 control cells GAPDH exerts predominantly cytoplasmic functions 
 
In normal R6 fibroblasts, the major function of GAPDH is in glycolysis in the cytosol for energy 
production. It also enhances bundling of tubulin into microtubules (Kumagai and Sakai, 1983) regulated 
by ATP (Huitorel and Pantaloni, 1985). GAPDH binds to the C-terminal region of α-tubulin (Volker and 
Knull, 1997). Both dimeric and tetrameric GAPDH bind to microtubules, but bundling is only observed 
with tetrameric GAPDH (Huitorel and Pantaloni, 1985). GAPDH also catalyses the formation of triad 
junctions from isolated transverse tubules and terminal cisternae (TC) (Caswell and Corbett, 1985). 
Binding of GAPDH/TC triad binding inhibits GAPDH dehydrogenase activity. Dissociation of tetrameric 
GAPDH to the monomeric form is responsible for diminution of dehydrogenase activity (Durrieu et al., 
1987, Muronetz et al., 1994) and ATP facilitates tetramer to monomer GAPDH dissociation (Bartholmes 
and Jaenicke, 1978, Constantinides and Deal, 1969, Oguchi et al., 1973, Stancel and Deal, 1969) which 
may provide a cellular control mechanism to regulate the functional diversity of GAPDH, its glycolytic 
activity and cellular requirements for ATP generation. The specificity of GAPDH as a tubulin bundling 
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protein (Walsh et al., 1989) and its microtubule bundling activity has been well demonstrated (Launay et 
al., 1989), and glycolytic enzymes which do not bind to microtubules have no effect on bundling (Volker 
and Knull, 1993, Volker et al., 1995, Somers et al., 1990).  
 
All these studies agree with our observation in control R6 cells that GAPDH is localised predominantly 
in the cytoplasm where staining of the cytoskeleton can be observed. Concentration of GAPDH in the 
perinuclear area therefore can be explained by the fact that the cytoskeleton is more dense around the 
nucleus. 
 
GAPDH may have other activities after nuclear translocation induced by apoptotic agents 
 
Translocation of GAPDH into the nucleus is probably important during apoptosis and very relevant in 
oxidative stress and may be due to a conformational change induced by an apoptotic agent in the NAD+ 
binding domain. Probably GAPDH exerts another function in the nucleus. Recent investigations suggest 
an activity as a nuclear RNA transport protein (Singh and Green, 1993). The T stem-loop region may 
provide a recognition site and its interaction may regulate both GAPDH glycolytic activity and nuclear 
tRNA binding/export activity. Furthermore a post-transcriptional regulatory cis-element (PRE) is 
required for the increase in viral transcripts which colocalises with GAPDH into a GAPDH/PRE complex 
in the nucleus and was immunoprecipitated by anti-GAPDH antibody (Zang et al., 1998). This provides a 
potential function for GAPDH in the nucleus and indicates the emerging role of GAPDH in viral 
pathogenesis. Nevertheless, GAPDH-mediated tRNA export in apoptosis is disputed (Sawa et al., 1997). 
 
More relevant to apoptosis and oxidative stress may be the nuclear function of GAPDH as uracil DNA 
glycosylase (UDG) with DNA repair activity. As cytosine deamination to uracil is a mutagenic event, 
UDG has a significant function, although the role in vivo is unclear at the present time (Arenaz and 
Sirover, 1983, Vollberg et al., 1987, Vollberg et al., 1989, Meyer-Siegler et al., 1991, McNulty and 
Toscano, 1995). A recent study  showed that although GAPDH concentration increases in the nucleus of 
apoptotic cells, the UDG activity which was measured was lower than in control cells (Saunders et al., 
1999). 
 
Binding of GAPDH to cellular molecules may thus influence the response to apoptosis or to oxidative 
stress. Specific binding of GAPDH to the 5'-UTR and the 3'-UTR regions of mRNA have been reported, 
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e.g. the specific binding to AU sequences in 3'UTR regions of lymphokine mRNA (Nagy and Rigby, 
1995). Also GAPDH stimulates the activity of a TNFα ribozyme (Sioud and Jespersen, 1996). 
 
Finally GAPDH also binds specifically to the dinucleoside polyphosphate, Pl,P4-di(adenosine-5') 
tetraphosphate (Ap4A) (Vishwanatha and Wei, 1992, Baxi and Vishwanatha, 1995), either to a subunit 
within the multiprotein DNA pol α complex (Baril et al., 1983) or to cell membranes (Edgecombe et al., 
1996). Several reports link diadenine nucleotides to apoptosis (Gasmi et al., 1996, Gasmi et al., 1996). 
The Ap3/Ap4 ratio changes during programmed cell death (Vartanian et al., 1997), thus Ap4A and Ap3A 
may be physiological antagonists in determination of the cellular status: Ap4A induces apoptosis whereas 
Ap3A is a co-inductor of differentiation (Vartanian et al., 1999). 
 
Increased expression of GAPDH is observed in apoptotic cells  
 
In the next stage, the nucleus is fragmented and GAPDH is expressed at very high levels. However, 
GAPDH is probably not bound to DNA, since it is expressed everywhere except where the fragmented 
nucleus is detected. These cells have shrunk and are rounded up, which could be related to the loss of 
tubulin bundling activity of GAPDH in the cytoplasm. 
 
At the final stage, in some cells only the fragmented nucleus can be seen, but no GAPDH. The cell 
membrane is probably disrupted and GAPDH could have been released. 
 
 
 
Translocation of GAPDH is different in NB41A3 cells and in R6 cells  
 
In NB41A3 cells the same different stages of apoptosis are observed, except that GAPDH is localised in 
the nucleus already before exposure to MG132 or to staurosporine. Perhaps neuronal cell lines like 
NB41A3, need per se more nuclear than cytoplasmic functions of GAPDH and therefore express 
GAPDH predominantly in the nucleus. 
 
 
 111 
h) There is increasing evidence that GAPDH is involved in apoptosis 
 
Although several studies demonstrate a role of GAPDH in apoptosis, the relevance of these data is not 
known. Initial studies (Ishitani and Chuang, 1996a, Ishitani, et al., 1996c, Ishitani, et al., 1996b, Ishitani, 
et al., 1997, Sunaga, et al., 1995) in cerebellar granular cells showed that GAPDH expression was co-
ordinated with the induction of apoptosis and reduced by actinomycin D and cycloheximide. Transfection 
of cerebellar granular cells with antisense, but not sense, GAPDH oligonucleotides inhibited programmed 
cell death. The generality of GAPDH function in apoptosis was established using a variety of agents to 
induce apoptosis in various cell types. GAPDH biosynthesis during programmed cell death was observed 
using cytosine arabinoside (Ishitani and Chuang, 1996a), low K+ (Ishitani et al., 1997), dexamethasone 
(Sawa et al., 1997), and serum deprivation (Sawa et al., 1997). 
 
Analysis of the subcellular regulation of GAPDH during apoptosis performed by other groups support 
our findings. It was observed that its participation in apoptosis may involve its specific translocation to 
the nucleus (Ishitani et al., 1998, Saunders et al., 1997, Saunders et al., 1999, Sawa et al., 1997, 
Shashidharan et al., 1999). This was established using cell fractionation coupled with immunoblot 
analysis or immunocytochemistry to detect the presence of nuclear GAPDH as a function of programmed 
cell death. Interestingly, antisense GAPDH studies demonstrated that its inhibition of apoptosis precluded 
the appearance of nuclear GAPDH. Further, enzymatic analysis demonstrated the absence of GAPDH 
glycolytic activity subsequent to the translocation of the GAPDH protein into the nucleus. In accord with 
this finding, treatment of neuronal NG108-15 cells with koningic acid (which inhibits GAPDH glycolytic 
activity) resulted in DNA fragmentation and the appearance of apoptotic cells (Nakazawa et al., 1997). 
However, koningic acid also produces free radicals (Itoh et al., 1980, Tanaka et al., 1998) which can 
cause programmed cell (Nomura et al., 1996).  
 
Apoptosis in neuronal cells may be delayed by ONO-1603, an anti-dementia drug and a prolyl 
endopeptidase inhibitor, or by tetrahydroaminoacridine (THA), another anti- dementia drug (Katsube et 
al., 1999). Both, ONO-1603 and THA, robustly suppressed overexpression of GAPDH mRNA and 
accumulation of GAPDH protein in a particulate fraction of cultured neurones undergoing age-induced 
apoptosis. 
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i) GAPDH may have several roles in apoptosis 
 
The role of GAPDH in apoptosis may involve one or more of its nuclear, non-glycolytic functions. Its 
nuclear RNA export function may nevertheless be excluded, since GAPDH tightly binds to nuclear DNA, 
remaining in the nuclear fraction following treatment either with DNase or 5 M NaCI (Sawa et al., 1997), 
in accordance with early studies identifying GAPDH as a DNA binding protein (Grosse et al., 1986, 
Melero et al., 1975, Morgenegg et al., 1986, Perucho et al., 1977, Ronai, 1993, Tsai and Green, 1973). 
Accordingly, GAPDH may function in apoptosis as an Ap4A binding protein, a glutathione binding 
protein or as a uracil DNA glycosylase (UDG), although there is no report which links UDG and 
apoptosis and nuclear accumulation of GAPDH was associated with a progressive decrease in UDG 
activity (Saunders et al., 1999). Previous investigations link changes in Ap3A/Ap4A levels (Vartanian et 
al., 1999, Vartanian et al., 1997) as well as glutathione to apoptosis (Boggs et al., 1998, Froissard et al., 
1997, Macho et al., 1997, Zhao et al., 1997). 
 
A recent study indicates that the regulation of GAPDH during apoptosis is quite complex (Saunders et 
al., 1999). Six GAPDH isoforms were detected in the nuclei of AraC- treated cells. Various GAPDH 
isoforms were differentially regulated and may have distinct apoptotic roles. Pre-treatment of cells with 
GAPDH antisense oligonucleotide blocked the nuclear translocation of GAPDH isoforms. NAD labelling 
of nuclear GAPDH induced by FeCN showed a 60% loss of GAPDH labelling after AraC treatment, 
suggesting that the active site of GAPDH may be covalently modified, denatured, or improperly folded. 
This modification may be responsible for the fact, that cells exposed to FeCN translocate GAPDH back 
into the cytoplasm, in contrast to all other agents inducing oxidative stress or apoptosis which lead to a 
nuclear translocation of GAPDH. 
 
It is interesting to note that only apoptosis, but not necrosis involves overexpression of GAPDH in the 
nucleus of cells and that GAPDH antisense oligonucleotides preferentially blocked low K+-induced 
apoptosis rather than necrotic damage (Ishitani et al., 1997). 
 
j) GAPDH may act as a nuclear carrier during apoptosis  
 
Our results indicate that not the nuclear localisation of GAPDH itself, but rather an event coupled to the 
import of GAPDH into the nucleus is responsible for the apoptotic action of GAPDH, since under various 
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different conditions GAPDH is found at high levels in the nucleus without inducing or enhancing 
apoptosis. Therefore we suggest that GAPDH may function as a molecular chaperon, as supported by 
earlier studies (Katsube et al., 1999, Sawa et al., 1997). 
 
This may be related to studies on selective binding of GAPDH to gene products of neurodegenerative 
disease, such as huntingtin of Huntington disease (HD), atrophin of dentatorubropallidoluysian atrophy, 
ataxin of spinocerebellar ataxia type-1, ataxin-3 of Machado-Joseph disease and androgen receptor of 
spinobulbar muscular atrophy. It is note worthy that NH2-terminal fragments of huntingtin and ataxin-3 
are located to intranuclear inclusions in neurones of affected brain regions (Davies et al., 1997, DiFiglia 
et al., 1997, Paulson et al., 1997), supporting the notion that GAPDH may serve as a carrier to mediate 
the translocation of these disease gene products to the nucleus. 
 
Our observations also suggest that GAPDH acts as pro-apoptotic enzyme downstream of Bcl-2. Its 
nuclear translocation may be a key event during apoptosis in combination with other factors and have a 
great influence in several neurodegenerative disease. 
 
k) GAPDH has an important role in cells undergoing oxidative stress 
 
Our results demonstrate that GAPDH does not only have an important role in apoptosis but also in 
oxidative stress. Studies identified the interaction of GAPDH and glutathione as a result of oxidative 
stress (Schuppe-Koistinen et al., 1994). In vitro analysis probed the interaction of GAPDH and oxidised 
glutathione using human erythrocyte GAPDH (Lind et al., 1998). Membrane binding sites for glutathione 
conjugates were examined in inverted erythrocyte membranes (Puder and Soberman, 1997). Association 
of GAPDH in binding of glutathione to membranes was inhibited by ATP, an indication of 
GAPDH/glutathione interactions. Recent studies also suggest a role for glutathione in apoptosis (Boggs 
et al., 1998, Froissard et al., 1997, Macho et al., 1997, Zhao et al., 1997). 
 
A recent report identifies GAPDH as the major target of protein S-thiolation following treatment with 
hydrogen peroxide in S. cerevisiae (Grant et al., 1999). The GAPDH enzyme activity of the two 
isoenzymes Tdh2 and Tdh3 was decreased following exposure to H2O2 and restored for Tdh3 (but not for 
Tdh2) within a 2-h recovery period, indicating that the inhibition of the S-thiolated Tdh3 polypeptide was 
reversible. The  S-thiolated Tdh3 are required for survival during conditions of oxidative stress. In 
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contrast, the non-thiolated Tdh2 polypeptide was required during exposure to continuous low levels of 
oxidants, conditions where Tdh3 is inactivated.  
 
Another study examined sub lethal oxidative stress obtained by treating human fibroblasts with 0.5 mM 
H2O2 in DMEM plus 5% FCS for times not exceeding 60 min (Mocali et al., 1995). Under these 
conditions cells remained viable throughout long-term incubation, whereas exposures of the fibroblasts to 
0.5 mM H2O2 for more than 60 min induced a lethal cell injury which was fully expressed 2 days later by 
leakage of cytosolic components. Early metabolic effects of sub lethal stress included partial decrease of 
specific activity of GAPDH. We suppose that this is due to the nuclear translocation of GAPDH. 
Microfilaments of H2O2-treated cells are morphologically altered due to partial fragmentation of 
cytoskeleton actin (Mocali et al., 1995). This supports our observations and may be explained by our 
findings that GAPDH in fibroblasts translocates into the nucleus after oxidative stress and so the tubulin 
bundling by GAPDH is decreased in the cytoplasm. Moreover, Molcali showed that sub-lethally injured 
fibroblasts exhibit a reduced adhesive strength to plastic once they were detached and re-seeded into new 
dishes. This may explain why stressed cells start to form long processes. 
 
Besides nuclear translocation of GAPDH we also observed translocation to other intracellular regions. 
Non-nuclear translocation was also found in a study that investigated the role of oxygen free radicals in 
the modulation of GAPDH binding to the erythrocyte membrane (Mallozzi et al., 1995). The reaction of 
peroxyl radicals with intact red cells induced a time-dependent loss of membrane-bound GAPDH, 
associated with a concomitant decrease in enzyme activity, which was completely reversible after 
removal of the oxidative stress. In that way cells can boost or reduce energy production in times of 
special need such as during a free radical attack.  
 
Increased levels of GAPDH mRNA were also observed in oxidatively stressed cells (Ito et al., 1996, Yan 
et al., 1999). It was suggested that NAD+ precursors may protect against oxidative stress and DNA 
damage by up-regulating the stress response genes of GAPDH. 
 
However, the response to oxidative stress is highly dependent on experimental conditions used to induce 
oxidative stress (Mocali et al., 1995, Castagne and Clarke, 1998, Castagne, et al., 1999). Protective 
effects of weak, non-lethal oxidative stress may stimulate defence mechanisms, including HSPs, as 
shown for hyperthermia (Barbe, et al., 1988, Caprioli, et al., 1996). 
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5.2 HSC 70 
 
a) Overexpression of Hsc70-GFP renders cells more resistant to oxidative stress 
 
As expected, R6Bcl-2 cells showed no difference in their Hsc70 expression and in their morphology to R6 
cells. R6Bcl-2 cells are less sensitive to MG132 or staurosporine induced apoptosis but not to oxidative 
stress by H2O2 or FeCN. 
 
Very few Hsc70-GFP transfected cells exposed to oxidative stress had a shrivelled cell body and formed 
long processes. This may indicate, that overexpression of Hsc70-GFP helps the cell to trigger cell 
damages induced by oxidative stress, because the loss of adhesive strength to the growth surface is 
viewed as marker for stress. The formation of long processes may therefore be a reaction of stressed cells 
loosing their adherence to the growth surface. However, only few cells form long, oligodendrocyte like 
processes. Hsc70-GFP does not significantly influence the rate of apoptotic cells.  
 
b) Translocation of endogenous Hsc70 into the nucleus is more pronounced during oxidative stress 
than during apoptosis  
 
Our results showed that Bcl-2 protects cells overexpressing Hsc70-GFP at the same rate as in cells 
expressing endogenous GAPDH. Compared to GAPDH-GFP overexpressing cells, less cells showed 
nuclear translocation of the Hsc70-GFP in response to induction of apoptosis. Moreover, apoptotic cells 
did not express increased levels of either endogenous Hsc70 or overexpressed Hsc70-GFP. 
 
Since nuclear translocation of endogenous Hsc70 is only observed during oxidative stress and not during 
apoptosis, it is tempting to speculate that a) Hsc70 transport to the nucleus is not directly linked to 
GAPDH translocation and is regulated by another mechanism and b) that the nuclear translocation 
mechanism for ROS-induced oxidative stress and for MG132 or staurosporine induced apoptosis is not 
identical. 
 
However, an observation that was made when cells were concomitantly co-transfected with GAPDH-
GFP and Hsc70-BFP has to be noted. While the localisation of Hsc70-BFP is not influenced by GAPDH-
GFP in unstressed control cells or in cells stressed by FeCN, in cells exposed to H2O2 significantly higher 
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rates of nuclear Hsc70-BFP translocation are observed than in cells transfected with Hsc70-BFP or 
Hsc70-GFP alone. 
 
Translocation of Hsc70 into the nucleus may be related to its function as a molecular chaperone in correct 
folding of proteins. Oxidative stress may induced damage to some nuclear proteins and Hsc70 may then 
be imported to the nucleus in order to refold them into a suitable conformation. However, other properties 
of Hsc70 may be relevant in response to oxidative stress, besides its role in catalysing folding of proteins. 
 
c) Different molecular mechanisms can be proposed for the nuclear translocation of Hsc70 
 
Interestingly, there is evidence for a mechanism for the nuclear import of Hsc70, since Hsc70 can shuttle 
between the nucleus and the cytoplasm. Nuclear import of purified Hsc70 was not inhibited by an excess 
of nuclear localisation signals (NLSs) conjugated with BSA (Lamian et al., 1996). A basic domain 
(246KRKHKKDISENKRAVRR262) of Hsc70 promotes nuclear import and, therefore, acts as a 
prototypical basic NLS. However, inactivation of this signal by deleting the first six amino acids had no 
effect on Hsc70 import, indicating that Hsc70 utilises a novel import signal and enters the nucleus by a 
different mechanism than that employed by simple and bipartite NLSs. In our studies the GFP tag 
coupled to Hsc70 may have disturbed nuclear translocation promoted by this signal, partially explaining 
our observations, that nuclear translocation after oxidative stress is greater for endogenous Hsc70 than for 
overexpressed Hsc70-GFP. Recently, nuclear translocation of Hsc70, but not of Hsp70, was observed 
during early S phase of the cell cycle, indicating a role for Hsc70 in the process of S phase entry (Zeise et 
al., 1998). 
 
In connection with was discussed on GAPDH, recent data indicate that the heat shock response inhibits 
nuclear translocation of the pro-inflammatory transcription factor NF-κB. Under basal conditions NF-κB 
is retained in the cytoplasm by the inhibitory protein I-κB. Heat shock increases I-κB mRNA expression 
by activating the I-κB promoter which leads to inhibition of NF-κB activation (Wong et al., 1999). This 
supports our observation that GAPDH and Hsc70 may exert opposite roles in the cellular response to 
stress. 
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d) Nuclear translocation of Hsc70 has functional relevance during oxidative stress  
 
Induction of HSPs by oxidative stress contributes to cellular protection and adaptation to stress and is 
mediated by differential translocation. This is supported by investigations in human monocytes on the 
expression and subcellular distribution of hsp70 and Hsc70 after heat-shock and inflammation-related 
stresses leading to generation of reactive oxygen species, such as erythrophagocytosis (E-phi) and the 
phorbol ester PMA (Mariethoz et al., 1997). All stress factors resulted in an increase in hsp70 expression, 
but the subcellular distribution pattern was different depending on the type of stress. While heat-shock 
induced a rapid translocation of hsp70 into the nucleus, no nuclear translocation of hsp70 was observed 
after PMA or E-phi. Neither of the examined stresses induced membrane expression of hsp70. These 
observed differences in subcellular distribution pattern were consistent with our findings showing 
different type of subcellular localisation of Hsc70 depending whether oxidative stress or apoptosis was 
induced. This differential expression might relate to distinct regulation and specific functions of Hsc70 in 
apoptosis or oxidative stress. 
 
Another study shows that overexpression of both inducible (hsp70i) and constitutive (hsp70c) forms 
confers resistance to oxidative challenges generated by ROS, again suggesting an antioxidant role for 
these proteins (Chong et al., 1998). 
 
Hsc70 may also have a role in hypoxia and apoptosis 
 
While the phenomenon of heat-shock protection to various types of stresses has been often described, the 
molecular mechanism underlying this protection remains poorly defined. ROS production is common to 
apoptosis induced by camptothecin and actinomycin D (agents against which HSPs conferred protection), 
whereas Fas-mediated apoptosis (against which HSPs showed no protective effect) occurs via a ROS-
independent mechanism (Creagh and Cotter, 1999). The selective protection observed against these 
agents was mimicked by pre-treatment with antioxidant compounds and occurrs downstream of ROS 
production. Consistent with our results, this study showed no direct correlation between Bcl-2- and 
HSP70-mediated protection. However, other reports indicate some connections between HSPs and Bcl–2. 
Investigations on the intracellular responses to metabolic oxidative stress by glucose deprivation show an 
increase in the level of HSP70 mRNA, which could be suppressed by overexpression of Bcl-2. (Lee and 
Corry, 1998). The signal transduction pathway in heat shock gene expression under glucose deprivation 
involved the stress-activated protein kinase. 
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Experiments in hypoxic cells are of special interest since besides Hsc70 expression, also the expression of 
GAPDH and enolase γ was significantly changed after hypoxia (Graven and Farber, 1995, Graven and 
Farber, 1998, Graven et al., 1998, Graven et al., 1994). GAPDH and enolase γ are up-regulated in the 
cytoplasm of hypoxic cells, whereas GAPDH is also up-regulated in the nucleus. GAPDH activity is 
decreased, suggesting that during hypoxia GAPDH and perhaps enolase exert functions aside from their 
catalytic function in glycolysis. This is an interesting observation since we isolated a multi-enzyme 
complex containing among others Hsc70, GAPDH and enolase γ (Bulliard et al., 1997). 
 
Experiments where macrophage cells exposed to hypoxia underwent apoptosis give indications for the 
role of Hsc70 in apoptosis (Yun et al., 1997). Subpopulations of cells were resistant to hypoxia-induced 
apoptosis. In contrast to the other cells, in these hypoxia-induced apoptosis-resistant macrophages 
(HARMs) Hsc70 expression did not decrease, indicating that Hsc70 may play a role in protection against 
hypoxia-induced apoptosis. After hypoxic treatment, a significant increase in TNFα production in HARM 
but decrease in other macrophage cells was observed. These results suggest that a selective population of 
macrophages can adapt to hypoxic conditions by overcoming the apoptotic signal. This selectivity 
supports our observation that for a given cell population cells do not all react in the same manner in 
response to oxidative stress. 
 
Altogether, these findings demonstrate, that the differential translocation of Hsc70 observed in our 
experiments after either induction of oxidative stress or apoptosis, is most probably in direct correlation 
with one of the specific actions of Hsc70 described above. 
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5.3 Aldolase 
 
a) Aldolase C is predominantly expressed in the cytoplasm and bound to the cytoskeleton 
 
Distribution of aldolase C in control cells and cells exposed to oxidative stress or apoptosis induction was 
very similar to the one of Hsc70 discussed above. Endogenous aldolase and overexpressed aldolase-GFP 
both are predominantly expressed in the cytoplasm of unstressed cells, best visible in the perinuclear area 
and at the bases of axons. The fibril staining of the cytoskeleton was more distinct in fibroblasts than in 
neuroblastomas. This observation is confirmed by other studies in which the micro-compartmentation of 
aldolase and GAPDH was investigated in four different cell types (3T3 cells, SV 40 transformed 3T3 
cells, mouse fibroblasts, chick embryo cardiomyocytes) (Minaschek et al., 1992). It was shown that both 
enzymes exist in a soluble as well as in a structure-bound form. Their findings that the soluble fraction of 
aldolase and GAPDH is distributed homogeneously throughout the cytoplasm, excluding the nucleus and 
vesicles and that the permeabilisation-resistant form is associated with the actin cytoskeleton is consistent 
with our observations. Furthermore they also observed that a considerable amount of both enzymes is 
located in the perinuclear region and cannot be attributed to a definite structure. Comparing the staining 
patterns of aldolase and GAPDH in the four different cell types it was found that the distribution of the 
enzymes corresponds with diverse forms of actin cytoskeletal organisation of these cells. There are also 
other studies that show interaction of aldolase together with GAPDH with cytomatrix components 
(Balaban and Goldman, 1990, Mathur et al., 1992, Walsh et al., 1989). Further association of aldolase 
with GAPDH was also shown in the presence of extracellular stress agents (Maine and Ciejek-Baez, 
1991) and in trypanosomes, where aldolase and GAPDH co-purify with unique trypanosomal 
microtubule-associated protein (p52) (Balaban et al., 1995) 
 
b) Changes in aldolase C expression are higher during oxidative stress than during apoptosis 
 
Induction of oxidative stress by either FeCN or H2O2 leads to enhanced nuclear expression of endogenous 
aldolase in NB41A3 cells. An increase of nuclear aldolase-GFP expression is also observed in transiently 
or permanently transfected cells, but nevertheless cytoplasmic expression of aldolase-GFP is still higher. 
This may be due to the fact that NB41A3 cells overexpressing aldolase-GFP have very high expression of 
aldolase-GFP in the cytoplasm prior to oxidative stress and that only a small amount of this translocates 
into the nucleus. Therefore the absolute amount expressed in the nucleus after oxidative stress may be the 
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same as in untransfected cells, but the relative amount  is lower. However, both transfected and 
untransfected cells show formation of aldolase-positive speckles after induction of stress. 
 
R6 and R6Bcl-2 fibroblasts showed less effects to oxidative stress than NB41A3 cells. No significant 
translocation of endogenous aldolase to the nucleus was observed. This may be due to the fact that the 
percentage of cytoskeleton-bound aldolase compared to soluble aldolase is higher in fibroblasts than in 
neuroblastoma cells, as discussed for other cell lines in the study mentioned above (Minaschek et al., 
1992). Therefore less free aldolase is available for translocation into the nucleus after oxidative stress. 
 
Our results demonstrate that aldolase C has no crucial function during apoptosis, but may be involved in 
oxidative stress. It was reported that oxidation of enzyme-substrate carbanion intermediates by extrinsic 
oxidants may result in irreversible paracatalytic inactivation of aldolase (Gupta et al., 1993). Aldolase 
was paracatalytically modified in the presence of fructose 1,6-bisphosphate and hexacyanoferrate(III). 
That means that ROS cause self-inactivation of aldolase. However, this modification may create a new, 
unknown function of aldolase. It was shown that mRNA levels of aldolase A is up regulated in 
proliferating cells and during anoxia (Gautron et al., 1991). 
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5.4 Ulip 
 
a) Ulip is detected in neuronal and in non-neuronal cell lines 
 
Ulip is described as a neurone-specific intracellular protein implicated in the relay of signals by attracting 
and repelling molecules which direct neuronal outgrowth. We detected endogenous Ulip in both R6 
fibroblasts and NB41A3 neuroblastoma cells. This is an interesting finding, since previous studies stated 
that Ulip is almost exclusively expressed in the brain and strongly regulated during development. Rat 
protein TOAD-64 and chick CRMP-62, which correspond to Ulip-2 are used as an early marker in 
differentiated neurones and have been described to be then down-regulated (Minturn et al., 1995a). 
Chick-protein CRMP-62 is implicated in the collapsing induced mediation of growth collapse of chick 
dorsal root ganglion (DRG) neurones (Goshima et al., 1995). This correlates with the findings that Ulip 
strongly expressed in neurones preferentially localise in the growth cone, and can be readily detected in 
the pre-synaptic region of the neuromuscular junction (Byk et al., 1996).  
 
Ulip may have additional functions during apoptosis and oxidative stress 
 
The possible involvement of Ulip in oxidative stress in unknown and therefore the translocation into the 
nucleus is intriguing. These findings indicate that Ulip may exert additional functions to the ones known 
in neuritic outgrowth and axonal guidance (Minturn et al., 1995b). It's known that Ulip 1-4, all members 
of the Ulip family, are expressed as differentially phosphorylated forms and are differentially regulated 
during development and neuronal differentiation, and that they differ in their tissue specificity (Byk et al., 
1998). However, it is not clear whether phosphorylation plays an important role in response to oxidative 
stress and whether this regulates their nuclear translocation. 
 
A recent study provides evidence linking induction of axon guidance molecules with repulsive cues to the 
early stages of neuronal apoptosis caused by dopamine (Shirvan et al., 1999). It was shown that mRNA 
expression of collapsin-1 and of Ulip-2 is induced during neuronal apoptosis and that this induction 
precedes the time point of commitment of neurones to the death process. It was further indicated that 
these proteins are not only induced but may have an active role in determining the fate of neurones that 
are exposed to an oxidative stress-inducing apoptotic trigger. Antibodies directed against a collapsin-
derived peptide were capable of conferring protection against the oxidative stress-inducing agent 
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dopamine. Thus the up-regulation of Ulip-2 during the early stages of dopamine-induced neuronal 
apoptosis (Shirvan et al., 1999), may be related to the nuclear translocation of Ulip that we observed after 
three hours of oxidative stress. This may be a major step in the signalling cascade of apoptosis and 
oxidative stress, in analogy to our observations on GAPDH. 
 
Although caution should be practised when evaluating the relevance of our cellular observations to 
neurodegenerative disease, it is tempting to speculate that in pathological apoptotic cell death, Ulip 
together with GAPDH affects the faith of the cell. In support of this view is the recent finding that Ulip2 
protein plays a role in the formation of neurofibrillary tangles in Alzheimer's disease (Yoshida et al., 
1998). 
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5.5 Enolase γ 
 
a) Enolase does not show any major translocation after induction of apoptosis or oxidative stress 
 
Enolase and enolase-GFP do not show great changes in their predominantly cytoplasmic expression after 
induction of oxidative stress. However, although cytoplasmic enolase-GFP was dominant, an increase of 
nuclear enolase-GFP levels was observed. This may indicate that if enolase is up-regulated and at the 
same time the cell is stressed, some enolase can translocate into the nucleus. 
 
This can be interesting in context with the hypoxia studies discussed above, showing that enolase together 
with GAPDH and Hsc70 are up-regulated in hypoxic cells (Graven and Farber, 1998). Both enzymes are 
so called hypoxia-associated proteins (HAPs), which are distinct from the classical stress proteins induced 
by heat shock (HSPs) or glucose deprivation. While GAPDH expression during hypoxia is regulated 
primarily at the level of transcription, the mechanism of enolase mRNA accumulation remains unclear. 
Enolase is up-regulated by transition metals and desferoxamine and is not inhibited by carbon monoxide. 
In accordance with our results, subcellular fractionation of hypoxic cells has showed that GAPDH and 
enolase are up-regulated in the cytoplasmic fraction, whereas only GAPDH is also up-regulated in the 
nuclear fraction (Graven and Farber, 1998). 
 
Further α-enolase has a close relationship with tau-Crystallin (Wistow et al., 1988). Tau-Crystallin is a 
major component of the cellular lenses of species throughout vertebrate evolution. Tau-Crystallin is a 
multi-functional protein and possesses enolase activity, but the activity is greatly reduced, probably 
because of age-related posttranslational modification. Apparently, in the lens enolase is not recruited for 
its catalytic activity but for some distinct structural property. This shows that tau-Crystallin/α-enolase is a 
multi-functional protein. 
 
Like tau-Crystallin, enolase is up-regulated and exerts an important role in differentiation (Deloulme et 
al., 1996). It was demonstrated that enolase γ is expressed in oligodendroglial cells only at a certain stage 
of differentiation. The level of γ, but not α, mRNA increased when precursor cells differentiated into 
oligodendrocytes. So, γ-enolase gene expression is associated with the differentiation of the 
oligodendrocytes and is repressed in mature cells. 
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5.6 Conclusion: Co-operation of the proteins 
associated to the PMO complex 
 
a) All PMO proteins except GAPDH are localised in the cytoplasm of transfected and untransfected 
control cells  
 
Since GAPDH, Hsc70, enolase, aldolase and Ulip were previously immuno-precipitated together in a 
PMO complex (Bulliard et al., 1997), it made sense to investigate whether a functional co-operation 
between these proteins occurs. Under unstressed conditions, in R6 and R6Bcl-2 fibroblasts, and – except for 
GAPDH -  also in NB41A3 neuroblastomas, all endogenous proteins were expressed predominantly in 
the cytoplasm. However, their cytoplasmic patterns were quite different and there was no clear 
colocalisation between the proteins. This can be explained if one considers that not all of GAPDH, 
Hsc70, aldolase C, enolase γ and Ulip is associated with the PMO complex, and that the remaining 
proteins have also alternate roles with no relation to the PMO complex. Furthermore it is possible that the 
PMO proteins form a tight complex only in the plasma membrane and disperse when they leave it. 
 
In unstressed cells overexpressing the PMO proteins, the subcellular localisation did not change, except 
for GAPDH. Overexpression of GAPDH per se induced nuclear translocation. All other overexpressed 
proteins remained in the cytoplasm of transfected control cells.  
 
b) When overexpressed, all proteins display increased nuclear expression after oxidative stress  
 
After exposure to H2O2 nuclear translocation of the endogenous protein is observed for GAPDH, Hsc70, 
Ulip and aldolase, but not for enolase. This translocation was most pronounced in GAPDH and Hsc70. 
Furthermore nuclear translocation of endogenous aldolase and Hsc70 was much less significant in non-
neuronal R6 cells compared to NB41A3 cells. Aggregation of proteins into speckles was observed in 
untransfected cells after oxidative stress with endogenous GAPDH, aldolase and Hsc70.  
 
When the proteins are overexpressed, all five components of the PMO complex have increased 
expression levels in the nucleus after oxidative stress induced by H2O2. Nuclear translocation is highest in 
GAPDH-GFP and Hsc70-GFP transfected cells and least in enolase-GFP transfected cells. Except 
enolase-GFP all transfected proteins show formation of speckles filled with the respective protein (in 5-
10% of oxidatively stressed cells). 
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These observations suggest that co-operation of the proteins may not be operative in resting cells, but is 
induced after oxidative stress.  
 
c) Pronounced nuclear translocation is only observed with GAPDH, whereas all tested proteins 
showed expression in speckles and in long processes 
 
After induction of apoptosis, the effects of GAPDH, Hsc70 and aldolase is quite different. The response 
of GAPDH is dramatic, showing nuclear translocation leading to apoptotic cells, whereas differential 
translocation of Hsc70 is less pronounced and aldolase is relatively unchanged. 
 
Therefore, in contrast to oxidative stress, induction of apoptosis does not reveal a common action of the 
proteins. This may indicate that the complex falls apart during apoptosis, liberating the individual 
proteins. 
 
d) GAPDH-GFP expression is influenced by the overexpression of other proteins 
 
In respect to its important function during apoptosis it is interesting to note that GAPDH-GFP expression 
is affected by expression of any of the co-transfected PMO proteins. Co-expression with enolase-BFP or 
Ulip-BFP enhanced formation of speckles where GAPDH-GFP accumulated after oxidative stress. This 
increase of speckles formation after oxidative stress was also observed for Hsc70-GFP when co-
transfected with enolase-BFP and for Ulip-GFP when co-transfected with either enolase-BFP, Hsc70-BFP 
or GAPDH-BFP.  
 
We cannot exclude that this phenomenon is an unspecific aggregation of highly overexpressed proteins, 
but some of our observations indicate that this is not the case. First, we never observed this formation of 
speckles in unstressed cells, but only in stressed cells. Second, GFP alone and also enolase-GFP or 
enolase-BFP, under all tested conditions never showed formation of speckles. Furthermore, co-
overexpression of BFP with any PMO protein did not influence expression or speckles formation of the 
PMO protein. 
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e) GAPDH and Hsc70 seem to have an antagonistic interaction 
 
Nuclear localisation of GAPDH-GFP was also affected in co-transfections. Ulip-BFP decreased 
cytoplasmic translocation of GAPDH-GFP after exposure to FeCN. Since Ulip-BFP itself normally 
increases nuclear expression after oxidative stress induced by FeCN, an interaction with GAPDH-GFP 
retaining it partially in the nucleus can be hypothesised. 
 
Furthermore, overexpression of aldolase and of Hsc70 both lead to an increased expression of GAPDH-
GFP in the cytoplasm, both before and after oxidative stress. Nuclear translocation of Hsc70 is increased 
after oxidative stress when it is overexpressed together with GAPDH. This observation could indicate that 
overexpressed GAPDH is normally translocated into the nucleus after exposure to H2O2, but that this 
effect can be counteracted by Hsc70, which also shows increased nuclear translocation after oxidative 
stress in double transfectants. Thus, Hsc70 may protect cells by partially preventing nuclear translocation 
of GAPDH.  
 
This antagonistic interaction between Hsc70 and GAPDH is especially interesting, because both of them 
are considered to play important roles in cell viability. The effects of other components of the PMO 
complex overexpressed in stable cell lines on endogenous GAPDH and Hsc70 are also very interesting, 
mainly in the case of cells permanently transfected by aldolase-GFP. While GAPDH showed less nuclear 
localisation than control cells and was partially retained in the cytoplasm, nuclear translocation of Hsc70 
after oxidative stress was slightly increased. 
 
Although we do not yet know how the proteins associated to the PMO complex exactly co-operate with 
each other, our results indicate that co-operation and interaction between these proteins changes after 
oxidative stress, and probably somehow regulate the antagonistic roles of GAPDH and Hsc70. 
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7 APPENDIX 
 
7.1 Additional studies 
 
7.1.1 S1-Nuclease mapping assay 
 
To get a first indication whether the proteins in the PMO complex are induced after stress, the induction 
of the components of the PMO complex was investigated by S1-nuclease protection assay. The agents 
used to stress synchronised NB41A3 cells were DCIP (up to 400 µM) and H2O2 (up to 200 µM). We 
observed a concentration dependent increase of Ulip in stressed NB41A3 cells (see figure 7b of the 
attached article (Bulliard et al., 1997)). The induction reached its peak at 100 µM DCIP or 100 µM H2O2 
respectively, where mRNA levels were at about 150 %, before they decreased at higher concentrations. 
This induction was significant and was able to re-produced by several different probes used to detect the 
same mRNA. For Ulip four DNA probes that were different in size (114, 203, 250 and 395 nt), were used.  
 
 
7.1.2 Two-hybrid system 
 
7.1.2.1 Method and principle of the two-hybrid assay 
 
We used the MATCHMAKER two-hybrid systems from CLONTECH to test our five previously cloned 
proteins for interaction. The MATCHMAKER Two-Hybrid System is a complete GAL4-based two-
hybrid system that provids a transcriptional assay for detecting specific protein-protein interactions in 
yeast. For general reviews on yeast two-hybrid systems, see (Allen, et al., 1995, Bartel, et al., 1993, 
Fields and Sternglanz, 1994, Luban and Goff, 1995, McNabb and Guarente, 1996, Mendelsohn and 
Brent, 1994). 
 
The yeast two-hybrid assay is based on the fact that many eukaryotic trans-acting transcription factors are 
composed of physically separable, functionally independent domains. Such regulators often contain a 
DNA-binding domain (DNA-BD) that binds to a specific enhancer-like sequence, which in yeast is 
referred to as an upstream activation site (UAS). One or more activation domains (AD) direct the RNA 
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polymerase II complex to transcribe the gene downstream of the UAS (Hope and Struhl, 1986, Keegan, et 
al., 1986, Ma and Ptashne, 1987, Ma and Ptashne, 1987, Ma and Ptashne, 1987). Both the DNA-BD and 
the AD are required to activate a gene and normally, as in the case of the native yeast GAL4 protein, the 
two domains are part of the same protein. If physically separated by recombinant DNA technology and 
expressed in the same host cell, the DNA-BD and AD peptides do not directly interact with each other 
and thus cannot activate the responsive genes (Brent and Ptashne, 1985, Brent and Ptashne, 1985, Ma and 
Ptashne, 1988).  However, if the DNA-BD and AD can be brought into close physical proximity in the 
promoter region, the transcriptional activation function will be restored. In principle, any AD can be 
paired with any DNA-BD to activate transcription,with the DNA-BD providing the promoter specificity 
(Brent and Ptashne, 1985, Brent and Ptashne, 1985). 
 
In the two-hybrid systems we used, the DNA-BD and the AD are both derived from the yeast GAL4 
protein (a.a. 1–147 and 768–881, respectively). Two different cloning vectors are used to generate fusions 
of these domains to genes encoding proteins that potentially interact with each other. The recombinant 
hybrid proteins are co-expressed in yeast and are targeted to the yeast nucleus. An interaction between a 
first protein (fused to the DNA-BD) and a second library-encoded protein (fused to the AD) creates a 
novel transcriptional activator with binding affinity for a GAL4-responsive UAS. This factor then 
activates reporter genes having upstream GAL4- responsive elements in their promoter and this makes the 
protein-protein interaction phenotypically detectable. If the two hybrid proteins do not interact with each 
other, the reporter genes will not be transcibed. 
 
Our GAL4 two-hybrid saccharomyces cerevisiae Y187 host strain contains the lacZ reporter. We utilised a lacZ 
reporter gene under the control of a GAL4-responsive UAS. The b-galactosidase encoded by the lacZ reporter was 
detected by using the Colony Lift β-galactosidase Filter assay. For detailed protocols see product protocol 
“MATCHMAKER Two-Hybrid System 2” (PT1030-1) and “Yeast Protocols Handbook” (PT3024-1) from 
CLONTECH (Paolo Alto, CA, USA). 
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7.1.2.2 Results 
 
Control experiments 
 
The phenotype of our Y187 yeast strain was verified successfully. Y187 cells did not grow on SD/-Trp, 
SD/-Leu, SD/-His and YPD/+cycloheximide plates, whereas positive colonies were detected on SD/-Ura 
and YPD plates. 
 
To test the functionality of our system and to avoid false positives we performed some control 
transformations with the following plasmids: 
 
 
Plasmid 
name 
Purpose Description 
pAS2-1 8.4-kb cloning vector used to generate fusions of the bait protein with the 
GAL4 DNA-BD. 
pACT2 8.1-kb cloning vector used to generate fusions of a known protein with the 
GAL4 AD. 
pVA3-1 9.4-kb positive control plasmid 
used with pTD1-1 
encodes a DNA-BD/murine p53 fusion protein in 
pAS2-1. 
pTD1-1 9.9-kb positive control plasmid 
used with pVA3-1 
encodes an AD/SV40 large T-antigen fusion protein 
in pACT2. 
pCL1 15.3-kb positive control plasmid encodes the full-length, wild-type GAL4 protein. 
pLAM5'-1 9.1-kb false-positive detection 
plasmid 
encodes a DNA-BD/human lamin C fusion protein 
in pAS2-1. 
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The results of the control transformations performed with these plasmids are listed below:  
 
Plasmid 1 (DNA-
BD) 
Plasmid 2 (AD) SD Selection 
Medium 
Colony growth LacZ ex-pression 
- pCL1 -Leu yes yes 
pAS2-1 - -Trp yes no 
- pACT2 -Leu yes no 
pAS2-1 pACT2 -Leu, -Trp yes no 
pVA3-1 - -Trp yes no 
pVA3-1 pACT2 -Leu, -Trp yes no 
- pTD1-1 -Leu yes no 
pAS2-1 pTD1-1 -Leu, -Trp yes no 
pVA3-1 pTD1-1 -Leu, -Trp yes yes 
pLAM5'-1 - -Trp yes no 
pLAM5'-1 pTD1-1 -Leu, -Trp yes no 
 
The results of these transformations demonstrate that besides transformation of pCL1 which encodes the 
full-length, wild-type GAL4 protein, also double-transformation of pVA3-1 and pTD1-1 (which are 
DNA-BD and AD fusion plasmids, respectively, containing Murine p53 and SV40 large T-antigen which 
are known to interact in a yeast two-hybrid assay) provide positive results for the -galactosidase assay. 
In contrast, pLam5'-1 which encodes a fusion of the DNA-BD with human lamin C (which has been 
reported not to form complexes nor to interact with most other proteins and therefore provides a control 
for a fortuitous interaction) did not interact with AD/T-antigen control (pTD1-1). In all other 
transformations we also obtained the expected results, confirming the relevance of our two-hybrid 
system.  
 
We then constructed fusion genes using standard techniques. The genes coding for GAPDH, Hsc70, 
enolase γ, aldolase C, Ulip 2 and Ulip 3 were each fused separately to the DNA-BD in the pAS2-1 vector 
and to the AD in the pACT2 vector. These constructs are referred to as DNA-BD/protein X and 
AD/protein Y, respectively. The orientation and reading frame of each fusion was maintained so that 
hybrid proteins were able to be expressed. 
 
We first verified that the hybrid constructs alone did not activate the reporter genes. The DNA-
BD/protein X and AD/protein Y constructs were transformed independently into strain Y187 and were 
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tested for activation of the lacZ reporter gene. None of the transformant colonies turned blue, thus 
autonomous activation could be excluded. 
 
Two-hybrid system assay between proteins of the PMO complex 
 
To assay the proteins for interaction two types of hybrid plasmids (DNA-BD/protein X and AD/protein Y 
were co-transformed into Y187. We tested all possible combinations between the proteins. The co-
transformation mixtures were plated on SD/–Leu/–Trp to select for colonies containing both hybrid 
plasmids. The 4-day-old transformant colonies were assayed for activation of the lacZ reporter gene using 
the β-galactosidase colony-lift filter. Colonies were about 1-5 mm in diameter when they were transferred 
to the filter. The results of the two-hybrid experiment were compared with the positive and negative 
controls performed in parallel. While positive control transformant colonies with pVA3-1 and pTD1-1 
(see above) turned blue within about 1-2 h, all other transformants did not show any significant β–
galactosidase activity even after 24 h. 
 
Different possibilities can be considered as reason for this surprising result. First, the fused GAL4 domains may 
occlude the site of interaction. Second, the hybrid proteins may fold improperly or the hybrid protein cannot be 
localised to the yeast nucleus. However, the probability that one of this is the case is quite small, since we cannot 
find interaction between any of our PMO complex proteins. Therefore it was more accurate to propose that either all 
our proteins needed another unknown, additional protein to interact with each other, or that the hybrid proteins may 
not be stably expressed in the host cell at all.  
 
To test whether the last hypothesis is true, we tried to verify whether the fusion proteins are expressed in 
yeast. The DNA-BD/protein X and AD/protein Y constructs were transformed separately into Y187. 
Western blots using soluble protein extracts were prepared from the transformants and probed with PMO 
protein specific and GAL4 domain-specific antibodies (Abs), such as the GAL4 DNA-BD and AD mAbs. 
Quite interestingly we observed multiple bands for each band indicating that the transformed proteins 
rather then being stably expressed, they were degraded in the yeast cells. We therefore suppose that 
degradation of our proteins in yeast cells is the reason why we were not able to detect interaction between 
proteins of the PMO complex by the two-hybrid system. 
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7.2 Detailed protocols 
 
7.2.1 Stock Solutions 
 
Buffers and solutions that we routinely used in molecular biology 
 
Water: 
It is recommended to keep using the same bottles for ddH2O, to avoid contamination with detergents. 
Preparation of “H2O certified storage bottles” is done as follows: Rinse bottle several times with 
ddH2O. Fill 1/3 of the volume and autoclave. Empty the autoclaved water, fill with fresh ddH2O and 
autoclave again. Keep using the same bottle (rinse before refilling and autoclaving only with 
ddH2O). 
 
Acids and bases (do not autoclave!!): 
NaOH (40 g/mol) 10M Dissolve 80 g of solid NaOH in 200 ml ddH20 
 2M Dissolve 16 g of solid NaOH in 200 ml ddH20 
HCl (36.5 g/mol) 1M Dilute 15 ml conc. HCl (11.6M) in 160 ml ddH20 
TCA 100% To a bottle containing 500 g of Trichloroacetic   
 acid, add 227 ml of H2O. The resulting solution    will contain 100% (w/v) 
TCA. 
Salt solutions 
NaCl (58.44 g/mol) 5M Dissolve 146.1 g of NaCl in 400 ml ddH2O. 
  Adjust the volume to 500 ml. Autoclave. 
 3M Dissolve 35 g of NaCl in 160 ml ddH2O. 
  Adjust the volume to 200 ml. Autoclave. 
KCl (74.56 g/mol) 1M Dissolve 37.3 g KCl in 400 ml ddH2O. 
  Adjust the volume to 500 ml. Autoclave. 
NaOAc pH=7.0 3M Dissolve 98.45 g of Natrium acetate anhydrous in 
(anhidrous.82.04 g/mol) 300 ml ddH2O. Adjust the pH with acetic acid   
 glacial. Adjust the volume to 400 ml, aliquote in 2   bottle of 200 ml each 
and autoclave  
MgCl2 1M Dissolve 40.66 g of MgCl2.6H2O in 160 ml (.6H20 203.31 
g/mol) ddH2O. Adjust the volume to 200 ml. Autoclave 
 
Buffers 
Tris.Cl pH=9, 8.5, 8.3, 8.0, 7.5 
(121.1 g/mol) 1M Dissolve 60.55 g Tris base in 400 ml ddH2O. 
  Adjust the pH with conc. HCl and ajust the  
  volume to 500 ml. Autoclave. Prepare only 100  
  ml if shorter time work planned. 
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Hepes pH=7.5 1M Dissolve 23.83 g of Hepes in 80 g ddH2O. 
(238.31 g/mol)  Adjust the pH with 10 M NaOH. Adjust the   
 volume to 100 ml. Filter sterilize. 
 
Chelators 
EDTA pH=8.0 0.5M "Dissolve" 93.1 g of Na2EDTA.2H2O in 400 ml 
  (Na2 salt, .2H2O 186,1 g/mol) ddH2O.  
  Adjust the pH with 10M NaOH.  
  Adjust  the voume to 500 ml. Autoclave.  
  Prepare 200 ml if shorter time planned. 
 
Pre-Mixed buffer solutions 
Make them in sterile containers (e.g autoclaved bottles or sterile plastic tubes) and with sterile 
components. In general it is not recommended to autoclave these mixes if they are made with pre-
autovclaved reagents.. 
10x TE 100 mM Tris pH=7.5 for 200 ml: 20 ml 1 M 
 10 mM EDTA pH=8.0  4 ml 0.5 M 
   
10x TNE 3 M NaCl for 200 ml: 120 ml 5 M 
 200 mM Tris pH=7.5  40 ml 1 M 
 100 mM EDTA  40 ml 0.5 M 
   
*10x TAE 400 mM Tris-acetate for 10 l 484 g Tris base 
   114.2 ml glacial acetic acid 
 10 mM EDTA  37.2 g Na2EDTA.2H2O 
*10x LOE 0.36 M Tris for 10 l 436 g Tris base 
 2.65 M NaH2PO4  414 g NaH2PO4.2H2O 
 10 mM EDTA  37.2 g Na2EDTA.2H2O 
*5x TBE 445 mM Tris for 10 l 540 g Tris base 
 445 mM boric acid  275 g boric acid 
 5 mM EDTA  18.6 g Na2EDTA.2H2O 
* electrophoresis buffers are kept in centralised, 10 L stocks 
 
Organic solvents 
 
H2O saturated Phenol: Melt phenol in its original container, supplemented with H2O (400 ml) and a few 
milligram of the radical scavenger 8-hydroxyquinoline at 50°C. Transfer into a brown glass bottle. 
This stock solution can be stored at 4°C for several months. Watch out, phenol is extremely 
aggressive, thus avoid mouth pipetting, aerosols etc. Keep adsorbing paper at hand. In case of spill 
on skin: wash first abundantly with water, then with soap. Generous rubbing with a fine cloth wetted 
with olive oil is the best cure to restore normal skin in minor phenol burns. 
Na/Tris saturated phenol working solution:  
to 200 ml of stock solution add:  20 ml ddH2O 
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 10 ml 1M Tris 8.0 
 10 ml 5M NaCl 
Mix well, can be stored for one month at room temperature in a dark bottle. 
1 Volume of this  working solution can be mixed with 1 vol. chloroform to obtain 
Phenol/Chloroform 1:1 solution (Exclusion of 10% water) 
Chloroform. Make an aliquot of 100-200 ml preferably in a brown bottle. 
100% ethanol. Store this working solution in a 100 or 200 ml bottle, well labelled. You can also fill a 
squirt plastic bottle (please rinse two or three times with clean alcohol before. Brown bottles should 
be preferred. When you use for rinsing pellets, be sure you do not go back with a pipette that has 
touched any of the samples or that may be sprayed by aerosols. DNA keeps for several years in 
EtOH!!!. 
80% ethanol. You prepare it by adding 20%  ddH2O. Preferably in brown bottle. It is not necessary to 
have a cold ethanol stock as suggested in many protocols. 
75% Ethanol. This is mostly used as a disinfectant in cell cultures. A good lab should have one or two 
squirt bottles of this in a conventional place. Do not squirt directly onto surface: rather do wet a 
paper with the alcohol and rub it on the surface. 
Detergents 
SDS  20% Dissolve 40 g of SDS in 150 ml ddH2O + 10 ml  
  1M Tris pH=8.0. Adjust the volume to 200 ml.   
Can be autoclaved (max 20 min) 
Titon X-100 10% Dissolve 20 g Triton X-100 in 160 ml ddH2O   
Adjust the volume to 200 ml. 
  Can be autoclaved.  
 
Miscellaneous 
DTT (154.5 g/mol) 1 M Dissolve 1.55 g of DTT in 10 ml ddH2O.   
 Dispense into 1 ml aliquots and store at -20°C. 
  NEVER AUTOCLAVE DTT! 
BSA 10 mg/ml Dissolve 100 mg BSA (fraction V) in 10 ml   
 ddH2O. Add 10 µl 1M DTT. 
  Dispense into 1 ml aliquots and store at -20°C. 
Ethidium bromide 10 mg/ml Dissolve 1 g EtBr in 100 ml ddH2O. Mix well.   
Wrap the bottle in aluminium foil and store in a    dark place. Do not make your 
own if one  
  bottle already exists in the same room! 
   
ATP 100 mM Dissolve 30 mg of ATP disodium salt in 800 µl  
(2NaCl  551.2 g/mol)  ddH2O. Adjust the pH to 7.0 with 0.1M NaOH. 
  (Ph Paper). Adjust the volume to 1 ml.  
  Dispense into small  aliquots and store at -20°C . 
 
Solutions for PAGE  
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40 % Acrylamide/ N,N'-Methylenbisacrylamide (19:1) stock solution (AA/MBAA), deionised: 
 
1) 380 g Acrylamide 
 20 g N,N'-Methylenebisacrylamide 
2) fill up to almost 1 litre with distilled H2O, mix until completely dissolved, then set  volume 
to 1 litre. 
3) add a big spoon of Amberlite MB-1 to remove ions, stir the solution 30 min. 
4) filtrate solution (paper filter), store in a dark bottle at 4 ˚C (for some months). 
 
20 % Acrylamide,1xTBE, 8 M Urea solution: 
 
1) In a GLASS beaker, add: 
 240.2 g Urea 
 250 ml 40 % AA/MBAA (19:1) stock solution 
 50 ml 10xTBE stock solution 
2) add distilled H2O to reach 450 ml, help dissolve the urea by heating (max 60 ˚C; on 
 magnetic strirrer heater)) 
3) adjust to 500 ml with H2O 
 
1xTBE, 8 M Urea solution: 
 
1) Add in a GLASS beaker: 
 240.2 g Urea 
 50 ml 10xTBE stock solution 
2) add distilled H2O to reach 450 ml, dissolve the urea by heating (≤ 60 ˚C) 
3) Adjust to 500 ml with H2O 
 
30 % Acrylamide/ N,N'-Methylene-bisacrylamide (29:1) stock solution: 
 
1) 290 g Acrylamide 
 10 g N,N'-Methylenebisacrylamide 
2) fill up with H2O to aprox. 950 ml, dissolve completely, then fill up to 1 litre 
3) deionise with a spoon Amberlite MB-1 stirring during half an hour 
4) filtrate solution (paper filter), store in a dark bottle at 4 ˚C (for some months). 
Polymerisation is done by adding 1/1000 vol TEMED and 1/100 Vol 10% APS 
 
Loading buffer 
 
Blue Juice (agarose or PAA native gels): 
 
80 % glycerol (v/v) 
20 % 0.5 M EDTA pH 8.0 
Bromophenoleblue, Xylenecyanol FF 
Used for standard horizontal agarose electrophoresis or native PAA EE. 
 
Blue Juice with SDS: 
 
80 % glycerol (v/v) 
20 % 0.5 M EDTA pH 8.0 
0.1 % SDS 
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Bromophenoleblue, Xylenecyanol FF 
Used for SCOPs, RNA gels, to disrupt DNA protein complexes (RNAase tests!) 
 
Formamide gel loading buffer 1: 
 
10 ml deionised formamide 
200 µl 0.5 M EDTA pH 8.0 
Bromophenoleblue, Xylenecyanol FF 
Used for sequencing, S1-mapping etc. 
 
Formamide gel loading buffer 2 : 
 
10 ml formamide 
50 µl 10 x TBE 
Bromophenoleblue, Xylenecyanol FF 
Used for sequencing, S1-mapping etc. 
 
Sample loading buffer for Northern Blot: 
 
50 % deionised formamide 
1 mM EDTA pH 8.0 
Bromophenoleblue, Xylenecyanol FF 
Used for Northern Blot (see related protocol) 
 
Sample loading buffer for alkaline gels: 
 
500 µl glycerol 
400 µl H2O 
15 µl  10 N NaOH 
Bromophenoleblue, Xylenecyanol FF (become purple-red because of high pH) 
Used for alkaline agarose gel electrophoresis 
 
7.2.2 Assays 
 
7.2.2.1 Vesicle Preperation 
 
Cell harvesting: 
- Remove the medium of cells that have reached 80 % confluence 
- Rinse the cells with 10 ml of PBS 
- Incubate the cells for about 2 min at 20°C in 5 ml of 0.25 % Trypsin and 0.1 % EDTA 
- Remove the Trypsin/EDTA containing the cells and collect in a sterile tube containing 5 ml of growth 
media 
- Centrifuge the cells for 10 min at 500 g 
- Discard the supernatant and resolve the cells carefully in 10 ml PBS 
- Centrifuge the cells for 10 min at 500 g 
- Remove PBS and add homogenisation buffer 
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Homogenisation: 
Solution A:  10.9% Saccharose (fresh!) 
(at 4° C !) 1 mM EDTA 
   0.3 mM PMSF 
   0.1 µg/ml Aprotinin (= 25 U/ml) 
   0.7 µg/ml Pepstatin 
The cells are homogenised at 20% (weight/volume) in Solution A by 5 strokes for 5 s with a Polytron 
1200 at full speed. After each stroke the homogenate is cooled for 50 s on ice. 
 
Preparation of synaptic vesicles 
Material : Biofuge 17 RS Ultracentrifuge Sorval OTD 65 B, rotor T 865 
 
Solutions:   A: 10.9% Saccharose (always fresh!) 
  (at 4° C !) 1 mM EDTA 
    0.3 mM PMSF 
    0.1 mg/ml Aprotinin (= 25 U/ml) 
    0.7 µg/ml Pepstatin 
 
To prepare 2 ml of A:    70 µl Pepstatin (= 1.4 µg) 
        10 µl Aprotinin (= 0.2 µg) 
        20 µl PMSF 30 mM 
        20 µl EDTA 100 mM 
             218 mg Saccharose 
   Always prepare a fresh solution ! 
 
   B:  30 mM PMSF in EtOH, dilute 1:100 in water just before   
 use 
 
To prepare Solution B (5 ml): 26 mg PMSF 
   Dissolve in 5 ml EtOH ⇒ 30 mM PMSF 
 
   C:  Tris/malate 10 mM pH 6.5 
 
To Prepare C (100 ml): 116 mg Maleate (Maleinsäure) 
     121 mg Tris 
     200  µl NaOH 4 N 
 Fill up to 100 ml with H2O, check if pH= 6.5   ⇒ 10 mM Tris/ maleic acid (=10x) 
 
   D:  MgCl2 . 6 H2O 100 mM 
 
To prepare D (50 ml): 1.017 g  MgCl2.6H2O ⇒ 100 mM 
 
100 mM EDTA (1 l): 29.225 g  EDTA 
 
All procedures are performed at 4°C 
- Centrifuge the cell-homogenate for 10 min at 1000g (precool to 4°C) 
- Centrifuge the supernatant for 13 min at 25000 g 
- Wash the pellet with solution A (Vortex)  and re centrifuge for 13 min at 25000 g (15000 rpm) 
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- Homogenise the pellet with 10 strokes in a glass homogenisator in 800 µl of solution B 
- Neutralise with 40 µl of solution C after 30 sec (This osmotic shock must be performed as fast as 
possible to ensure that the big vesicles are broken up and that their organelles and cytoplasm is 
evacuated without lysing the mitochondria) 
- Centrifuge the extract for 25 min at 20000 g (13000 rpm) 
- Add so much of solution D to the supernatant that you obtain a final concentration of 1 mM Mg2+ 
- Centrifuge for 45 min at 55000 g (21000 or 22000 rpm) 
- The supernatant (can be stored at -80°C)  is centrifuged for 4h at 140000 g (34000 rpm) 
- Take up the vesicles in 10 µl of solution A 
- Store the extracts in liquid nitrogen 
 
7.2.2.2 Cytoplasmic RNA Harvesting (if not Amplicon Kit is used) 
 
The aim of this protocol is the purification of cytoplasmic RNA from transfected or non transfected cells 
grown in culture. A yield between 50 and 300 µg from a confluent 10 cm Petri dish is expected (it 
depends on cell type). This protocol works fine for most established cell lines. 
Protocol: 
1) Rinse cells 2 times with 5 ml PBS (1x); add 2 ml Trypsin /EDTA (1x); incubate 10 minutes at room 
temperature. 
2) Collect cells with ice cold PBS and pool them in a 50 ml Falcon tube with 5 ml of medium, 
centrifuge for 5 min at 1000 g. Wash pellet once with 10 ml ice-cold PBS and re-centrifuge. From 
now on, work on ice.  
3) Aspirate the supernatant. Rapidly suspend pellets in 500 µl IsoHi* by pipetting up and down 3-4 
times. Transfer pelleted cells in a sterile Eppendorf. Incubate at least 5 min (no more than 7-8 min). 
Therefore, split your samples in convenient series (max 12 dishes per series) 
 *“IsoHi” lysis buffer: 140 mM NaCl 
 1.5 mM MgCl2 
 10 mM Tris.HCl pH 8.6 
 0.5 % Nonidet P-40 
 0.015% (w/v) Macaloid 
4) Spin 5 minutes at 13000 rpm, 4 oC. Next step to be conducted swiftly, have all prepared!!! 
5) Transfer the supernatants to fresh ED tubes containing 500 µl Phenol and 25 µl 10x TNE; mix well 
immediately.(The mix can be stored at -20oC before further processing.) Spin 10 min at 13 000 rpm 
at 4°C. After extraction with 1x Phenol transfer upper phase of supernatant to a fresh tube.  
6) Add 500 µl 1x Phenol/Chloroform1:1 and mix well. Spin 5 min at 13 000 rpm at 4°C. After 
extraction transfer upper phase of supernatant to a fresh tube.  
7) Add 500 µl 1x Chloroform (or put already before in fresh tube) and mix well. Spin 3 min at 13 000 
rpm at 4°C. After extraction  transfer upper phase of supernatant to a fresh tube. This last supernatant 
can be stored for several weeks at -20°C. 
You can work at RT, provided you do it rapidly. 
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OPTIONS: 
A) At stage 6,  RNA can be directly used for S1 nuclease mapping, It is recommended to verify 
concentrations by loading 4 µl RNA (about 1/100 of the prep) on a fresh 0.8% agarose minigel for 
semi-quantitation (SDS should be included in the loading buffer and in the electrophoresis buffer for 
best results). 
B) If more precise quantification is required, then proceed further to steps 8-10 
 
8) Precipitate by adding 1000 µl ethanol 100%. Mix. Let 30 minutes at -20oC, spin 15 minutes at 4 oC, 
13000 rpm. 
9) Remove the supernatant, rinse with first ice cold ethanol (100% / 80%) and dry tube for 5 min in a 
vacuumed desiccator (or let dry the inverted tube on a cleenex). 
10) Resuspend in 100 µl 1x TE (or smaller volumes if necessary). Measure OD. Label tubes. Store at -
20oC for short term (less than one week), or at -80oC for long term (more than a week) 
Measure the OD at 260 by diluting 1:100 in 1x TE (400 µl; OD value multiplied by 4 gives µg/µl 
 
7.2.2.3 Preparation of Agarose Gels 
 
Material: 
a) A glass plate with sharp edges, measuring 6 cm x 8 cm 
b) 1 mm thick Teflon combs. The theets width is 3 mm for analytical gels and ca. 1 cm for 
preparative gels. Distance between theets is 1 mm for the analytical and 2 mm for the preparative. 
The teeth depth is 5 mm for both types 
c) Agarose: there are two fundamental types: Type II is suited for analytical gels (about 1 Fr/gram). 
Type VII (usually called “low melting”) is suitable for preparative gels (better purified). 
d) Ethidium bromide: 10 mg/ml solution (see StockSol) 
e) Buffer: Two types of buffers are currently used: LOE (Loeninger) buffer and TAE buffer. LOE 
buffer is not suitable for preparative gels because the phosphate it contains may cause precipitation 
in the preparative steps or during ligation. 
 10x LOE: for 10 litres: 436. g Tris base 
 414. g NaH2PO4 ·2 H2O 
 37.2g Na2EDTA·2 H2O 
 
10xTAE: for 10 litres: 484 g Tris base 
 114.2 ml glacial acetic acid 
 37.2 g Na2EDTA.2H2O 
 
LOE buffer should be used at a end concentration of 0.6x 
 
Protocol: 
1) Dissolve 0.8 to 2 g of agarose in 100 ml of 1x TAE containing 0.5 µg/ml EtBr (100 µl EtBr stock 
in 2 litres; preparative gels) or in 0.6x LOE containing 1 µg/ml (200 µl EtBr stock in 2 litres; 
analytic gels). The gel concentration depends on the length of the bands you want to visualize. See 
Appendix) 
 Analytic gel (2%, 100 ml):   2 g Agarose (Mol. biol. grade) 
      10 µl Ethidium bromide (10 mg/ml) 
      99 ml 0.6 LOE 
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2) Boil the mixture in the oven until the agarose is completely dissolved. Sometimes it is necessary 
to boil two or three times (don't overboil, the solution spills out!).  
3) Let the agarose cool down. This can be speeded by putting the erlenmeyer under running water 
(keep shaking). desired temperature: 50-55 degrees (Criterion: Erlenmeyer can be touched by hands 
without serious burning). Meanwhile, adjust plates and combs such that comb is parallel to plate 
border (distance ca. 5 mm, distance from glass, ca 0.1 mm). You can use the combs in both 
orientation depending on the number of samples and on the separation you desire. In wide 
orientation it gives 20-22 slots, in narrow orientation, 16 slots. 
4) When the gel has reached the desired temperature (see 3), pour 16 ml (=1/3 cm3 per cm2) of gel 
on the plates with a 20 ml pipette. 
5) Let cool the gel to room temperature, then remove the comb. The gel can be stored in the 
refrigerator for several days in a box humidified at 100%. 
LOADING THE GEL 
 
6) Mix 5 µl of PCR product with 1 µl of "blue juice" and load it on the gel 
7) Load 4 µl of 100 bp ladder marker on gel, too. 
8)  Run gel at 100 V for 20 min, until lower blue line has reached the two third of the gel. 
 
Appendix: 
% Type II Agarose gel and resolution of linear DNA: 
0.8 %   700-11000 bp                2%   50-2000 bp 
 
7.2.2.4 Preparation of 5’ labelled S1-oligonucleotide probe: 
 
The aim of this protocol is to prepare a 5’ end-labelled oligonucleotide for S1 mapping. A specific 
radioactivity of ca 2 x 106 cpm/pmol is expected. 
 
Protocol: 
 
1) Prepare or use ready made 10 x T4 Polynucleotide Kinase Buffer: 
 10 x T4 Polynucleotide Kinase Buffer: 500 mM Tris.HCl pH 
7.6 
(Maniatis/Boehringer recipe) 100 mM MgCl2 
 50 mM DTT 
 1 mM Spermidine HCl 
 1 mM EDTA  
 
 Pipet in an ED-tube: 1 µl 10xPNK Buffer + 1 µl H2O 
 1 µl S1 Oligo (1 pmol/µl) 
 3 µl [γ-32P]-ATP (20 to 30 µCi)(3000 Ci/mMol, 10 mCi/ml;  
 Amerham) 
 3 µl H2O 
Start the reaction adding 2 µl T4 Polynucleotide Kinase (1 U/µl)(New England Biolabs). This 
mixture can be scaled up to larger amounts if required. 
 Incubate at RT 30 min to 1 h. Meanwhile prepare heating block at 100 
˚C and assembly gel. 
2) Preparative PAGE: Normally 8 % PAA/Urea (8M) gel is OK. For 
other probes use the appropriate gel percentage. Use comb with wide slots (2 cm). Prerun 30 min at 
25 W. 
3) Add 40 µl of formamide gel loading buffer to the reaction tube, mix, 
quickspin, denature 3 minutes at 100 ˚C in the heating block, the chill on ice. Alternatively, the 
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reaction can be first extracted with Phenol, precipitated and then load on freshly rinsed slot. 
4) Run the gel at 25 W . Stop the electrophoresis if possible before the 
free [32P]-γATP comes out from the gel into the lower buffer tank (in our case BPB dye has 
migrated ca 50 % of the gel length. 
5) Remove the ear-notched glass plate, cover gel with a Saran wrap (fix 
well behind the glass plate), put a tape onto the wrap beside and below the gel (for the easier 
positioning of the X-Ray film with magic marker) and expose a X-Ray film during 2-5 min in the 
dark room. Develop the film, carve out a window on the signal corresponding to kinased oligo and 
position the film onto the gel with heel of the pen marks. 
6) Excise gel slice with a scalpel blade, if necessary, crush the gel slice 
by centrifuging through a bottom-pierced ED tube placed inside an intact tube. Add 500 µl 
1xTNE/0.2 % SDS count total cpms, and incubate at 50 ˚C  30 min - 1 h.  
7) Chill on ice 5 min , spin at 4 ˚C 10 min, transfer carefully supernatant 
to a fresh tube (if kept in the cold, the SDS will precipitate and form a thin interphase between 
crushed gel and supernatant). Check eluted counts and compare with residual on crushed PAA. If 
necessary, repeat extraction from the crushed gel with a second aliquot of 1xTNE/0.2 % SDS. 
8) Pool elution aliquots; 1 x Phenol CHCl3, 1 x CHCl3 
9) Measure counts of an aliquot with ß-Counter (Cerenkov). Probe should have ca 2 Mio cpm/pmol. 
Yield of gel elution is around 70% 
Store at -20 ˚C. 
 
7.2.2.5 S1 MAPPING 
 
The aim of this protocol is the quantification of the amount of specific mRNAs classes in RNAs extracted 
from transfected cultured cells. The mRNA of interest is hybridised to an end-labelled single 
stranded DNA probe (S1 probe, see "S1 probe" protocol) and non hybridised regions are digested 
with S1 nuclease. Digestion products are run on a PAA gel. The resultant autoradiogram is analysed 
by densitrometric scanning. Reference: (Westin et al., 1987) 
 
Protocol: 
1) Mix in an ED tube: 
20-40 µg RNA 
50 kcpm-300 kcpm S1 probe (depending on specific activity) 
in a total volume ranging between 100 and 300 µl of 1x TNE.(Add 1x TNE where necessary). 
Briefly check uniformity of counts with Geiger counter  
2) Add 3 volumes ethanol. Mix well by inverting tubes. Incubate 15-30 minutes at -20oC, spin at least 
15 minutes at 4oC, 13 krpm. Remove the supernatant, rinse the pellet with ethanol, dry the tube 
inverted on a cleenex. 
3) Add 16 µl Formamide (Fluka), mix well (it takes several minutes of work). 
  Prepare 5x Hybridisation buffer: 
  200mM PIPES pH 6.4 
 2M NaCl 
 25mM EDTA pH 8 
 Add 4 µl of 5x Hybridisation buffer, mix, spin to collect liquid. 
4) Denature 5 minutes at 100 oC, transfer tubes to a 30oC bath and incubate at least 4 hours. During 
this incubation it is recommended to prepare the gel for the analysis and two series of labelled tubes 
5) Prepare 10x S1 digest buffer: 
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 2.5M NaCl 
0,3 M NaOAc pH 4.6 
10 mM ZnSO4  
For S1 digestion, prepare the following cocktail (For n samples, mix on ice): 
-270 µl x (n+1) ice-cold water 
-30 µl x (n+1) S1 digest buffer 
-3 µg x(n+1) calf thymus DNA (sonicated, average size ca 400 bp; freshly  denatured 5 min at 100 
˚C), mix well 
-150 units x (n+1) S1 nuclease (Sigma) 
Mix very well the components (beware of enzyme-glycerol sedimenting at bottom!) 
6) Add 300 µl of the digest cocktail to each sample, mix well by pipetting up and down. Put 
immediately on ice. 
7) Warm samples shortly at 37oC for 10-20 seconds, centrifuge briefly to collect liquid. 
8) Incubate 1 hour at RT. 
9) Transfer the reaction into ED tubes containing 300 µl PC+ 15 µl TNE; vortex briefly, centrifuge 5 
minutes at 13 krpm, RT. IMPORTANT: do not add PC to S1 digestion tubes! 
10) Transfer the supernatants into new tubes, add 900 µl ethanol, measure the counts (Cerenkov input 
cpm). 
11) Incubate at least 15 minutes on ice or at -20oC. Centrifuge 20 minutes at 13 krpm, 4oC. Discard the 
supernatant. Rinse 1x with ethanol, dry on a cleenex. 
12) Add 5 or 10 µl of Formamide loading buffer (vol depends on gel size and shape), count Cerenkov 
the S1-resistant cpm. Centrifuge briefly, boil 5 minutes and load on the denaturing gel. For β-globin 
S1 probe use 8% or 10% PAA 19:1 with 8M Urea. 
13) Count residual radioactivity in emptied tubes. 
Remarks 
-Point 4: For probes different from β-globin the temperature may vary (up to 65 oC) 
-Point 9: a certain amount of the ss DNA probe sticks to plastic and is only partially digested by S1. If PC 
is added to reaction tubes then adsorbed material is released and gives a high background of partially 
digested signals. 
 
7.2.2.6 Klenow DNA polymerase treatment: 
 
Aim: fill up 5'-overhangs to create blunt ends 
 
Buffer: 10 mM Tris.HCl pH 7.5, 5 mM MgCl2, 7.5 mM DTT 
 Klenow is also active in the standard NEB or in L, H and M salt buffers  
 
Conditions: DNA at ca 50 µg/ml in Klenow buffer or restriction buffer; 
 dNTPs: each 200 µM (from 10 or 5 mM stock) 
 use 1 U of enzyme per µg DNA 
 
Reaction time:  30 min at 25 ˚C. 
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Stop reaction adding 1/10 vol of 10xTNE (if necessary raise volume in order to allow the following 
extraction steps but always adjust the end concentrations to 10 mM EDTA, 300 mM NaCl using 
10xTNE) 
Extract 1xPh, 1xPh / CHCl3, 1xCHCl3, precipitate with 3 vol. of EtOH  
 
7.2.2.7 T4 DNA polymerase treatment: 
 
Aim: removal of 3'-overhangs to create blunt ends 
 fill -in of 5'-overhangs 
 
Buffer: 10 mM Tris.HCl pH 7.9, 10 mM MgCl2, 50 mM NaCl, 1 mM DTT 
 supplement with 50 µg/ ml acetylated BSA 
 T4 DNA polymerase is also active in the standard restriction-buffers. 
 
Conditions: DNA at ca 50 µg/ml in T4 DNA pol- buffer or NEB-buffer; 
 dNTPs: each 200 µM (from 10 or 5 mM stock) 
 use 1 U of enzyme per µg DNA 
 
Reaction time:  30 min at 16 ˚C. 
Stop reaction adding 1/10 vol of 10xTNE (if necessary raise volume in order to allow the following 
extraction steps but always adjust the end concentrations to 10 mM EDTA, 300 mM NaCl using 
10xTNE). Alternatively, heat inactivate 10 min. at 75 ˚C. 
Extract 1xPh, 1xPh / CHCl3, 1xCHCl3, precipitate with 3 vol. of EtOH  
 
7.2.2.8 Dilution of T4 Ligase 
 
Method: 
Prepare 10x Ligase Storage Buffer Salts: 
 
100 mM Tris.HCl pH 7.5 
500 mM KCl 
10 mM DTT 
1 mM EDTA 
 
filter 0.2 µm,  
store at ≤ 4 ˚C / -20 ˚C 
 
Prepare a 1x Storage Buffer with 50 % glycerol content and 100 µg/ml BSA ( can also be frozen) from 
the solutions above and use it to dilute T4 DNA Ligase  
Make some aliquots of this diluted ligase and store at -20 ˚C. 
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7.2.2.9 Ligation in Low Melting Agarose 
 
This is a method for the in agarose  ligation of DNA fragments separated on preparative "low 
melting" agarose (type V, e.g. FMC SeaPlaque) gels without further purification steps. The 
procedure is based on the fact that this kind of agarose can be melted at 65 ˚C and stays in the liquid 
state at 37 ˚C. 
 
Protocol: 
 
1) Separate the DNA restriction fragments on a "low melting" agarose gel Low melting agarose (type 
V, FMC Bioproducts SeaPlaque , Cat.Nr. 50102) of convenient percentage with 1xTAE buffer and 
0.5 µg/ml ethidium bromide1 in the preparative gel and in the running buffer. 
Load ca 1 µg of total DNA per lane for a plasmid of 3 kb like an empty cloning vector (Bluescript) 
or proportionally more DNA for bigger plasmids. 
2) Take a picture of the gel 2, mark the relevant DNA bands with a pen. Cut out the interesting bands 
with a clean scalpel blade with the aid of a UV hand lamp or on the UV transilluminator (don't 
expose too long to UV light!) and transfer them into sterile ED tubes 3. Keep on ice or freeze if not 
used at that time point. 
3) Meanwhile set one heating block on 65 ˚C and the other on 37 ˚C. Put a ED tube with 500 µl of 
ddH2O in the block at 65 ˚C. 
Prepare enough ED tubes as required for the ligation and all necessary pos. and neg. controls 4. 
 
 Prepare Ligation buffers (can be made as stock solutions): 
 
 10 x A  10 x B 
 10 mM ATP  500 mM Tris.HCl pH 7.5 
 100 mM DTT  100 mM MgCl2 
   2 mg/ml BSA (Fraction V) 
 
 Pipet into each tubes  7.5 µl 10xA, 7.5 µl 10xB and 25 µl ddH2O (should be made poolwise!). We 
assume that 5 µl of each needed DNA fragment in form of melted agarose and 1-2 µl of T4 DNA 
Ligase will be added into the tube later. If the amount of DNA in the excised bands is not exactly 
known, other volumes have to be pipetted based on the estimation made with the fluorescence 
intensity. It is very useful to have a detailed table 5 for the ligation components and their required 
amounts. Generally the total volume of the ligation is about 50 µl.6 Keep on ice until needed. 
However, there can be some flexibility in the final volume, depending on how many fragments will 
be present in a particular tube 5. 
4) Melt the excised DNA bands in the heating block at 65 ˚C (for higher percentage gels (e.g. 2%) some 
degrees more are needed to completely melt the agarose), mix well with vortexer, quick spin and 
keep in the heating block.7 
Put the tubes with the prepipetted buffers and ddH2O in the heating block at 37 ˚C. 
Prewarm each pipette tip in the water-containing ED tube at 65 ˚C aspirating up and down, pipet 
DNA fragments where required (following the mentioned table) into the tubes at 37 ˚C. The melted 
agarose will remain liquid until kept at this temperature. 
5) While keeping the tubes at 37 ˚C, add 1-2 µl of ligase at 0.2 U/µl or 1 µl of ligase at 1 U/µl T4 DNA 
Ligase (Pharmacia 27-0870-04, appropriately diluted to 0.2 or 1.0 Weiss U/ µl.), depending on 
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complexity of the ligation 8 (keep the enzyme in a cooling block (-20˚C)! 
Mix well, quick spin, incubate at 4 ˚C, 16°C or RT for few hours to overnight, depending on 
complexity of the ligation 8. 
6) For transformation of bacteria: melt ligation again at 65 ˚C before pipetting 10 µl to an aliquot of 
CaCl2 competent bacteria on ice (see protocol BacTransfo). 
 
Remarks 
1 this is half the amount of ethidium bromide normally used in analytical gels. TAE should be used as 
running buffer instead of LOE to avoid the presence of phosphate in the ligation reaction. The 
running buffer in the electrophoresis tank should be used only once due to the reduced buffer 
capacity of TAE and to avoid contamination. 
2 A picture of the gel is essential in the case where the digested DNAs were not loaded in equimolar 
amount on the preparative gel. The relative amounts of the fragments to be ligated can be estimated 
proportionally to the intensity of the bands on the gel picture (provided that the picture is not 
overexposed). 
3 the approximate volume of an excised band is 100 µl. Otherwise the volume can be adjusted with 
ddH2O comparing with a second ED tube containing 100 µl of H2O. 
4 One essential control is for example the DNA-fragment encoding the antibiotic resistance gene alone 
(with or without enzymatic treatment with calf intestinal phosphatase (CIP)), but other combinations 
of fragments are sometimes useful to determine the reason of the presence of background in the 
ligation. This, however, is mostly depending on the adopted cloning strategy. 
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5 Example: 
558  BamH I
 HinD III
  Mun I
  PflM I
 Xho I
pEXAMPLEA
B
C
DAmpR
 
 A Plasmid 1 XhoI-HindIII 2584 bp 
 B Plasmid 2 XhoI-PflMI 642 bp 
 C Plasmid 3 PflMI-MunI 1312 bp 
 D Plasmid 4 MunI-HindIII 978 bp 
 
 A+B+C+D = pEXAMPLE 
 
 Fragment        
Nr A B C D 10xA 
10xB 
H2O Product 
Name 
Nr of 
colonies 
1 5 µl 8 µl 5 µl 10 µl 5 µl 
5 µl 
12 µl pEXAMPLE 226 
2 5 µl    5 µl 
5 µl 
35 µl neg. 
control 1 
54 
3 5 µl 8 µl 5 µl  5 µl 
5 µl 
25 µl neg. 
control 2 
96 
 
  
6 The important parameters in a ligation are: 
 
 the equimolarity of each DNA fragment 
 a concentration < 0.5 fmol/µl of each fragment 
 
Assuming the presence of 1µg of a fragment of 3 kb (e.g. corresponding to 0.5 pmol of linearised 
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cloning vector) in an excised band of 100 µl volume, the contribution of 5 µl of melted agarose of 
this fragment into 50 µl end ligation volume leads to a final concentration of 0.5 fmol/µl, so much as 
required; higher concentrations lead to the formation of multimers, too low concentrations 
preferentially lead to intramolecular reaction (e.g. vector closing himself). 
7 The melted agarose can be stored at -20 ˚C and eventually used again. However, not more than once 
again, due to the high mutagenesis risk heating in presence of ethidium bromide. 
8 General rules:  
 
 Ligations with overhangs(oh):  16 ˚C (better hybridisation) 
 0.4 U ligase/ tube enough 
 3-4 hours enough 
Ligations with only blunt ends: RT (actually irrelevant for "hybridisation"). 
 0.4 - 1 U ligase/tube 
 overnight 
Ligations with mixed ends: Temperature gradient on melting ice in beaker at  RT (oh 
ligate first, then blunts). 
 0.4- 1 U ligase/tube 
 Overnight 
 
High number of fragments (>5) to be ligated also require some more ligase than normally (1 U/tube). 
 
7.2.2.10 Cloning with oligonucleotides 
 
1) Dissolve oligonucleotides (0.01 or 0.04 µmol synthesis scale) in 200 µl of TE or more. 
2) Measure concentration of this stock dissolving 10 µl oligonucleotide into 490 µl TE according to this 
formula: 
 
 for oligos below 40 NT: 1OD~30µg/ml (dilute 1/30 or multiple thereof) 
 for oligos above 50 NT: 1OD~40 µg/ml (dilute 1:25 or multiple thereof) 
 OD has only a sense if the oligo is reasonably pure. In case of doubts purify oligos by gel 
electrophoresis (see OligoPurif) 
3) Mix 100 pmol of each oligonucleotide (sense + antisense) in a total volume of 40 µl of TE. Heat 
shortly at 100 ˚C and letting cool down to 37 ˚C. (if oligos are insufficiently concentrated, volume 
can be scaled up to 80 µl 
4) Add 10 µl of 5xligase buffer (A+B 1:1; see DNALigation), keep on ice; add 50 µl 1x ligase buffer 
 This solution (Co)has a concentration of 1 pmol/µl. 
5) Generally the molarity in ligations is kept  0.5 fmol/µl ( this means 25 fmol of a fragment in a 50 µl-
reaction): 
 Make dilutions in 1 x Ligation Buffer ( 1xLiB)of the annealed oligos in order to obtain the 10-fold, 
3-fold, 1-fold, 0.3-fold molar amount of oligos in the ligations and keep them on ice. 
 e.g.: 10 µl Co + 190 µl 1xLB → 50 fmol /µl  (C1) 
  30 µl C1 + 70 µl 1xLB → 15 fmol /µl  (C2) 
  10 µl C1 + 90 µl 1xLB → 5 fmol /µl  (C3) 
  10 µl C2 + 90 µl 1xLB → 1.5 fmol /µl  (C4) 
6) Use 5 µl of solution C1-C4 for 4 different ligations to titrate the best result. 
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7.2.2.11 Bacterial agar dishes 
 
Protocol: 
 
1) Dissolve 25 g LB-Broth Base (Gibco 12780-052, 500g) per each litre of distilled H2O. 
2) Add 13 g (in general 1.25 %) of agar bacteriological (Gibco 30391-023, 500 g) per litre of LB-
medium. 
3) Autoclave. 
4) Let cool down to ca 50 ˚C, then add 1 ml (2 ml if dishes shall be kept longer than 3 weeks) of 
ampicilline stock solution* for each litre of LB/agar-solution. Mix well. 
 *Ampicilline stock solution at 50 mg/ml in H2O (Ampicilline from Sigma, A0166, 100 g or 
Boehringer 835269, 50 g ). This is a 1000x solution. Store at -20 ˚C 
5) Distribute about 20 ml of this solution into each bacteria dish. 
6) Let solidify and partly dry (at least 2 hrs to avoid humidity condensation problems), then store in 
plastic bags at 4 ˚C. 
 
-Ampicillin: add 1 ml stock solution (1000x) for each litre of LB/agar 
=> agar dish supplemented with 50 µg/ml (100 µg/ml) ampicillin 
-X-Gal and IPTG can be plated out on solidified Amp/Tet dishes (40 µl of each stock solution** for each 
dish) or also added to the liquefied LB/agar at 50 ˚C. Add 40 µl of each stock for 3 ml of top agar. 
 **IPTG stock solution, 20 mg/ml in H2O (Bachem Q-1280); X-Gal stock solution, 20 mg/ml in 
N,N'-DMF (Biofinex B80C) 
 
7.2.2.12 Transformation of bacteria 
 
Protocol: 
 
1) Prepare for each DNA to be transfected into the bacteria a ED-tube on ice. Prepare an additional ED-
tube for the transformation positive control. 
2) Resuspend well the competent bacteria using a micropipette, distribute 100 µl (≈ 108 bacteria) in the 
precooled, appropriately labelled ED-tubes, keep tubes on ice. 
3) Add 25 µl ligation mix (liquefy if low-melting agar!)  to the bacteria, mix well with the pipette 
(never use vortexer). 
4) Incubate on ice 5 min. 
Meanwhile distribute the bacterial dishes open on the desk to allow them to dry (this is necessary to 
evaporate condensation water that accumulates during storage at 4 ˚C ). 
Also put a L-Broth  culture flask into the 46 ˚C water bath to prewarm it. 
5) First temperature shock:  a) put the tubes 3 min into the 37 ˚C water bath 
    b) let stand ca 5 min on ice 
6) Second temperature shock: Pipet ca 1 ml of prewarmed L-Broth to the bacteria tubes using 
 a glass pipette. (The 50 ˚C warm L-Broth should be allowed to 
 cool down in the pipette to ca 40 ˚C otherwise the bacteria will 
 die). Close tube and mix well (invert , don't vortex). 
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7) Incubate ca 5 min. in the 37 ˚C water bath (mix occasionally). During this time bacteria will recover 
and start synthesising resistance genes, there should be no more than one duplication. 
8) Prepare Pasteur pipettes for bacteria plating: Melt the end of the Pasteur pipettes on the 
Bunsenburner flame to close the hole, then melt the pipette in order to create a plating tool like 
depicted in the following illustration. 
  
9) Spin down the bacteria in a ED-centrifuge for about 20 seconds, aspirate all supernatant but ca 100 
µl (Sterile Pasteur) 
10) Resuspend the bacteria well (up and down with Pasteur), plate 50 µl onto an appropriate agar plate 
and store the other 50 µl at -20°C 
11) Put the dishes turned upside down into a 37 ˚C incubator and incubate overnight. 
12) Colonies shall be clearly visible after 14-16 hr. If the density of colonies cannot be anticipated, it is 
recommended to plate the transformed bacteria at different densities. 
 
7.2.2.13 SCOP-Assay 
The aim of this protocol is to quickly analyse the size of plasmid DNA from a large number of 
transformed bacterial colonies or streaks (SCOP= Single COlony Prep). 
Protocol: 
1) Fill 15 µl LETR in labelled Eppendorf tubes, put on ice. 
2)  Prepare LETR, 15 µl pro colony to analize: 
  Lysozyme 2 mg/ml 
 EDTA pH 8 100 mM 
 Tris pH 8 50 mM 
 RNaseA (DNase free) 20 mg/ml in H2O stock  0.1 mg/ml 
 
Dissolve first lysozyme in H2O and then add the rest in the order shown. Can be stored at -20°C for 
several months. Avoid repeated Thawing. 
 Gently aspirate entire colony or 0.5 cm length of a streak with 20 µl pipette and resuspend in the 
LETR. Incubate 20-30 min. at RT . REMARK: Be sure you labeled your streak, or if you use a 
colony then save a streak of it with the yellow tip onto a fresh plate prior to resuspending in LETR. 
3) Add one drop of phenol to each tube, mix, centrifuge about 1 min. 
4) Take 3-5 µl supernatant and load onto gel together with comparative markers (plasmid DNA diluted 
to ca. 5 ng/µl). 
5) Run gel, take picture, compare with marker plasmids. 
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7.2.2.14 Minipreparation of DNA (if not performed by Spincolumn -Kits) 
 
The aim of this protocol is to purifiy plasmid DNA from transformed small bacterial cultures. 
 
Protocol: 
A] Growth 
1) Inoculate with one bacterial colony or streak 5 ml LB medium supplemented with 10µl ampicillin 
(50 mg/ml in H2O = 50x-100x solution) 
2) Grow the culture at 37°C in the shaker for 18-24 h (up to 36 h). 
 
B] Lysis & extraction 
1) Centrifuge the bacteria for 15 min at 5000 rpm.. 
2) Resuspend the pellet in 500 µl of ice cold LETR. 
LETR, 500µl pro 5 ml culture: 
 Lysozyme 2 mg/ml 
 EDTA pH 8 100 mM 
 Tris pH 8 50 mM 
 DNase-free RNaseA (20 mg/ml) 0.1 mg/ml 
Dissolve first lysozyme in H2O and then add the rest in the order shown. Can be stored at -20°C for 
several months. Do not thaw repeatedly. 
 Mix well. Transfer into Eppendorf tube, Incubate 20-30 min at RT. 
3) Add 25 µl 10 % triton X-100, mix gently. Incubate for further 5 min. at RT (optional). 
4) Centrifuge 10-15 min. in Eppendorf centrifuge (13 kRPM) 
5) Remove the pellet with the P20 pipette loaded with a yellow tip. 
6) Extract 1x phenol (centrifuge 15 min), 1x phenol:chloroform 1:1 (centrifuge 10 min), 1x chloroform 
(centrifuge 5 min) (500 µl each, transfer acqueous onto fresh tube each time) 
7) Adjust the volume to 500 µl with water, add 50 µl 3M NaCl and 300 µl isopropanol. Incubate 10 
min at RT. 
8) Centrifuge 10 min. in Eppendorf centrifuge at RT (13 kRPM). 
9) Discard supernatant, wash pellet 1x 80% EtOH and 1x 100% EtOH. Let dry . 
10) Resuspend the DNA in 50-100 µl 1x TE. 
 
 
C] If sequencing is foreseen 
1) Dilute to 300 µl. Add to your DNA 1 volume of 13% PEG6000/1.6M NaCl. Incubate 1 h on ice 
2) Centrifuge 15-20 min in Eppendorf centrifuge at 4°C (13kRPM) 
3) Discard the supernatant and rinse the pellet with 80% EtOH. Spin another 5 min. 
4) Discard the alcohol; let dry the pellet and resuspend it in 30-50 µl 1x TE. 
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7.2.2.15 Plasmid Preparation (if not performed with Midipreps of Qiagen) 
 
The aim of this protocol is to purifiy plasmid DNA from transformed bacterial cultures. The amount of 
DNA recovered should be ~ 500-1000ug/100 ml culture (for a pUC-like plasmid). DNA can be 
further purified by CsCl (see WhiteCes). 
 
Protocol: 
A] Growth 
1) Inoculate with one big bacterial colony or streak 100 ml LB medium supplemented with 200 ml 
ampicillin (50 mg/ml in H2O = 50x-100x solution). 
2) Grow the culture at 37°C in the shaker for 18-24 h (better 36-48 h). Optional: let stand the grown 
culture at 4°C for 24-72 h. (improves yield by a factor of 2). 
 
B] Lysis 
1) Centrifuge bacteria in a 100 ml tube at 3000-4000 RPM for 15-20 min. at 4°C (Hermle). (Optional: 
The pellet can be stored at -20°C ) 
2) Prepare LETR, 6-7 ml pro 100 ml culture: 
 Lysozyme 2 mg/ml 
 EDTA pH 8 100 mM 
 Tris pH 8 50 mM 
 DNase free RNaseA (20 mg/ml) 0.1 mg/ml 
Dissolve first lysozyme in H2O and then add the rest in the order shown. Can be stored at -20°C for 
several months 
 Resuspend the pellet in 6-7 ml of ice cold LETR (if frozen pellet is used, do not allow to thaw prior 
to LETR addition). Mix well. Transfer into an Oak Ridge tube. Incubate ~ 30 min at RT (suspension 
should get slightly viscous). 
3) Add 100 µl 10 % triton X-100, mix (2-3 strong strokes, rotate). Should get very viscous. Incubate for 
further 10-30 min. 
4) Centrifuge at 10000-15000 RPM for 30-40 min at 4°C in SS-34 rotor (or Hermle) Transfer the clear 
supernatant to a fresh corex tube or another suitable tube for organicextractions 
 
C] Purification 
All manipulations at room temperature! 
1) Extract 1x1 vol. phenol. If you don't foresee a caesium chloride purification then extract also 1x1 
vol. phenol/chloroform and 1x1 vol. chloroform (You can use 15 ml polypropilene Falcon tubes or 
corex tubes sealed with Parafilm M (phenol) or with Dura Seal (phenol:chloroform & chloroform).  
2) Adjust the volume to 7 ml. Add 0.7 ml 3M NaCl (3M NaOAc can also be used), add 4.2 ml 
isopropanol. Mix well, incubate ~10 min at RT and spin at 10000 RPM for 15-20 min in HB-4 rotors 
(not more than 9000 RPM if you use snap cap tubes!).  
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3) Discard the supernatant and rinse the pellet carefully with 80% ethanol and with 100% ethanol. Put 
the tube inverted on a Kleenex until the DNA pellet is dry (you can carefully help drying with a tiny 
jet of compressed air or N2). 
4) Resuspend the pellet in  a) 0.5-1 ml TE if you don't  foresee CsCl or  
 b) 1.1 ml TE if you plan a CsCl purification. 
 (-> WhiteCes) 
 
7.2.2.16 CsCl Plasmid Purification: White Caesium (6 ml) 
 
The aim of this protocol is to obtain highly purified plasmid DNA from a 100-200 ml culture preparation.  
 
Equipment:  
6 ml Kontron polycarbonate tubes with crimper system, 12 ml disposable polystyrene or polypropylene 
tubes, 15 ml corex tubes . 
Kontron Centrikon T-1190 ultracentrifuge with Sorvall T-865 rotor and teflon adapters (with caps), 
(Alternatively, Sorwall ultracentrifuge with same rotor); Selecta angular centrifuge, Sorvall 
centrifuge with HB-4 rotor at RT.  
2 ml syringes loaded with 18 gauge needles (pink), long wave UV transilluminator or hand-held lamp, 
Quartz cuvettes and spectrophotometer, scale. 
 
Protocol: 
1) Mix in a 12 ml PP tube: 4.35 ml CsCl stock, 1.00 ml DNA, 5 µl of diluted EtBr. Transfer into a 6 ml 
Kontron tube (fill the remaining volume with isoionic CsCl solution obtained by mixing 1 ml TE 
with 4.35 ml CsCl stock). Check weight on the scale. Seal the tubes with the crimper. 
CsCl stock Solution: dissolve 200 g CsCl in 120 ml of 20 mM Tris pH 8 / 5 mM EDTA 
Final vol. should be ~172 ml; refractive index between 1.4135 and 1.4142 
2) Ultracentrifuge at 45000 RPM for 20-24 h at 22°C in T-865 rotor. Use the option "Slow". Remove 
tubes carefully. Inspect on top of Long wave UV or hand-held lamp (360 nm, protect eyes in either 
cases, avoid prolonged illumination of DNA+EtBr.) 
3) Punch the top of the tube with a syringe and aspirate the fluorescent band (monitor work with the 
UV hand-led lamp or on the transilluminator) by puncturing under the band with the syringe. 
Aspirated volume should be ~1 ml or less. Transfer into a 12 ml polystirene tube. 
4) Extract 2x2 vol. isoamyl alcohol saturated with H2O (=isopentyl alcohol; =3-methyl-1-
butanol).(Watch out! Organic phase this time is above!). (Vortex well and spin 2-3 min). Monitor 
extraction by inspecting under UV, and repeat as often as necessary. Transfer the acqueous phase 
into a 15 ml corex or into a snap cap tube 
5) Add H2O to 6 ml, add 6 ml isopropanol, mix and incubate up to 30 min at RT. Centrifuge at 11000 
RPM (9000 RPM if snap-cap plastic Falcon tube) for 20 min at RT in HB-4 rotor. 
6) Discard the supernatant and rinse the walls and pellet carefully but throughly with 80% ethanol and 
(now be x-careful, since pelllet usually detaches) with 100% ethanol. Put the tube inverted or side-
side on a cleenex until the DNA pellet is dry. 
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7) Resuspend in 400 µl TE. Transfer into an Eppendorf tube, add 40 µl 3M NaCl, fill the tube with 
ethanol and mix. A white clump of DNA should appear. Incubate a few minutes at RT. 
8) Spin 5 min (or even less, depending on the amount of DNA). Discard supernatant and wash the DNA 
pellet once with 80% ethanol and once with 100% ethanol. Put the tube inverted on a Kleenex until 
the DNA pellet is dry. 
9) Resuspend the DNA in 400-500 µl TE (be patient) and calculate the concentration by measuring the 
OD260 (typically you dilute 10 µl of the stock DNA in TE to 400 µl. The OD260 value x2 gives 
your stock DNA concentration in µg/µl). Use quartz cuvette! 
 
7.2.2.17 Lipofection (using DOTMA) 
 
This protocol is to transfect 10 cm diameter cell culture dishes1 by the reagent DOTMA (PNAS USA 
84:7413-7417 (1987)), which can be easily synthesised by an organic chemist. 
 
MATERIALS: 
 15 ml or 6 ml Falcon Snap Cap tubes (and no other kind of plastics) 
Optimem PSG (Gibco BRL) 
DOTMA Solution (1 mg/ml, diluted from stock 10 mg/ml) in ddH20 or Lipofectin™, 
LipofectAMIN™, LipofectACE™  or other lipofection reagents from commercial suppliers (Gibco 
BRL, Boehringer) 
 
PROTOCOL: 
 
All solutions must be at room temperature in the sterile hood. 
 
1)Prepare a serie of 15 ml snap cap tubes containing the DNA (5-20 µg in up to 100 µl) 
2)Prepare a second serie of 15 ml snap cap tubes containing 80 µl DOTMA (1 mg/ml). 
(40 µl for Lipofectin from Gibco BRL (1 mg/ml)) 
3) Add 2 ml of Optimem to all tubes, mix heavily by finger flicking, let stand at least 10 min. 
4)Meanwhile rinse the cells once with TBS. 
5)Combine the tubes containing DNA and DOTMA by pouring from one tube to the other, mix 
heavily by finger flicking, let stand for at least 10 min. 
6)Meanwhile rinse the culture dishes once with TBS, then aspirate completely and pour the DNA-
DOTMA-Optimem mix onto the cells while gently moving the dish. 
7) Incubate 3-4 hours at 37 ˚C / 5 % CO2. 
8)Aspirate lipofection medium, rinse dishes with TBS, add medium appropriately complemented for 
the particular cell line used. 
9) Incubate 36-48 hrs at 37 ˚C / 5 % CO2, then proceed as required for your particular experiment 
(harvest, fix, stain etc.) 
 
Remarks 
 
1 For 5 cm diameter dishes use half of the volumes. 
2Recommended cell density: for RNA mapping:30-40 % confluent 
for protein expression: 70-80 % confluent 
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Calcium and Phosphate Mixes for DNA Transfection in cell cultures 
 
The aim of this protocol is to describe a DNA-calcium phosphate co-precipitation method to 
transfect eukaryotic adherent cells. 
 
Protocol: 
A) 4x Ca-Mix (500 ml) 0.5 M CaCl2  [CaCl2.2H2O: Mr: 147.02] 
 0.05 M Hepes pH=7.05 
 
fill a 500 ml bottle with 500 ml ddH2O. Put a mark on it to recognise the volume. 
Discard 50-100 ml of the water. 
Dissolve 36.76 g of CaCl2.2H2O in the bottle and autoclave. 
Add 25 ml 1 M Hepes pH=7.05 [c]. Adjust the volume with autoclaved ddH2O. 
Store at 4°C 
B) 2x P-Mix (1 liter)0.75 mM Na2HPO4 
 0.75 mM NaH2PO 
 0.05 M Hepes pH=7.0 
 0.28 M NaCl 
 
Fill a 1000 ml bottle with 1000 ml ddH2O. Put a mark on it to recognise the volume. 
Discard ca. 200 ml of water and autoclave. 
Add: 2.5 ml 400x Phophate solution (0.3 M Na2HPO4, 0.3 M NaH2PO4) 
 100 ml 2.8 M NaCl NaCl solution (=10x) 
 50 ml 1 M Hepes pH=7.05  
Adjust the volume with autoclaved ddH2O 
Store at 4°C. 
D) Test the solutions! 
Test the solutions with Ca and Pi aliquots at room temperature. Transfect  10 cm diameter cell 
culture (NB41A3) or dishes with 10 ml CO2 equilibrated medium. 
Prepare several samples with 20 µg of CsCl purified plasmid DNA ( e.g. OVEC) and 5 µg carrier DNA. 
Dilute the DNAs with TE to 50 µl. 
standard test: to three samples: Add H2O to 250 µl, add 250 4x Ca-Mix (RT!).  
Wait 5 min. Add 500 µl of 2x P-Mix (RT!) and pour onto cells after 5, 10 and 20 minutes incubation. 
Observe the precipitates (take about 30-40 min to be at bottom). A value between 1 and 10 (see 
below) is acceptable, much larger or much finer precipitates will give erratic transfections. 
Scale of precipitate is: 10 if diameter of crystals is equivalent to diameter of average nucleoli; values 
such as 5, 2, 1 and <1 are indicative of smaller precipitates; value of 20, 50 or 100 indicate 
proportionately larger crystals. 
The 2x P-Mix is conceived in such a way that it should give rather fine crystals (scale 1-10) in 10 min 
incubation. If they are too large even at 5 min incubation then start from scratch or inform a more 
experienced colleague. If the precipitate is <1, then add 1/4000 to 1/2000 vol of 400x phosphate 
solution to an aliquot. Test again until satisfactory. Then supplement rest of solution with equivalent 
amounts of 400x Pi. Test again and store if ok. 
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